Psychiatric Solutions, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-K

(Mark One)


þ		Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

for the fiscal year ended December 31, 2007


o		Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

for the transition period from to

Commission file number 0-20488

Psychiatric Solutions, Inc.

(Exact Name of Registrant as Specified in Its Charter)


Delaware		23-2491707
(State or Other Jurisdiction of Incorporation or Organization)		(I.R.S. Employer Identification No.)

6640 Carothers Parkway, Suite 500
Franklin, TN 37067
(Address of Principal Executive Offices, Including Zip Code)

(615) 312-5700
(Registrant’s Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act:


Title Of Each Class		Name of Each Exchange On Which Registered
Common Stock, $.01 par value		NASDAQ Global Select Market

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. þ Yes o No

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. o Yes þ No

Note — Checking the box above will not relieve any registrant required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act from their obligations under those Sections.

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. þ Yes o No

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):


Large accelerated filer þ		Accelerated filer o		Non-accelerated filer o (Do not check if a smaller reporting company)		Smaller Reporting Company o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). o Yes þ No

As of February 21, 2008, 55,108,472 shares of the registrant’s common stock were outstanding. As of June 30, 2007, the aggregate market value of the shares of common stock of the registrant held by non-affiliates of the registrant was approximately $1.86 billion. For purposes of calculating such aggregate market value, shares owned by directors, executive officers and 5% beneficial owners of the registrant have been excluded.

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the registrant’s definitive proxy statement for its 2008 annual meeting of stockholders to be held on May 20, 2008 are incorporated by reference into Part III of this Form 10-K.

PART I

Unless the context otherwise requires, all references in this Annual Report on Form 10-K to “Psychiatric Solutions,” “the Company,” “we,” “us” or “our” mean Psychiatric Solutions, Inc. and its consolidated subsidiaries and all shares and per share amounts have been adjusted to reflect a 2-for-1 stock split that was effected on January 9, 2006.

Item 1. Business

Overview

We are a leading provider of inpatient behavioral health care services in the United States. We operate 90 inpatient behavioral health care facilities with more than 10,000 beds in 31 states, Puerto Rico, and the U.S. Virgin Islands. We generated revenue of approximately $1.5 billion and $1.0 billion, respectively, for the years ended December 31, 2007 and 2006. We believe that our primary focus on the provision of inpatient behavioral health care services allows us to operate more efficiently and provide higher quality care than our competitors.

Our inpatient behavioral health care facilities accounted for 91.6% of our revenue for the year ended December 31, 2007. These inpatient facilities offer a wide range of inpatient behavioral health care services for children, adolescents and adults. We offer these services through a combination of acute inpatient behavioral facilities and residential treatment centers (“RTCs”). Our acute inpatient behavioral facilities provide the most intensive level of care, including 24-hour skilled nursing observation and care, daily interventions and oversight by a psychiatrist and intensive, highly coordinated treatment by a physician-led team of mental health professionals. Our RTCs offer longer term treatment programs primarily for children and adolescents with long-standing chronic behavioral health problems. Our RTCs provide physician-led, multi-disciplinary treatments that address the overall medical, psychiatric, social and academic needs of the patients.

Other behavioral health care services accounted for 8.4% of our revenue for the year ended December 31, 2007. This portion of our business primarily consists of our contract management and employee assistance program (“EAP”) businesses. Our contract management business involves the development, organization and management of behavioral health care programs within medical/surgical hospitals. Our EAP business contracts with employers to assist employees and their dependents with resolution of behavioral conditions or other personal concerns.

Psychiatric Solutions was incorporated in the State of Delaware in 1988. Our principal executive offices are located at 6640 Carothers Parkway, Suite 500, Franklin, Tennessee 37067. Our telephone number is (615) 312-5700. Information about Psychiatric Solutions and our filings with the Securities and Exchange Commission can be found at our website at www.psysolutions.com.

Recent Development

On May 31, 2007, we completed the acquisition of Horizon Health Corporation (“Horizon Health”), a provider of behavioral health care services, for $426.7 million in cash and the assumption of a mortgage loan of approximately $7.0 million. Prior to this acquisition, Horizon Health’s common shares were traded on The NASDAQ Global Select Market under the ticker symbol “HORC”. We also repurchased, in a tender offer, substantially all of our 10⁵/₈% Senior Subordinated Notes due 2013 (the “10⁵/₈% Notes”). These transactions were financed with an additional $225 million of term loans pursuant to our senior secured credit facility and the net proceeds of our offering of $250 million of 7³/₄%Senior Subordinated Notes due 2015 (the “7³/₄%Notes”). In connection with these financing transactions, we recorded a loss of $8.2 million, which consists primarily of the amount above par value paid to repurchase our 10⁵/₈% Notes, the write-off of capitalized financing costs associated with our 10⁵/₈% Notes and the amount paid to exit our interest rate swap agreements associated with our 10⁵/₈% Notes.

Our Industry

According to the most recent data available from the National Association of Psychiatric Health Systems’ 2005 Annual Survey, an estimated 26% of the U.S. general population suffers from a diagnosable mental disorder in a given year. Based on the 2000 U.S. census issued in 2002, this figure translates to approximately 73 million Americans.

The behavioral health care industry is extremely fragmented with only a few large national providers. During the 1990s, the behavioral health care industry experienced a significant contraction following a long period of growth. The reduction was largely driven by third-party payors who decreased reimbursement, implemented more stringent admission criteria and decreased the authorized length of stay. We believe this reduced capacity has resulted in an underserved patient population.

Reduced capacity, mental health parity legislation, and increased demand for behavioral health care services have resulted in favorable industry fundamentals over the last several years. Behavioral health care providers have enjoyed significant improvement in reimbursement rates, increased admissions and stabilized lengths of stay. According to the National Association of Psychiatric Health Systems, payments for the inpatient care of behavioral health and addictive disorders have increased nationwide. Inpatient admissions increased approximately 0.6% from 2004 to 2005, while the average occupancy rates decreased to approximately 73% for 2005 from approximately 74% for 2004, primarily due to a 5% increase in total licensed beds driven by expansions of existing facilities.

Following a rapid decrease during the early 1990s, inpatient average length of stay stabilized between 9 and 11 days from 1997 to 2005. In 2005, the inpatient average length of stay was 9.6 days. The average inpatient net revenue per day increased from $537 in 2003 to $576 in 2004. The average RTC net revenue per day increased from $310 in 2004 to $332 in 2005 for freestanding RTC facilities. The average number of admissions for freestanding RTC facilities was 165 for 2004. Total patient days of care increased 3.5% from 2004 to 2005 in RTC facilities, with an average length of stay of 177 days in 2005.

Our Competitive Strengths

We believe the following competitive strengths contribute to our strong market share in each of our markets and will enable us to continue to successfully grow our business and increase our profitability:

	•		Singular focus on behavioral health care — We focus primarily on the provision of inpatient behavioral health care services. We believe this allows us to operate more efficiently and provide higher quality care than our competitors. In addition, we believe our focus and reputation have helped us to develop important relationships and extensive referral networks within our markets and to attract and retain qualified behavioral health care professionals.

	•		Strong and sustainable market position — Our inpatient facilities have an established presence in each of our markets, and many of our owned and leased inpatient facilities have the leading market share in their respective service areas. We believe that the relationships and referral networks we have established will further enhance our presence within our markets. In addition, many of the states in which we operate require a certificate of need to open a behavioral health care facility, which may be difficult to obtain and may further preclude new market participants.

	•		Demonstrated ability to identify and integrate acquisitions — We attribute part of our success in integrating acquired inpatient facilities to our rigorous due diligence review of these facilities prior to completing the acquisitions as well as our ability to retain key employees at the acquired facilities. We employ a disciplined acquisition strategy that is based on defined criteria including quality of service, return on invested capital and strategic benefits. We also have a comprehensive post-acquisition strategic plan to facilitate the integration of acquired facilities that includes improving facility operations, retaining and recruiting psychiatrists and expanding the breadth of services offered by the facilities.

	•		Diversified payor mix and revenue base — As we have grown our business, we have focused on diversifying our sources of revenue. For the year ended December 31, 2007, we received 32% of our revenue from Medicaid, 13% from Medicare, 33% from HMO/PPO, commercial and private payors, 16% from various state agencies and 6% from other payors. As we receive Medicaid payments from more than 40 states, we do not believe that we are significantly affected by changes in reimbursement policies in any one state. Substantially all of our Medicaid payments relate to the care of children and adolescents. We believe that children and adolescents are a patient class that is less susceptible to reductions in reimbursement rates. For the year ended December 31, 2007, no single inpatient facility represented more than 3% of our revenue.

	•		Experienced management team — Our senior management team has extensive experience in the health care industry. Joey A. Jacobs, our Chairman, President and Chief Executive Officer, has over 30 years of experience in various capacities in the health care industry. Our senior management operates as a cohesive, complementary group and has extensive operating knowledge of our industry and understanding of the regulatory environment in which we operate. Our senior managers employ conservative fiscal policies and have a successful track record in both operating our core business and integrating acquired assets.

	•		Consistent free cash flow and minimal maintenance capital requirements — We generate consistent free cash flow by profitably operating our business, actively managing our working capital and having low maintenance capital expenditure requirements. As the behavioral health care business does not require the procurement and replacement of expensive medical equipment, our maintenance capital expenditure requirements are less than that of other facility-based health care providers. Historically, our maintenance capital expenditures have amounted to approximately 2% of our revenue. In addition, our accounts receivable management is less complex than medical/surgical hospital providers because there are fewer billing codes for inpatient behavioral health care facilities.

Our Growth Strategy

We have experienced significant growth in our operations as measured by the number of our facilities, admissions, patient days, revenue and net income. We intend to continue successfully growing our business and increasing our profitability by improving the performance of our inpatient facilities and through strategic acquisitions. The principal elements of our growth strategy are to:

•

Continue to Drive Same-Facility Growth — We increased our same-facility revenue by approximately 6.5% for the year ended December 31, 2007 compared to the year ended December 31, 2006. Same-facility revenue also increased by approximately 9.0%, 8.0%, and 9.0% for the years ended December 31, 2006, 2005, and 2004, respectively, compared to the immediately preceding years. Same-facility revenue refers to the comparison of the inpatient facilities we owned during a prior period with the comparable period in the subsequent period, adjusted for closures and combinations for comparability purposes. We intend to continue to increase our same-facility growth by increasing our admissions and patient days and obtaining annual

reimbursement rate increases. We plan to accomplish these goals by:


	•		expanding bed capacity at our facilities to meet demand;

	•		expanding our services and developing new services to take advantage of increased demand in select markets where we operate;

	•		building and expanding relationships that enhance our presence in local and regional markets;

	•		developing formal marketing initiatives and expanding referral networks; and

	•		continuing to provide high quality service.

	•		Grow Through Strategic Acquisitions — Our industry is highly fragmented and we plan to selectively pursue the acquisition of additional inpatient behavioral health care facilities. There are approximately 500 freestanding acute and residential treatment facilities in the United States and the top two providers operate approximately one-third of these facilities. We believe there are a number of acquisition candidates available at attractive valuations, and we have a number of potential acquisitions that are in various stages of development and consideration. We believe our focus on inpatient behavioral health care provides us with a strategic advantage when assessing a potential acquisition. We employ a disciplined acquisition strategy that is based on defined criteria, including quality of service, return on invested capital and strategic benefits.

	•		Enhance Operating Efficiencies — Our management team has extensive experience in the operation of multi-facility health care services companies. We intend to focus on improving our profitability by optimizing staffing ratios, controlling contract labor costs and reducing supply costs through group purchasing. We believe that our focus on efficient operations increases our profitability and will attract qualified behavioral health care professionals and patients.

Services

Inpatient Behavioral Health Care Facilities

We operate 81 owned and 9 leased inpatient behavioral health care facilities. These facilities offer a wide range of inpatient behavioral health care services for children, adolescents and adults. Our inpatient facilities work closely with mental health professionals, including licensed professional counselors, therapists and social workers; psychiatrists; non-psychiatric physicians; emergency rooms; school systems; insurance and managed care organizations; company-sponsored employee assistance programs; and law enforcement and community agencies that interact with individuals who may need treatment for mental illness or substance abuse. Many of our inpatient facilities have mobile assessment teams who travel to prospective clients in order to assess their condition and determine if they meet established criteria for inpatient care. Those clients not meeting the established criteria for inpatient care may qualify for outpatient care or a less intensive level of care also provided by the facility. During the year ended December 31, 2007, our inpatient behavioral health care facilities division produced approximately 91.6% of our revenue.

Through the diversity of programming and levels of care available, a patient can receive a seamless treatment experience from acute care to residential long-term care to group home living to outpatient treatment. This seamless care system provides the continuity of care needed to step the patient down and allow the patient to develop and use successful coping skills and treatment interventions to sustain long-term treatment success. Treatment modalities include comprehensive assessment, multi-disciplinary treatment planning including the patient and family, group, individual and family therapy services, medical and dental services, educational services, recreational services and discharge planning services. Specialized interventions such as skills training include basic daily living skills, social skills, work/school adaptation skills and symptom management skills. Collateral consultations are provided to significant others such as family members, teachers, employers and other professionals when needed to help the patient successfully reintegrate back into his or her world. Services offered and disorders treated at our inpatient facilities include:

	•		bipolar disorder

	•		major depression

	•		schizophrenia

	•		attention deficit/hyperactivity disorder

	•		impulse disorder

	•		oppositional and conduct disorders

	•		partial hospitalization

	•		intensive outpatient

	•		acute eating disorders

	•		reactive attachment disorder

	•		dual diagnosis

	•		rehabilitation care

	•		day treatment

	•		detoxification

	•		developmentally delayed disorders

	•		therapeutic foster care

	•		neurological disorders

	•		rapid adoption services

	•		day treatment

	•		independent living skills

	•		vocational training

	•		chemical dependency

Acute inpatient hospitalization is the most intensive level of care offered and typically involves 24-hour skilled nursing observation and care, daily oversight by a psychiatrist, and intensive, highly coordinated treatment by a physician-led team of mental health professionals. Every patient admitted to our acute inpatient facilities is assessed by a medical doctor within 24 hours of admission. Patients with non-complex medical conditions are monitored during their stay by the physician and nursing staff at the inpatient facility. Patients with more complex medical needs are referred to more appropriate facilities for diagnosis and stabilization prior to treatment. Patients admitted to our acute inpatient facilities also receive comprehensive nursing and psychological assessments within 24 to 72 hours of admission. Oversight and management of patients’ medication is performed by licensed psychiatrists on staff at the facility, and individual, family, and group therapy is performed by licensed counselors as appropriate to the patients’ assessed needs. Education regarding patients’ illnesses is also provided by trained mental health professionals.

Our RTCs provide longer term treatment programs for children and adolescents with long-standing behavioral/mental health problems. Twenty-four hour observation and care is provided in our RTCs, along with individualized therapy that usually consists of one-on-one sessions with a licensed counselor, as well as process and rehabilitation group therapy. Another key component of the treatment of children and adolescents in our inpatient facilities is family therapy. Participation of the child’s or adolescent’s immediate family is strongly encouraged in order to heighten the chance of success once the resident is discharged. Medications for residents are managed by licensed psychiatrists while they remain at the inpatient facility. Our RTCs also provide academic programs conducted by certified teachers to child and adolescent residents. These programs are individualized for each resident based on analysis by the teacher upon admission. Upon discharge, academic reports are forwarded to the resident’s school. Specialized programs for children and adolescents in our RTCs include programs for sexually reactive children, sex offenders, reactive attachment disorders, and children and adolescents who are developmentally delayed with a behavioral component. Our RTCs often receive out-of-state referrals to their programs due to the lack of specialized programs for these disorders within a patient’s own state.

Our inpatient facilities’ programs have been adapted to the requests of various sources to provide services to patients with multiple issues and specialized needs. Our success rate with these difficult to treat cases has expanded our network of referrals. The services provided at each inpatient facility are continually assessed and monitored through an ongoing quality improvement program. The purpose of this program is to strive for the highest quality of care possible for individuals with behavioral health issues, and includes regular site visits to each inpatient facility in order to assess compliance with legal and regulatory standards, as well as adherence to our compliance program. Standardized performance measures based on a national outcomes measurement data base comparing our inpatient facilities’ performance with national norms are also reported and reviewed and corrective steps are taken when necessary.

Other Behavioral Health Care Services

Other behavioral health care services accounted for 8.4% of our revenue for the year ended December 31, 2007. This portion of our business primarily consists of our contract management and EAP businesses. Our contract management business involves the development, organization and management of behavioral health care programs within medical/surgical hospitals. Our EAP business contracts with employers to assist employees and their dependents with resolution of behavioral conditions or other personal concerns.

Through our contract management business we develop, organize and manage behavioral health care programs within third-party general medical/surgical hospitals. Our broad range of services can be customized into individual programs that meet specific inpatient facility and community requirements. Our contract management business is dedicated to providing high quality programs with integrity, innovation and sufficient flexibility to develop customized individual programs. We provide our customers with a variety of management options, including clinical and management infrastructure, personnel recruitment, staff orientation and supervision, corporate consultation and performance improvement plans. Under the management contracts, the hospital is the actual provider of the mental health services and utilizes its own facilities, support services, and generally its own nursing staff in connection with the operation of its programs. Our management contracts generally have an initial term of two to five years and are extended for successive one-year periods unless terminated by either party.

Seasonality of Services

Our inpatient behavioral health care facilities typically experience lower patient volumes and revenue during the summer months, the year-end holidays and other periods when school is out of session.

Marketing

Our local and regional marketing is led by clinical and business development representatives at each of our inpatient facilities. These individuals manage relationships among a variety of referral sources in their respective communities. Our national marketing efforts are focused on increasing the census at our RTCs from various state referral sources by developing relationships and identifying contracting opportunities in their respective territories.

Competition

The inpatient behavioral health care facility industry is highly fragmented and subject to continual changes in the method in which services are provided and the types of companies providing such services. We primarily compete with regional and local competitors. Some of our competitors are owned by governmental agencies and supported by tax revenue and others are owned by nonprofit corporations and may be supported to a large extent by endowments and charitable contributions.

In addition, we compete for patients with other for-profit providers of mental health care services, including other inpatient behavioral health care facilities, medical/surgical hospitals, independent psychiatrists and psychologists. We also compete with hospitals, nursing homes, clinics, physicians’ offices and contract nursing companies for the services of registered nurses. We attempt to differentiate ourselves from our competition through our singular focus on the provision of behavioral health care services, our reputation for the quality of our services, recruitment of first rate medical staff and accessibility to our facilities. In addition, we believe that the active development of our referral network and participation in selected managed care provider panels enable us to successfully compete for patients in need of our services.

Reimbursement

Our inpatient owned and leased facilities receive payment for services from the federal government, primarily under the Medicare program; state governments, primarily under their respective Medicaid programs; private insurers, including managed care plans; and directly from patients. Most of our inpatient behavioral health facilities are certified as providers of Medicare and/or Medicaid services by the appropriate governmental authorities. The requirements for certification are subject to change, and, in order to remain qualified for such programs, it may be necessary for us to make changes from time to time in our inpatient facilities, equipment, personnel and services. If an inpatient facility loses its certification, it will be unable to receive payment for patients under the Medicare or Medicaid programs. Although we intend to continue participating in such programs, there can be no assurance that we will continue to qualify for participation.

Patient service revenue is recorded net of contractual adjustments at the time of billing by our patient accounting systems at the amount we expect to collect. This amount is calculated automatically by our patient accounting systems based on contractually determined rates, or amounts reimbursable by Medicare or Medicaid under provisions of cost or prospective reimbursement formulas, or a combination thereof. Most payments are determined based on negotiated per-diem rates. An estimate of contractual allowances is manually recorded for unbilled services based upon these contractually negotiated rates.

Any co-payments and deductibles due from patients are estimated at the time of admission based on the patient’s insurance plan, and payment of these amounts is requested prior to discharge. If the payment is not received prior to discharge or completion of service, collection efforts are made through our normal billing and collection process.

Our consolidated day’s sales outstanding were 53 for the years ended December 31, 2007 and 2006.

Medicare

Medicare provides insurance benefits to persons age 65 and over and some disabled persons. Current freestanding psychiatric hospitals and certified psychiatric units of acute care hospitals are transitioning to reimbursement based on an inpatient services prospective payment system (“PPS”) from reimbursement based on a reasonable cost basis.

The Centers for Medicare and Medicaid Services (“CMS”) implemented a three-year transition period to PPS, starting with the cost reporting periods beginning on or after January 1, 2005. The payment for the first year of the transition period (cost reporting periods beginning on or after January 1, 2005) consisted of 75% based on the cost-based reimbursement system and 25% at the prospective payment rate. In the second year, the split was 50% each and in the third year the split was 25% based on the cost-based system and 75% PPS. The prospective payment rate percentage is 100% for cost reporting periods beginning on or after January 1, 2008. Inpatient psychiatric facilities received a 3.2% increase in the Medicare prospective base rate beginning July 1, 2007. Annual updates are anticipated thereafter.

Under CMS regulations, the PPS base per diem is adjusted for specific patient and facility characteristics that increase the cost of patient care. Payment rates for individual inpatient facilities are adjusted to reflect geographic differences in wages, and rural providers and teaching facilities receive an increased payment adjustment. Additionally, the base rate is adjusted by factors that influence the cost of an individual patient’s care, such as each patient’s diagnosis related group, certain other medical and psychiatric comorbidities (i.e., other coexisting conditions that may complicate treatment) and age. Because the cost of inpatient behavioral care tends to be greatest at admission and a few days thereafter, the per diem rate is adjusted for each day to reflect the number of days the patient has been in the facility. Medicare pays this per diem amount, as adjusted, regardless of whether it is more or less than a hospital’s actual costs. Please see www.cms.hhs.gov/InpatientPsychFacilPPS for additional information.

Medicare generally deducts from the amount of its payments to hospitals an amount for patient “deductible or coinsurance,” or the amount that the patient is expected to pay. These deductible or coinsurance amounts that are not paid by the patient result in “bad debts.” Medicare will reimburse 70% of these bad debts to the extent that neither a Medicare patient, a guarantor or any secondary

payor for that patient pays the Medicare coinsurance amount, provided that a reasonable collection effort or the patient’s indigence is documented.

Recovery Audit Contractors

In 2005, CMS began using recovery audit contractors (“RACs”) to detect Medicare overpayments not identified through existing claims review mechanisms. The RAC program relies on private auditing firms to examine Medicare claims filed by health care providers. Fees to RACs are paid on a contingency basis. The RAC program began as a demonstration project in three states (New York, California, and Florida), but was made permanent by the Tax Relief and Health Care Act of 2006. CMS plans to expand the RAC program to additional states beginning in 2008 and to have RACs in place in all 50 states by 2010.

RACs perform post-discharge audits of medical records to identify Medicare overpayments resulting from incorrect payment amounts, non-covered services, incorrectly coded services, and duplicate services. CMS has given RACs the authority to look back at claims up to three years old, provided that the claim was paid on or after October 1, 2007. Claims identified as overpayments will be subject to the Medicare appeals process.

RACs are paid a contingency fee based on the overpayments they identify and collect. Therefore, we expect that RACs will review claims submitted by our facilities in an attempt to identify possible overpayments. Although we believe the claims for reimbursement submitted to the Medicare program are accurate, we cannot predict whether we will be subject to RAC audits in the future, or if audited, what the result of such audits might be.

Medicaid

Medicaid, a joint federal-state program that is administered by the respective states, provides hospital benefits to qualifying individuals who are unable to afford medical care. All Medicaid funding is generally conditioned upon financial appropriations to state Medicaid agencies by the state legislatures. As many states face pressures to control their budgets, political pressures have led some state legislatures to reduce such appropriations.

Some states may adopt substantial health care reform measures that could modify the manner in which all health services are delivered and reimbursed, especially with respect to Medicaid recipients and other individuals funded by public resources. As we receive Medicaid payments from more than 40 states, we are not significantly affected by changes in reimbursement policies by any one state. Most states have applied for and been granted federal waivers from current Medicaid regulations in order to allow them to serve some or all of their Medicaid participants through managed care providers. The majority of our Medicaid payments relate to the care of children and adolescents. We believe that children and adolescents are a patient class that is less susceptible to reductions in reimbursement rates.

Managed Care and Commercial Insurance Carriers

Our inpatient facilities are also reimbursed for certain behavioral health care services by private payors including health maintenance organizations (“HMOs”), preferred provider organizations (“PPOs”), commercial insurance companies, employers and individual private payors. To attract additional volume, our inpatient facilities offer discounts from established charges to certain large group purchasers of health care services. Generally, patients covered by HMOs, PPOs and other private insurers will be responsible for certain co-payments and deductibles, which are paid by the patient.

The Mental Health Parity Act of 1996 (“MHPA”) is a federal law that requires annual or lifetime limits for mental health benefits be no lower than the dollar limits for medical/surgical benefits offered by a group health plan. MHPA applies to group health plans or health insurance coverage offered in connection with a group health plan that offers both mental health and medical/surgical benefits. However it does not require plans to offer mental health benefits. MHPA was scheduled to “sunset” on December 31, 2003; however, MHPA has been extended several times on a year to year basis, most recently on December 31, 2006 when MHPA was extended through the end of 2007. We expect MHPA will be extended through the end of 2008. Bills have also been introduced in Congress from time to time that could potentially apply this concept on a more far-reaching scale, most recently in the form of the Mental Health Parity Act of 2007 (S. 558), but we cannot predict whether any such legislation will be implemented in the future. Approximately 45 states have also enacted some form of mental health parity laws. Some of these laws apply only to select groups such as those with severe mental illness or a specific diagnosis.

Annual Cost Reports

All facilities participating in the Medicare program and some Medicaid programs, whether paid on a reasonable cost basis or under a PPS, are required to meet certain financial reporting requirements. Federal regulations require submission of annual cost reports identifying costs associated with the services provided by each facility to Medicare beneficiaries and Medicaid recipients. Annual cost reports required under Medicare and some Medicaid programs are subject to routine governmental audits, which may result in adjustments to the amounts ultimately determined to be due to us under those reimbursement programs. These audits often require several years to reach the final determination of amounts earned under the programs. Nonetheless, once the Medicare fiscal intermediaries have issued a final Notice of Program Reimbursement (“NPR”) after an audit, any disallowances of claimed costs are

due and payable within 30 days of receipt of the NPR. Providers have rights to appeal, and it is common to contest issues raised in audits of prior years’ cost reports.

Regulation and Other Factors

Licensure, Certification and Accreditation

Health care facilities are required to comply with extensive regulation at the federal, state and local levels. Under these laws and regulations, health care facilities must meet requirements for state licensure as well as additional qualifications to participate in government programs, including the Medicare and Medicaid programs. These requirements relate to the adequacy of medical care, equipment, personnel, operating policies and procedures, fire prevention, maintenance of adequate records, hospital use, rate-setting, and compliance with building codes and environmental protection laws. Facilities are subject to periodic inspection by governmental and other authorities to assure continued compliance with the various standards necessary for licensing and accreditation.

All of the inpatient facilities operated by us are properly licensed under applicable state laws. Most of the inpatient facilities operated by us are certified under Medicare and/or Medicaid programs and accredited by The Joint Commission, a functional prerequisite to participation in the Medicare and Medicaid programs. Should any of our inpatient facilities lose its accreditation by The Joint Commission, or otherwise lose its certification under the Medicare and/or Medicaid program, that inpatient facility may be unable to receive reimbursement from the Medicare and/or Medicaid programs. If a provider for who we provide contract management services is excluded from any federal health care program, no services furnished by that provider would be reimbursed by any federal health care program. If one of our facilities is excluded from a federal health care program, that facility would not be eligible for reimbursement by any federal health care program.

We believe that the inpatient facilities we own and operate generally are in substantial compliance with current applicable federal, state, local and independent review body regulations and standards. The requirements for licensure, certification and accreditation are subject to change and, in order to remain qualified, it may be necessary for us to affect changes in our inpatient facilities, equipment, personnel and services. Additionally, certain of the employed and contracted personnel working at our inpatient facilities are subject to state laws and regulations governing their particular area of professional practice. We assist our managed client hospitals in obtaining required approvals for new programs.

Fraud and Abuse Laws

Participation in the Medicare and/or Medicaid programs is heavily regulated by federal law and CMS regulation. If a hospital fails to substantially comply with the numerous federal laws governing that facility’s activities, the facility’s participation in the Medicare and/or Medicaid programs may be terminated and/or civil or criminal penalties may be imposed.

The portion of the Social Security Act commonly known as the “Anti-Kickback Statute” prohibits the payment, receipt, offer or solicitation of anything of value with the intent of generating referrals or orders for services or items covered by a federal or state health care program. Violations of the Anti-Kickback Statute may be punished by criminal or civil penalties, exclusion from federal and state health care programs, imprisonment and damages up to three times the total dollar amount involved. While evidence of intent is a prerequisite to any finding that the Anti-Kickback Statute has been violated, the statute has been interpreted broadly by federal regulators and courts to prohibit the payment of anything of value if even one purpose of the payment is to influence the referral of Medicare or Medicaid business.

The Health Insurance Portability and Accountability Act of 1996 (“HIPAA”) broadened the scope of the fraud and abuse laws by adding several criminal statutes that are not related to receipt of payments from a federal health care program. HIPAA created civil penalties for proscribed conduct, including upcoding and billing for medically unnecessary goods or services. HIPAA established new enforcement mechanisms to combat fraud and abuse. These new mechanisms include a bounty system, where a portion of any payments recovered is returned to the government agencies, as well as a whistleblower program. HIPAA also expanded the categories of persons that may be excluded from participation in federal and state health care programs.

The Office of Inspector General (the “OIG”) of the Department of Health and Human Services (“HHS”) is responsible for identifying fraud and abuse activities in government programs. In order to fulfill its duties, the OIG performs audits, investigations and inspections.

The OIG is authorized to publish regulations outlining activities and business relationships that would be deemed not to violate the Anti-Kickback Statute. These regulations are known as “safe harbor” provisions. The safe harbor provisions delineate standards that, if complied with, protect conduct that might otherwise be deemed to violate the Anti-Kickback Statute. While compliance with the safe harbor provisions effectively insulates a practice from being found to be in violation of the Anti-Kickback Statute, the failure of a particular activity to comply with the safe harbor provisions does not mean that the activity violates the Anti-Kickback Statute. Rather, failure to comply with the safe harbor provisions simply denies us the opportunity to avail ourselves of the affirmative defense of

compliance. We have a variety of financial relationships with physicians who refer patients to our owned and leased facilities, as well as to behavioral health programs and facilities we manage, including employment contracts, independent contractor agreements, professional service agreements and medical director agreements. We use our best efforts to structure each of our arrangements, especially each of our business relationships with physicians, to fit as closely as possible within the applicable safe harbors. We cannot guarantee that these arrangements will not be scrutinized by government authorities or, if scrutinized, that they will be determined to be in compliance with the Anti-Kickback Statute or other applicable laws. If we violate the Anti-Kickback Statute, we would be subject to criminal and civil penalties and/or possible exclusion from participating in Medicare, Medicaid or other governmental health care programs.

We provide unit management services to acute care hospitals. Some of our management agreements provide for fees payable to us that are not fixed fees, but may vary based on revenue, the level of services rendered or the number of patients treated in the unit. We believe that the management fees reflect fair market value for the services rendered and are not determined in a manner that takes into account the volume or value of any referrals. Our management agreements satisfy many but not all of the requirements of the Personal Services and Management Contract Safe Harbor. We believe our management agreements comply with the Anti-Kickback Statute. As discussed above, the preamble to the Safe Harbor regulations specifically indicates that the failure of a particular business arrangement to comply with a Safe Harbor does not determine whether the arrangement violates the Anti-Kickback Statute.

The Social Security Act also includes a provision commonly known as the “Stark Law.” This law prohibits physicians from referring Medicare and Medicaid patients for the furnishing of any “designated health services” to health care entities in which they or any of their immediate family members have an ownership or other financial interest. These types of referrals are commonly known as “self referrals.” A violation of the Stark Law may result in a denial of payment, require refunds to patients and the Medicare program, civil monetary penalties of up to $15,000 for each violation, civil monetary penalties of up to $100,000 for circumvention schemes, civil monetary penalties of up to $10,000 for each day that an entity fails to report required information, and exclusion from the Medicare and Medicaid programs and other federal programs, and additionally could result in penalties for false claims. There are ownership and compensation arrangement exceptions for many customary financial arrangements between physicians and facilities, including employment contracts, personal services agreements, leases and recruitment agreements. We have structured our financial arrangements with physicians to comply with the statutory exceptions included in the Stark Law and subsequent regulations. However, future Stark Law regulations may interpret provisions of this law in a manner different from the manner in which we have interpreted them. We cannot predict the effect such future regulations will have on us.

Many states in which we operate also have adopted, or are considering adopting, laws similar to the Anti-Kickback Statute and/or the Stark Law. Some of these state laws, commonly known as “all payor” laws, apply even if the government is not the payor. These statutes typically provide criminal and civil penalties as remedies. While there is little precedent for the interpretation or enforcement of these state laws, we have attempted to structure our financial relationships with physicians and others in accordance with these laws. However, if a state determines that we have violated such a law, we may be subject to criminal and civil penalties.

Emergency Medical Treatment and Active Labor Act

The Emergency Medical Treatment and Active Labor Act (“EMTALA”) is a federal law that requires any health care facility with a dedicated emergency department that participates in the Medicare program to conduct an appropriate medical screening examination, within the capabilities of the facility, of every person who presents to the hospital’s emergency department for treatment and, if the patient is suffering from an emergency medical condition, to either stabilize that condition or make an appropriate transfer of the patient to a facility that can handle the condition. The obligation to screen and stabilize emergency medical conditions exists regardless of a patient’s ability to pay for treatment. There are severe penalties under EMTALA if a hospital fails to screen or appropriately stabilize or transfer a patient or if the hospital delays appropriate treatment in order to first inquire about the patient’s ability to pay. Penalties for violations of EMTALA include civil monetary penalties and exclusion from participation in the Medicare program. In addition, an injured patient, the patient’s family or a medical facility that suffers a financial loss as a direct result of another hospital’s violation of the law can bring a civil suit against the hospital.

The regulations adopted to implement EMTALA do not provide an abundance of specific guidance and effectively limit the types of emergency services that a hospital subject to EMTALA is required to provide to those services that are within the capability of the hospital. Although we believe that our inpatient behavioral health care facilities comply with the EMTALA regulations, we cannot predict whether CMS will implement additional requirements in the future or the cost of compliance with any such regulations.

The Federal False Claims Act

The federal False Claims Act prohibits providers from knowingly submitting false claims for payment to the federal government. This law has been used not only by the federal government, but also by individuals who bring an action on behalf of the government under the law’s “qui tam” or “whistleblower” provisions. When a private party brings a qui tam action under the federal False Claims Act, the defendant will generally not be aware of the lawsuit until the government determines whether it will intervene in the litigation.

Civil liability under the federal False Claims Act can be up to three times the actual damages sustained by the government plus civil penalties for each separate false claim. There are many potential bases for liability under the federal False Claims Act, including claims submitted pursuant to a referral found to violate the Anti-Kickback Statute. Although liability under the federal False Claims Act arises when an entity knowingly submits a false claim for reimbursement to the federal government, the federal False Claims Act defines the term “knowingly” broadly. Although simple negligence will not give rise to liability under the federal False Claims Act, submitting a claim with reckless disregard to its truth or falsity can constitute the knowing submission of a false claim. From time to time, companies in the health care industry, including us, may be subject to actions under the federal False Claims Act.

HIPAA Transaction, Privacy and Security Requirements

There are currently numerous laws at the state and federal levels addressing patient privacy concerns. Federal regulations issued pursuant to HIPAA contain, among other measures, provisions that require many organizations, including our inpatient facilities, to implement very significant and potentially expensive new computer systems, employee training programs and business procedures.

In response to HIPAA, HHS issued regulations requiring health care facilities to use standard data formats and code sets when electronically transmitting information in connection with various transactions, including health claims and equivalent encounter information, health care payment and remittance advice and health claim status. We have implemented or upgraded computer systems, as appropriate, at our facilities and at our corporate headquarters to comply with the HIPAA regulations.

On February 20, 2003, HHS finalized a rule that establishes, in part, standards to protect the confidentiality, availability and integrity of health information by health plans, health care clearinghouses and health care providers that receive, store, maintain or transmit health and related financial information in electronic form, regardless of format. These security standards require our facilities to establish and maintain reasonable and appropriate administrative, technical and physical safeguards to ensure the integrity, confidentiality and the availability of electronic health and related financial information. The security standards were designed to protect electronic information against reasonably anticipated threats or hazards to the security or integrity of the information and to protect the information against unauthorized use or disclosure. We believe that our facilities are in compliance with these security standards.

On December 28, 2000 (with revisions August 14, 2002), HHS published a final rule establishing standards for the privacy of individually identifiable health information, with compliance required by April 14, 2003. These privacy standards apply to all health plans, all health care clearinghouses and health care providers that transmit health information in an electronic form in connection with the standard transactions, including our facilities. The privacy standards apply to individually identifiable information held or disclosed by a covered entity in any form, whether communicated electronically, on paper or orally. These standards impose extensive administrative requirements on our facilities. They require our compliance with rules governing the use and disclosure of health information. They create new rights for patients in their health information, such as the right to amend their health information, and they require our facilities to impose these rules, by contract, on any business associate to whom they disclose such information in order to perform functions on their behalf. In addition, our facilities will continue to remain subject to any state laws that are more restrictive than the privacy regulations issued under HIPAA. These state laws vary by state and could impose additional penalties.

A violation of these regulations could result in civil money penalties of $100 per incident, up to a maximum of $25,000 per person per year per standard. HIPAA also provides for criminal penalties of up to $50,000 and one year in prison for knowingly and improperly obtaining or disclosing protected health information, up to $100,000 and five years in prison for obtaining protected health information under false pretenses, and up to $250,000 and ten years in prison for obtaining or disclosing protected health information with the intent to sell, transfer or use such information for commercial advantage, personal gain or malicious harm. Since there is no significant history of enforcement efforts by the federal government at this time, it is not possible to ascertain the likelihood of enforcement efforts in connection with HIPAA regulations or the potential for fines and penalties that may result from the violation of the regulations.

Compliance with these regulations has and will continue to require significant commitment and action by us and our facilities. We have appointed members of our management team to direct our compliance with these standards. Implementation of these regulations has and will continue to require our facilities and us to engage in extensive preparation and make significant expenditures. At this time we have appointed a privacy officer at each inpatient facility, prepared privacy policies, trained our workforce on these policies and entered into business associate agreements with the appropriate vendors. Because some of the regulations are proposed regulations, we cannot predict the total financial impact of the regulations on our operations.

Other Medical Record Disclosure Laws

Disclosure of health records relating to drug and alcohol treatment is regulated by the Federal Confidentiality of Alcohol and Drug Abuse Patient Records law. This law prohibits the disclosure and use of alcohol and drug abuse patient records that are maintained in connection with the performance of any federally assisted alcohol and drug abuse program. In most cases, disclosure is only permitted when the patient specifically consents to the proposed disclosure. Unlike HIPAA, consent is required even when the disclosure is for purposes of treatment, payment or health care operations. Violations of this law could result in criminal penalties, including fines of up to $500 for first offenses and up to $5,000 for each subsequent offense.

Additionally, some states have laws specifically dealing with the disclosure of medical records related to treatment for substance abuse and/or mental health disorders. Both HIPAA and the Federal Confidentiality of Alcohol and Drug Abuse Patient Records provide a baseline level of protection for disclosure of health records. As such, they supersede state laws that are more lenient on the same subject. However, the federal laws give way to any state law that provides more stringent protection of health records.

Certificates of Need (“CON”)

The construction of new health care facilities, the acquisition or expansion of existing facilities, the transfer or change of ownership and the addition of new beds, services or equipment may be subject to laws in certain states that require prior approval by state regulatory agencies. These CON laws generally require that a state agency determine the public need for construction or acquisition of facilities or the addition of new services. Failure to obtain necessary state approval can result in the inability to expand facilities, add services, complete an acquisition or change ownership. Violations of these state laws may result in the imposition of civil sanctions or revocation of a facility’s license.

Corporate Practice of Medicine and Fee Splitting

Some states have laws that prohibit unlicensed persons or business entities, including corporations or business organizations that own hospitals, from employing physicians. Some states also have adopted laws that prohibit direct and indirect payments or fee-splitting arrangements between physicians and unlicensed persons or business entities. Possible sanctions for violation of these restrictions include loss of a physician’s license, civil and criminal penalties and rescission of business arrangements. These laws vary from state to state, are often vague and have seldom been interpreted by the courts or regulatory agencies. Although we attempt to structure our arrangements with health care providers to comply with the relevant state laws and the few available regulatory interpretations, there can be no assurance that government officials charged with responsibility for enforcing these laws will not assert that we, or certain transactions in which we are involved, are in violation of such laws, or that such laws ultimately will be interpreted by the courts in a manner consistent with our interpretation.

Health Care Industry Investigations

Significant media and public attention has focused in recent years on the hospital industry. Because the law in this area is complex and constantly evolving, ongoing or future governmental investigations or litigation may result in interpretations that are inconsistent with industry practices, including our practices. It is possible that governmental entities could initiate investigations of, or litigation against, inpatient facilities owned, leased, or managed by us in the future and that such matters could result in significant penalties as well as adverse publicity.

Risk Management

As is typical in the health care industry, we are subject to claims and legal actions by patients in the ordinary course of business. To cover these claims, we maintain professional malpractice liability insurance and general liability insurance in amounts we believe to be sufficient for our operations, although it is possible that some claims may exceed the scope of the coverage in effect. At various times in the past, the cost of malpractice insurance and other liability insurance has fluctuated significantly. Therefore, there can be no assurance that such insurance will continue to be available at reasonable prices which would allow us to maintain adequate levels of coverage.

Conversion Legislation

Many states have adopted legislation regarding the sale or other disposition of hospitals operated by not-for-profit entities. In other states that do not have such legislation, the attorneys general have demonstrated an interest in these transactions under their general obligations to protect charitable assets. These legislative and administrative efforts primarily focus on the appropriate valuation of the assets divested and the use of the proceeds of the sale by the not-for-profit seller. These reviews and, in some instances, approval processes can add additional time to the closing of a not-for-profit hospital acquisition. Future actions by state legislators or attorneys general may seriously delay or even prevent our ability to acquire certain hospitals.

Regulatory Compliance Program

We are committed to ethical business practices and to operating in accordance with all applicable laws and regulations. Our compliance program was established to ensure that all employees have a solid framework for business, legal, ethical, and employment practices. Our compliance program establishes mechanisms to aid in the identification and correction of any actual or perceived violations of any of our policies or procedures or any other applicable rules and regulations. We have appointed a Chief Compliance Officer as well as compliance coordinators at each inpatient facility. The Chief Compliance Officer heads our Compliance Committee, which consists of senior management personnel and two members of our board of directors. Employee training is a key component of the compliance program. All employees receive training during orientation and annually thereafter.

Insurance

We are subject to medical malpractice and other lawsuits due to the nature of the services we provide. At December 31, 2007, all of our operations have professional and general liability insurance in umbrella form for claims in excess of a $3.0 million self-insured retention with an insured excess limit of $50.0 million. The self-insured reserves for professional and general liability risks are calculated based on historical claims, demographic factors, industry trends, severity factors, and other actuarial assumptions calculated by an independent third-party actuary. This self-insurance reserve is discounted to its present value using a 5% discount rate. This estimated accrual for professional and general liabilities could be significantly affected should current and future occurrences differ from historical claim trends and expectations. We have utilized our captive insurance company to manage the self-insured retention. While claims are monitored closely when estimating professional and general liability accruals, the complexity of the claims and wide range of potential outcomes often hampers timely adjustments to the assumptions used in these estimates.

Employees

As of December 31, 2007, we employed approximately 21,800 employees, of whom approximately 14,800 are full-time employees. Approximately 20,540 employees staff our owned and leased inpatient behavioral health care facilities, approximately 1,100 employees staff our other behavioral health care businesses and approximately 160 are in corporate management including finance, accounting, legal, operations management, development, utilization review, compliance, training and education, information systems, member services, and human resources. Approximately 320 employees are union members. We consider our employee relations to be in good standing.

Available Information

We make available free of charge through our website, which you can find at www.psysolutions.com, our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to these reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act as soon as reasonably practicable after we electronically file such material with, or furnish it to, the Securities and Exchange Commission.

Segments

See Note 13 to the Company’s Consolidated Financial Statements included elsewhere in this Annual Report on Form 10-K for financial information about each segment of the Company, as defined by U.S. generally accepted accounting principles.

Item 1A. Risk Factors

If we fail to comply with extensive laws and government regulations, we could suffer penalties, lose our licenses or be excluded from health care programs.

The health care industry is required to comply with extensive and complex laws and regulations at the federal, state and local government levels relating to, among other things:

	•		billing for services;

	•		relationships with physicians and other referral sources;

	•		adequacy of medical care;

	•		quality of medical equipment and services;

	•		qualifications of medical and support personnel;

	•		confidentiality, maintenance and security issues associated with health-related information and medical records;

	•		licensure;

	•		hospital rate or budget review;

	•		operating policies and procedures; and

	•		addition of facilities and services.

Among these laws are the portions of the Social Security Act commonly known as the Anti-Kickback Statute, and a provision of the Social Security Act commonly known as the Stark Law. These laws impact the relationships that we may have with physicians and other referral sources. The Office of Inspector General of the Department of Health and Human Services, or OIG, has enacted safe harbor regulations that outline practices that are deemed protected from prosecution under the Anti-Kickback Statute. Our current financial relationships with physicians and other referral sources may not qualify for safe harbor protection under the Anti-Kickback Statute. Failure to meet a safe harbor does not mean that the arrangement automatically violates the Anti-Kickback Statute, but may subject the arrangement to greater scrutiny. Further, we cannot guarantee that practices that are outside of a safe harbor will not be found to violate the Anti-Kickback Statute.

If we fail to comply with the Anti-Kickback Statute, the Stark Law or other applicable laws and regulations, we could be subjected to criminal penalties, civil penalties (including the loss of our licenses to operate one or more inpatient facilities) and exclusion of one or more of our inpatient facilities from participation in the Medicare, Medicaid and other federal and state health care programs. In addition, if we do not operate our inpatient facilities in accordance with applicable law, our inpatient facilities may lose their licenses or the ability to participate in third party reimbursement programs.

While we believe we are in substantial compliance with all applicable laws, we do not always have the benefit of significant regulatory or judicial interpretation of these laws and regulations. In the future, different interpretations or enforcement of these laws and regulations could subject our current or past practices to allegations of impropriety or illegality or could require us to make changes in our inpatient facilities, equipment, personnel, services, capital expenditure programs and operating expenses. A determination that we have violated these laws, or the public announcement that we are being investigated for possible violations of these laws, could have a material adverse effect on our business, financial condition, results of operations or prospects and our business reputation could suffer significantly. In addition, we are unable to predict whether other legislation or regulations at the federal or state level will be adopted or the effect such legislation or regulations will have on us.

If federal or state health care programs or managed care companies reduce reimbursement rates for services provided, revenue may decline.

A large portion of our revenue comes from the Medicare and Medicaid programs. In recent years, federal and state governments have made significant changes in these programs. On November 3, 2004, the Centers for Medicare and Medicaid Services, or CMS, announced final regulations adopting a prospective payment system, or PPS, for services provided by inpatient behavioral health care facilities. Inpatient behavioral health care facilities historically have been reimbursed based on reasonable cost, subject to a discharge ceiling. For cost reporting periods after January 1, 2005, CMS began to phase in PPS over a three-year period, which pays inpatient behavioral health care facilities a per diem base rate. With the phase in now complete, inpatient behavioral health care facilities will be paid solely on a PPS basis for cost reporting periods after January 1, 2008.

The per diem base rate will be adjusted by factors that influence the cost of an individual patient’s care, such as each patient’s diagnosis related group, certain other medical and psychiatric comorbidities (i.e., other coexisting conditions that may complicate treatment) and age. The per diem amounts are calculated in part based on national averages, but will be adjusted for specific facility characteristics that increase the cost of patient care. The base rate per diem is intended to compensate a facility for costs incurred to treat a patient with a particular diagnosis, including nearly all labor and non-labor costs of furnishing covered inpatient behavioral health care services as well as routine, ancillary and capital costs. Payment rates for individual inpatient facilities will be adjusted to reflect geographic differences in wages and will allow additional outlier payments for expenses associated with extraordinary cases. Additionally, rural providers will receive an increased payment adjustment. Medicare will pay this per diem amount, as adjusted, regardless of whether it is more or less than a facility’s actual costs. The per diem will not, however, include the costs of bad debt and certain other costs that are paid separately. Future federal and state legislation may reduce the payments we receive for our services.

Substantially all of the patients admitted to the units we manage for acute care hospitals are eligible for Medicare coverage. As a result, the providers rely upon payment from Medicare for the services. Many of the patients are also eligible for Medicaid payments. To the extent that a hospital deems revenue for a program we manage to be inadequate, it may seek to terminate its contract with us or not renew the contract. Similarly, we may not add new management contracts if prospective customers do not believe that such programs will generate sufficient revenue.

Under Medicare and certain Medicaid programs, hospital companies currently are required to file, on a timely basis, cost reports. Such cost reports are subject to amending, reopening and appeal rights, which could materially affect historical costs recognized and reimbursement received from such payors.

Insurance and managed care companies and other third parties from whom we receive payment are increasingly attempting to control health care costs by requiring that facilities discount their fees in exchange for exclusive or preferred participation in their benefit plans. This trend may continue and may reduce the payments received by us for our services.

Other companies within the health care industry continue to be the subject of federal and state investigations, which increases the risk that we may become subject to investigations in the future.

Both federal and state government agencies as well as private payors have heightened and coordinated civil and criminal enforcement efforts as part of numerous ongoing investigations of health care organizations. These investigations relate to a wide variety of topics, including:

	•		cost reporting and billing practices;

	•		quality of care;

	•		financial relationships with referral sources;

	•		medical necessity of services provided; and

	•		treatment of indigent patients, including emergency medical screening and treatment requirements.

The OIG and the U.S. Department of Justice have, from time to time, undertaken national enforcement initiatives that focus on specific billing practices or other suspected areas of abuse. Moreover, health care providers are subject to civil and criminal false claims laws, including the federal False Claims Act, which allows private parties to bring whistleblower lawsuits against private companies doing business with or receiving reimbursement under federal health care programs. Some states have adopted similar state whistleblower and false claims provisions. Publicity associated with the substantial amounts paid by other health care providers to settle these lawsuits may encourage our current and former employees and other health care providers to bring whistleblower lawsuits. Any investigations of us or our executives or managers could result in significant liabilities or penalties as well as adverse publicity.

As a provider of health care services, we are subject to claims and legal actions by patients and others.

We are subject to medical malpractice and other lawsuits due to the nature of the services we provide. Facilities acquired by us may have unknown or contingent liabilities, including liabilities related to patient care and liabilities for failure to comply with health care laws and regulations, which could result in large claims and significant defense costs. Although we generally seek indemnification covering these matters from prior owners of facilities we acquire, material liabilities for past activities of acquired facilities may exist and such prior owners may not be able to satisfy their indemnification obligations. We are also susceptible to being named in claims brought related to patient care and other matters at inpatient facilities owned by third parties and operated by us.

To protect ourselves from the cost of these claims, professional malpractice liability insurance and general liability insurance coverage is maintained in amounts and with self-insured retention common in the industry. We have professional and general liability insurance in umbrella form for claims in excess of a $3.0 million self-insured retention with an insured excess limit of $50.0 million for all of our inpatient facilities. The self-insured reserves for professional and general liability risks are calculated based on historical claims, demographic factors, industry trends, severity factors and other actuarial assumptions calculated by an independent third-party actuary. This self-insured reserve is discounted to its present value using a 5% discount rate. This estimated accrual for professional and general liabilities could be significantly affected should current and future occurrences differ from historical claim trends and expectations. We have utilized our captive insurance company to manage the self-insured retention. While claims are monitored closely when estimating professional and general liability accruals, the complexity of the claims and wide range of potential outcomes often hampers timely adjustments to the assumptions used in these estimates. There are no assurances that our insurance will cover all claims (e.g., claims for punitive damages) or that claims in excess of our insurance coverage will not arise. A successful lawsuit against us that is not covered by, or is in excess of, our insurance coverage may have a material adverse effect on our business, financial condition and results of operations. This insurance coverage may not continue to be available at a reasonable cost, especially given the significant increase in insurance premiums generally experienced in the health care industry.

We depend on our key management personnel.

We are highly dependent on our senior management team, which has many years of experience addressing the broad range of concerns and issues relevant to our business. Our senior management team includes talented managers of our divisions, who have extensive experience in all aspects of health care. We have entered into an employment agreement with Joey A. Jacobs, our Chief Executive Officer and President, which includes severance, non-competition and non-solicitation provisions. Key man life insurance policies are not maintained on any member of senior management. The loss of key management or the inability to attract, retain and motivate sufficient numbers of qualified management personnel could have a material adverse effect on us.

If competition decreases our ability to acquire additional inpatient facilities on favorable terms, we may be unable to execute our acquisition strategy.

An important part of our business strategy is to acquire inpatient facilities in growing markets. Some inpatient facilities and health care providers that compete with us have greater financial resources and a larger development staff focused on identifying and completing acquisitions. In addition, some competitors are owned by governmental agencies or not-for-profit corporations supported by endowments and charitable contributions and can finance capital expenditures on a tax-exempt basis. Any or all of these factors may impede our business strategy.

Covenant restrictions under our senior secured credit facilities and the indenture governing our 7³/4% Senior Subordinated Notes may limit our ability to operate our business.

Our senior secured credit facilities and the indenture governing the 7³/4% Notes contain, among other things, covenants that may restrict our ability and our subsidiary guarantors’ ability to finance future operations or capital needs or to engage in other business activities. These debt instruments restrict, among other things, our ability and the ability of our subsidiaries to:

	•		incur additional indebtedness and issue preferred stock;

	•		pay dividends or make other distributions;

	•		make certain restricted payments and investments;

	•		create liens;

	•		incur restrictions on our ability or the ability of our restricted subsidiaries to pay dividends or make other payments;

	•		sell assets, including the capital stock of our restricted subsidiaries;

	•		merge or consolidate with other entities; and

	•		engage in transactions with affiliates.

In addition, our senior secured credit facilities require us to maintain specified financial ratios and tests that may require that we take action to reduce our debt or act in a manner contrary to our business objectives. Events beyond our control, including changes in general business and economic conditions, may affect our ability to meet the specified financial ratios and tests. We cannot assure you that we will meet the specified ratios and tests or that the lenders under our senior secured credit facilities will waive any failure to meet the specified ratios or tests, A breach of any of these covenants would result in a default under our senior secured credit facilities and any resulting acceleration thereunder may result in a default under the indenture governing the 7³/4% Notes. If an event of default under our senior secured credit facilities occurs, the lenders could elect to declare all amounts outstanding thereunder, together with accrued interest, to be immediately due and payable.

Additional financing may be necessary to fund our acquisition strategy and capital expenditures, and such financing may not be available when needed.

Our acquisition program requires substantial capital resources. Likewise, the operation of existing inpatient facilities requires ongoing capital expenditures for renovation, expansion and the upgrade of equipment and technology.

In connection with our acquisition of Horizon Health on May 31, 2007, we incurred additional indebtedness to finance the $426.7 million purchase price. This significant indebtedness may adversely impact our ability to obtain additional financing for future acquisitions and/or capital expenditures on satisfactory terms. In addition, the terms of our outstanding indebtedness as well as our level of indebtedness at any time may restrict our ability to borrow additional funds. If we are not able to obtain additional financing, then we may not be in a position to consummate acquisitions or undertake capital expenditures.

Recently acquired businesses and businesses acquired in the future will expose us to increased operating risks.

On May 31, 2007, we completed the acquisition of Horizon Health for $426.7 million in cash and the assumption of a mortgage loan of approximately $7.0 million. We also repurchased in a tender offer substantially all of our 10⁵/₈% Senior Subordinated Notes due 2013. These transactions were financed with an additional $225 million of term loans pursuant to our senior secured credit facility and the net proceeds of our offering of $250 million of 7³/₄%Notes.

This acquisition, as well as other future acquisitions and expansions, exposes us to additional business and operating risk and uncertainties, including:

	•		our ability to effectively manage the expanded activities;

	•		our ability to realize our investment in the increased number of inpatient facilities;

	•		our exposure to unknown liabilities; and

	•		our ability to meet contractual obligations.

If we are unable to manage the acquired businesses efficiently or effectively, or are unable to attract and retain additional qualified management personnel to run the expanded operations, it could have a material adverse effect on our business, financial condition and results of operations.

If we fail to integrate or improve, where necessary, the operations of acquired inpatient facilities, we may be unable to achieve our growth strategy.

We may be unable to maintain or increase the profitability of, or operating cash flows at, an existing behavioral health care facility or other acquired inpatient facility, effectively integrate the operations of an acquired facility or otherwise achieve the intended benefit of our growth strategy. To the extent that we are unable to enroll in third party payor plans in a timely manner following an acquisition, we may experience a decrease in cash flow or profitability.

Hospital acquisitions generally require a longer period to complete than acquisitions in many other industries and are subject to additional regulatory uncertainty. Many states have adopted legislation regarding the sale or other disposition of facilities operated by not-for-profit entities. In other states that do not have specific legislation, the attorneys general have demonstrated an interest in these transactions under their general obligations to protect charitable assets from waste. These legislative and administrative efforts focus primarily on the appropriate valuation of the assets divested and the use of the proceeds of the sale by the non-profit seller. In addition, the acquisition of facilities in certain states requires advance regulatory approval under “certificate of need” or state licensure regulatory regimes. These state-level procedures could seriously delay or even prevent us from acquiring inpatient facilities, even after significant transaction costs have been incurred.

We depend on our relationships with physicians and other health care professionals who provide services at our inpatient facilities.

Our business depends upon the efforts and success of the physicians and other health care professionals who provide health care services at our inpatient facilities and the strength of the relationships with these physicians and other health care professionals.

Our business could be adversely affected if a significant number of physicians or a group of physicians:

	•		terminate their relationship with, or reduce their use of, our inpatient facilities;

	•		fail to maintain acceptable quality of care or to otherwise adhere to professional standards;

	•		suffer damage to their reputation; or

	•		exit the market entirely.

Failure to maintain effective internal controls in accordance with Section 404 of the Sarbanes-Oxley Act could have a material adverse effect on our business and stock price.

Each year we are required to document and test our internal control procedures in order to satisfy the requirements of Section 404 of the Sarbanes-Oxley Act of 2002, which requires annual management assessments of the effectiveness of our internal controls over financial reporting and a report by our independent registered public accounting firm addressing the effectiveness of internal control over financial reporting. During the course of our annual testing we may identify deficiencies that we may not be able to remediate in time to meet the deadline imposed by the Sarbanes-Oxley Act for compliance with the requirements of Section 404. In addition, if we fail to maintain the adequacy of our internal controls, as such standards are modified, supplemented or amended from time to time, we may not be able to ensure that we can conclude on an ongoing basis that we have effective internal controls over financial reporting in accordance with Section 404 of the Sarbanes-Oxley Act. Failure to achieve and maintain an effective internal control environment could have a material adverse effect on our business and stock price.

We may be required to spend substantial amounts to comply with legislative and regulatory initiatives relating to privacy and security of patient health information and standards for electronic transactions.

There are currently numerous legislative and regulatory initiatives at the federal and state levels addressing patient privacy and security concerns. In particular, federal regulations issued under HIPAA require our facilities to comply with standards to protect the privacy, security and integrity of health care information. These regulations have imposed extensive administrative requirements, technical and physical information security requirements, restrictions on the use and disclosure of individually identifiable patient health and related financial information and have provided patients with additional rights with respect to their health information. Compliance with these regulations requires substantial expenditures, which could negatively impact our financial results. In addition, our management has spent, and may spend in the future, substantial time and effort on compliance measures.

HIPAA also mandates the use of standard formats for electronic transactions and establishing standard unique health identifiers. As of May 23, 2007, all health care providers, including our inpatient facilities, were required to have obtained a new National Provider Identifier to be used in standard transactions instead of other numerical identifiers. Our inpatient facilities did not experience payment delays during the transition to the new identifiers.

Violations of the privacy and security regulations could subject our inpatient facilities to civil penalties of up to $25,000 per calendar year for each provision contained in the privacy and security regulations that is violated and criminal penalties of up to $250,000 per violation for certain other violations. Because there is no significant history of enforcement efforts by the federal government at this time, it is not possible to ascertain the likelihood of enforcement efforts in connection with these regulations or the potential for fines and penalties that may result from the violation of the regulations.

Forward-Looking Statements

This Annual Report on Form 10-K and other materials we have filed or may file with the Securities and Exchange Commission (the “SEC”), as well as information included in oral statements or other written statements made, or to be made, by our senior management, contain, or will contain, disclosures that are “forward-looking statements” within the meaning of the safe harbor provisions of The Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not relate solely to historical or current facts and can be identified by the use of words such as “may,” “will,” “expect,” “believe,” “intend,” “plan,” “estimate,” “project,” “continue,” “should” and other comparable terms. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of risks and uncertainties, including those set forth below, which could significantly affect our current plans and expectations and future financial condition and results.

We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Stockholders and investors are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in our filings and reports.

While it is not possible to identify all these factors, we continue to face many risks and uncertainties that could cause actual results to differ from those forward-looking statements, including:

	•		our ability to successfully integrate and improve the operations of acquired inpatient facilities;

	•		potential competition that alters or impedes our acquisition strategy by decreasing our ability to acquire additional inpatient facilities on favorable terms;

	•		our ability to maintain favorable and continuing relationships with physicians and other health care professionals who use our inpatient facilities;

	•		our substantial indebtedness and our ability to receive timely additional financing on terms acceptable to us to fund our acquisition strategy and capital expenditure needs;

	•		risks inherent to the health care industry, including the impact of unforeseen changes in regulation and exposure to claims and legal actions by patients and others;

	•		efforts by federal and state health care programs and managed care companies to reduce reimbursement rates for our services;

	•		our ability to comply with applicable licensure and accreditation requirements;

	•		our ability to comply with extensive laws and government regulations related to billing, physician relationships, adequacy of medical care and licensure;

	•		our ability to retain key employees who are instrumental to our operations;

	•		our ability to maintain effective internal controls in accordance with Section 404 of the Sarbanes-Oxley Act;

	•		our ability to ensure confidential information is not inappropriately disclosed and that we are in compliance with federal and state health information privacy standards;

	•		our ability to comply with federal and state governmental regulation covering health care-related products and services on-line, including the regulation of medical devices and the practice of medicine and pharmacology;

	•		our ability to obtain adequate levels of general and professional liability insurance;

	•		those risks and uncertainties described from time to time in our filings with the SEC; and

•

future trends for pricing, margins, revenue and profitability that remain difficult to predict in the industries that we serve.

We caution you that the factors listed above, as well as the risk factors included in this Annual Report on Form 10-K, may not be exhaustive. We operate in a continually changing business environment, and new risk factors emerge from time to time. We cannot predict such new risk factors nor can we assess the impact, if any, of such new risk factors on our businesses or the extent to which any factor or combination of factors may cause actual results to differ materially from those expressed or implied by any forward-looking statements.

Item 1B. Unresolved Staff Comments.

We have no unresolved SEC staff comments.

Item 2. Properties.

We operate 90 owned or leased inpatient behavioral health care facilities with over 10,000 licensed beds in 31 states, Puerto Rico, and the U.S. Virgin Islands. The following table sets forth the name, location, number of licensed beds and the acquisition date for each of our owned and leased inpatient behavioral health care facilities.


					Date
					Acquired/
Facility	Location	Beds		Own/Lease	Opened
Cypress Creek Hospital	Houston, TX		96	Own	9/01
West Oaks Hospital	Houston, TX		160	Own	9/01
Texas NeuroRehab Center	Austin, TX		151	Own	11/01
Holly Hill Hospital	Raleigh, NC		108	Own	12/01
Riveredge Hospital	Chicago, IL		210	Own	7/02
Whisper Ridge Behavioral Health System	Charlottesville, VA		102	Lease	4/03
Cedar Springs Behavioral Health System	Colorado Springs, CO		110	Own	4/03
Laurel Ridge Treatment Center	San Antonio, TX		196	Own	4/03
San Marcos Treatment Center	San Marcos, TX		265	Own	4/03
The Oaks Treatment Center	Austin, TX		118	Own	4/03
Shadow Mountain Behavioral Health System	Tulsa, OK		160	Own	4/03
Laurel Oaks Behavioral Health Center	Dothan, AL		114	Own	6/03
Hill Crest Behavioral Health	Birmingham, AL		177	Own	6/03
Gulf Coast Youth Academy	Fort Walton Beach, FL		168	Own	6/03
Manatee Palms Youth Services	Bradenton, FL		60	Own	6/03
Havenwyck Hospital	Auburn Hills, MI		182	Lease	6/03
Heartland Behavioral Health	Nevada, MO		159	Own	6/03
Brynn Marr Behavioral Health	Jacksonville, NC		88	Own	6/03
Mission Vista Hospital	San Antonio, TX		83	Lease	6/03
Benchmark Behavioral Health	Woods Cross, UT		145	Own	6/03
Macon Behavioral Health System	Macon, GA		155	Own	6/03
Manatee Adolescent Treatment Services	Bradenton, FL		85	Own	6/03
Alliance Health Center	Meridian, MS		194	Own	11/03
Calvary Center	Phoenix, AZ		50	Lease	12/03
Brentwood Acute Behavioral Health Center	Shreveport, LA		200	Own	3/04
Brentwood Behavioral Health of Mississippi	Flowood, MS		107	Own	3/04
Palmetto Lowcountry Behavioral Health System	North Charleston, SC		102	Own	5/04
Palmetto Pee Dee Behavioral Health System	Florence, SC		59	Own	5/04
Fort Lauderdale Hospital	Fort Lauderdale, FL		100	Lease	6/04
Millwood Hospital	Arlington, TX		120	Lease	6/04
Pride Institute	Eden Prairie, MN		36	Own	6/04
Summit Oaks Hospital	Summit, NJ		126	Own	6/04
North Spring Behavioral Healthcare	Leesburg, VA		77	Own	6/04
Peak Behavioral Health	Santa Teresa, NM		144	Own	6/04
Alhambra Hospital	Rosemead, CA		99	Own	7/05
Belmont Pines Hospital	Youngstown, OH		81	Own	7/05
Brooke Glen Behavioral Hospital	Fort Washington, PA		146	Own	7/05
Columbus Behavioral Center	Columbus, IN		61	Own	7/05
Cumberland Hospital	New Kent, VA		136	Own	7/05
Fairfax Hospital	Kirkland, WA		133	Own	7/05


					Date
					Acquired/
Facility	Location	Beds		Own/Lease	Opened
Fox Run Hospital	St. Clairsville, OH		93	Own	7/05
Fremont Hospital	Fremont, CA		96	Own	7/05
Heritage Oaks Hospital	Sacramento, CA		76	Own	7/05
Intermountain Hospital	Boise, ID		93	Own	7/05
Meadows Hospital	Bloomington, IN		78	Own	7/05
Mesilla Valley Hospital	Las Cruces, NM		121	Own	7/05
Montevista Hospital	Las Vegas, NV		101	Own	7/05
Pinnacle Pointe	Little Rock, AR		102	Own	7/05
Sierra Vista	Sacramento, CA		72	Own	7/05
Streamwood Hospital	Streamwood, IL		276	Own	7/05
Valle Vista Health System	Greenwood, IN		102	Own	7/05
West Hills Hospital	Reno, NV		95	Own	7/05
Willow Springs RTC	Reno, NV		76	Own	7/05
Canyon Ridge Hospital	Chino, CA		59	Own	8/05
Atlantic Shores Hospital	Fort Lauderdale, FL		72	Own	1/06
Wellstone Regional Hospital	Jeffersonville, IN		100	Own	1/06
Diamond Grove	Louisville, MS		50	Own	5/06
Hickory Trail Hospital	DeSoto, TX		86	Own	7/06
National Deaf Academy	Mount Dora, FL		132	Own	7/06
Windmoor Healthcare	Clearwater, FL		100	Own	9/06
University Behavioral Center	Orlando, FL		104	Own	9/06
Sandy Pines	Tequesta, FL		80	Own	9/06
Cumberland Hall Chattanooga	Chattanooga, TN		64	Own	12/06
Cumberland Hall Hopkinsville	Hopkinsville, KY		60	Own	12/06
Nashville Rehabilitation Hospital	Nashville, TN		111	Own	12/06
Panamericano	Cidra, Puerto Rico		195	Own	12/06
PRATS	Cidra/Bayamon, Puerto Rico		48	Own	12/06
The Pines Residential Treatment Center	Portsmouth, VA		424	Own	12/06
The Pines — Charleston	Summerville, SC		60	Lease	12/06
The Pines — Midlands	West Columbia, SC		59	Own	12/06
Virgin Islands Behavioral Services	St. Croix, U.S. Virgin Islands		30	Own	12/06
Virginia Beach Psychiatric Center	Virginia Beach, VA		100	Own	12/06
Three Rivers Behavioral Health	West Columbia, SC		86	Own	01/07
Copper Hills Youth Center	West Jordan, UT		153	Own	05/07
MeadowWood Behavioral Health System	New Castle, DE		53	Own	05/07
Focus Healthcare of Florida	Cooper City, FL		88	Own	05/07
Focus by the Sea	St. Simons, GA		101	Own	05/07
Arrowhead Behavioral Health	Maumee, OH		42	Own	05/07
Friends Hospital	Philadelphia, PA		219	Own	05/07
Kingwood Pines Hospital	Kingwood, TX		78	Own	05/07
Windsor-Laurelwood Center	Willoughby, OH		160	Lease	05/07
Lighthouse Care Center of Augusta	Augusta, GA		106	Own	05/07
Lighthouse Care Center of Conway	Conway, SC		108	Own	05/07
Lighthouse Care Center of Oconee	Tamassee, SC		28	Own	05/07
Michiana Behavioral Health Center	Plymouth, IN		80	Own	05/07
Poplar Springs Hospital	Petersburg, VA		184	Own	05/07
River Park Hospital	Huntington, WV		187	Own	05/07
Lighthouse Berkley	Summerville, SC		*	Own	05/07
Austin Lakes Hospital	Austin, TX		48	Lease	08/07
The Hughes Center for Exceptional Children	Danville, VA		56	Own	09/07


*		We acquired a non-operating facility, Lighthouse Berkley, in the acquisition of Horizon Health. Currently no patients are being served at this facility.

In addition, our principal executive offices are located in approximately 65,000 square feet of leased space in Franklin, Tennessee. We do not anticipate that we will experience any difficulty in renewing our lease upon its expiration in February 2012, or obtaining different space on comparable terms if such lease is not renewed. We believe our executive offices and our hospital properties and equipment are generally well maintained, in good operating condition and adequate for our present needs.

Item 3. Legal Proceedings.

We are subject to various claims and legal actions that arise in the ordinary course of our business. In the opinion of management, we are not currently a party to any proceeding that would have a material adverse effect on its financial condition or results of operations.

Item 4. Submission of Matters to a Vote of Security Holders.

None.

PART II

Item 5. Market For Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.

Our common stock trades on The NASDAQ Global Select Market under the symbol “PSYS”. The table below sets forth, for the calendar quarters indicated, the high and low sales prices per share as reported on The NASDAQ Global Select Market for our common stock adjusted to give effect to our 2-for-1 stock split on January 9, 2006.


	High		Low
2006
First Quarter	$	34.78	$	29.08
Second Quarter	$	34.48	$	26.14
Third Quarter	$	36.35	$	25.59
Fourth Quarter	$	38.84	$	30.19

2007
First Quarter	$	42.93	$	35.18
Second Quarter	$	42.75	$	33.96
Third Quarter	$	40.00	$	31.81
Fourth Quarter	$	40.71	$	31.92

At the close of business on February 21, 2008, there were approximately 106 holders of record of our common stock.

We currently intend to retain future earnings for use in the expansion and operation of our business. Our Second Amended and Restated Credit Agreement, as amended, prohibits us from paying dividends on our common stock. Also, the indenture governing our 7³/₄% Notes provides certain financial conditions that must be met in order for us to pay dividends. Subject to the terms of applicable contracts, the payment of any future cash dividends will be determined by our Board of Directors in light of conditions then-existing, including our earnings, financial condition and capital requirements, restrictions in financing agreements, business opportunities and conditions, and other factors.

Item 6. Selected Financial Data.

The selected financial data presented below for the years ended December 31, 2007, 2006 and 2005, and at December 31, 2007 and 2006, are derived from our audited consolidated financial statements included elsewhere in this Annual Report on Form 10-K. The selected financial data for the years ended December 31, 2004 and 2003, and at December 31, 2005, 2004 and 2003, are derived from our audited consolidated financial statements not included herein. The selected financial data presented below should be read in conjunction with “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and with our consolidated financial statements and notes thereto included elsewhere in this Annual Report on Form 10-K.

Psychiatric Solutions, Inc.
Selected Financial Data
As of and for the Years Ended December 31,


	2007		2006		2005		2004		2003
	(In thousands, except per share amounts and operating data)
Income Statement Data:
Revenue	$	1,481,952	$	1,022,428	$	715,324	$	470,969	$	277,575
Costs and expenses:
Salaries, wages and employee benefits		824,645		577,237		392,309		254,897		142,292
Other operating expenses		389,857		264,901		202,229		143,560		95,025
Provision for doubtful accounts		27,554		19,530		13,498		10,794		6,312
Depreciation and amortization		31,080		20,475		14,738		9,808		5,707
Interest expense		75,100		40,307		27,056		18,964		14,778
Other expenses		8,179		—		21,871		6,407		5,271

Total costs and expenses		1,356,415		922,450		671,701		444,430		269,385

Income from continuing operations before income taxes		125,537		99,978		43,623		26,539		8,190
Provision for income taxes		47,779		37,754		16,805		10,085		3,477

Income from continuing operations	$	77,758	$	62,224	$	26,818	$	16,454	$	4,713

Net income	$	76,208	$	60,632	$	27,154	$	16,801	$	5,216

Basic earnings per share from continuing operations	$	1.43	$	1.18	$	0.60	$	0.54	$	0.23


Basic earnings per share	$	1.40	$	1.15	$	0.61	$	0.55	$	0.26


Shares used in computing basic earnings per share		54,258		52,953		44,792		29,140		16,740


Diluted earnings per share from continuing operations	$	1.40	$	1.15	$	0.58	$	0.47	$	0.20


Diluted earnings per share	$	1.37	$	1.12	$	0.59	$	0.48	$	0.22

Shares used in computing diluted earnings per share from continuing operations		55,447		54,169		46,296		35,146		23,498

Balance Sheet Data:
Cash	$	39,975	$	18,572	$	54,700	$	33,451	$	44,948
Working capital		157,831		103,287		138,844		39,843		66,446
Property and equipment, net		694,018		539,758		378,162		217,927		149,275
Total assets		2,179,523		1,580,922		1,175,031		496,684		346,202
Total debt		1,172,024		743,307		482,389		174,336		175,003
Series A convertible preferred stock		—		—		—		—		25,316
Stockholders’ equity		754,742		627,779		539,712		244,515		91,328

Operating Data:
Number of facilities		90		73		55		34		24
Number of licensed beds		10,155		8,330		6,389		4,295		3,128
Admissions		141,331		107,903		78,204		49,484		26,278
Patient days		2,471,835		1,891,685		1,430,090		996,840		525,055
Average length of stay		18		18		18		20		20

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion and analysis should be read in conjunction with the selected financial data and the accompanying consolidated financial statements and related notes thereto included in this Annual Report on Form 10-K.

Overview

Our business strategy is to acquire inpatient behavioral health care facilities and improve operating results within new and existing inpatient facilities and our other behavioral health care operations. From 2001 to 2004, we acquired 34 inpatient behavioral health care facilities. During 2005, we acquired 20 inpatient behavioral health care facilities in the acquisition of Ardent Health Services, Inc.

(“Ardent Behavioral”) and one other inpatient facility. During 2006, we acquired 19 inpatient behavioral health care facilities, including nine inpatient facilities with the acquisition of the capital stock of Alternative Behavioral Services, Inc. (“ABS”) on December 1, 2006. During 2007, we acquired 16 inpatient behavioral health care facilities, including 15 inpatient facilities in the acquisition of Horizon Health.

We strive to improve the operating results of new and existing inpatient behavioral health care operations by providing the highest quality service, expanding referral networks and marketing initiatives and meeting increased demand for behavioral health care services by expanding our services and developing new services. We also attempt to improve operating results by optimizing staffing ratios, controlling contract labor costs and reducing supply costs through group purchasing. Our same-facility revenue from owned and leased inpatient facilities increased 6.5% for the year ended December 31, 2007 compared to the year ended December 31, 2006. Same-facility growth in 2007 was primarily the result of increases in patient days and revenue per patient day of 1.4% and 5.0%, respectively. Same-facility growth refers to the comparison of each inpatient facility owned during 2006 with the comparable period in 2007, adjusted for closures and combinations for comparability purposes.

Sources of Revenue

Patient Service Revenue

Patient service revenue is generated by our inpatient facilities for services provided to patients on an inpatient and outpatient basis within the inpatient behavioral health care facility setting. Patient service revenue is recorded at our established billing rates less contractual adjustments. Generally, collection in full is not expected at our established billing rates. Contractual adjustments are recorded to state our patient service revenue at the amount we expect to collect for the services provided based on amounts reimbursable by Medicare or Medicaid under provisions of cost or prospective reimbursement formulas or amounts due from other third-party payors at contractually determined rates. Patient service revenue comprised approximately 91.6% of our total revenue in 2007.

Other Revenue

Other behavioral health care services accounted for 8.4% of our revenue for the year ended December 31, 2007. This portion of our business primarily consists of our contract management and EAP businesses. Our contract management business involves the development, organization and management of behavioral health care programs within medical/surgical hospitals. Our EAP business contracts with employers to assist employees and their dependents with resolution of behavioral conditions or other personal concerns. Services provided are recorded as revenue at contractually determined rates in the period the services are rendered, provided that collectability of such amounts is reasonably assured.

Results of Operations

The following table illustrates our consolidated results of operations from continuing operations for the years ended December 31, 2007, 2006 and 2005 (dollars in thousands).


	Results of Operations, Consolidated Psychiatric Solutions
	For the Year Ended December 31,
	2007					2006					2005
	Amount		%			Amount		%			Amount		%
Revenue	$	1,481,952		100.0	%	$	1,022,428		100.0	%	$	715,324		100.0	%
Salaries, wages, and employee benefits (including share-based compensation of $16,104 and $12,535 in 2007 and 2006, respectively)		824,645		55.6	%		577,237		56.5	%		392,309		54.8	%
Professional fees		147,521		10.0	%		97,116		9.5	%		73,177		10.2	%
Supplies		82,244		5.5	%		58,986		5.8	%		42,993		6.0	%
Provision for doubtful accounts		27,554		1.9	%		19,530		1.9	%		13,498		1.9	%
Other operating expenses		160,092		10.8	%		108,799		10.6	%		86,059		12.0	%
Depreciation and amortization		31,080		2.1	%		20,475		2.0	%		14,738		2.1	%
Interest expense, net		75,100		5.1	%		40,307		3.9	%		27,056		3.8	%
Other expenses:
Loss on refinancing long-term debt		8,179		0.5	%		—		0.0	%		21,871		3.1	%

Income from continuing operations before income taxes		125,537		8.5	%		99,978		9.8	%		43,623		6.1	%
Provision for income taxes		47,779		3.3	%		37,754		3.7	%		16,805		2.4	%

Income from continuing operations	$	77,758		5.2	%	$	62,224		6.1	%	$	26,818		3.7	%

Year Ended December 31, 2007 Compared To Year Ended December 31, 2006

The following table compares key total facility statistics and same-facility statistics for 2007 and 2006 for owned and leased inpatient facilities


	Year Ended December 31,				%
	2007		2006		Change
Total facility results:
Revenue (in thousands)	$	1,357,827	$	976,324		39.1	%
Number of facilities at period end		90		73		21.6	%
Admissions		141,331		107,903		31.0	%
Patient days		2,471,835		1,891,685		30.7	%
Average length of stay		17.5		17.5		0.0	%
Revenue per patient day	$	549	$	516		6.4	%

Same-facility results:
Revenue (in thousands)	$	1,017,840	$	955,849		6.5	%
Number of facilities at period end		73		73		0.0	%
Admissions		108,302		105,900		2.3	%
Patient days		1,871,557		1,846,189		1.4	%
Average length of stay		17.3		17.4		-0.6	%
Revenue per patient day	$	544	$	518		5.0	%

Revenue. Revenue from continuing operations was $1.5 billion for the year ended December 31, 2007 compared to $1.0 billion for the year ended December 31, 2006, an increase of $460.0 million, or 44.9%. Revenue from owned and leased inpatient facilities accounted for $1.4 billion in 2007 compared to $976.3 million in 2006, an increase of $381.5 million, or 39.1%. The increase in revenue from owned and leased inpatient facilities relates primarily to the acquisitions of Horizon Health and ABS. The remainder of the increase in revenue from owned and leased inpatient facilities is primarily attributable to same-facility growth in patient days of 1.4% and revenue per patient day of 5.0%. Other revenue was $124.1 million in 2007 compared to $46.1 million in 2006, an increase of $78.0 million, resulting primarily from other operations acquired in the ABS and Horizon Health acquisitions.

Salaries, wages, and employee benefits. Salaries, wages and employee benefits (“SWB”) expense was $824.6 million in 2007 compared to $577.2 million in 2006, an increase of $247.4 million, or 42.9%. SWB expense includes $16.1 million and $12.5 million of shared-based compensation expense for the years ended December 31, 2007 and 2006, respectively. Based on our stock option and restricted stock grants outstanding at December 31, 2007, we estimate remaining unrecognized share-based compensation expense to be approximately $41.1 million with a weighted-average remaining amortization period of 3.3 years. Excluding share-based compensation expense, SWB expense was $808.5 million, or 54.6% of total revenue, in 2007 compared to $564.7 million, or 55.2% of total revenue, in 2006. SWB expense for owned and leased inpatient facilities was $739.0 million in 2007, or 54.4% of revenue. Same-facility SWB expense for owned and leased inpatient facilities was $547.3 million in 2007, or 53.8% of revenue, compared to $521.9 million in 2006, or 54.3% of revenue. SWB expense for other operations was $44.2 million in 2007 compared to $15.8 million in 2006. The increase in SWB expense from other operations is primarily the result of businesses acquired in the acquisitions of ABS and Horizon Health. SWB expense for our corporate office was $41.5 million, including $16.1 million in share-based compensation, for 2007 compared to $31.6 million, including $12.5 million in shared-based compensation, for 2006. The increase in SWB expense for our corporate office was primarily as the result of hiring additional staff necessary to manage the inpatient facilities acquired during 2006 and 2007.

Professional fees. Professional fees were $147.5 million in 2007, or 10.0% of total revenue, compared to $97.1 million in 2006, or 9.5% of total revenue. Professional fees for owned and leased inpatient facilities were $127.5 million in 2007, or 9.4% of revenue. Same-facility professional fees for owned and leased inpatient facilities were $91.5 million in 2007, or 9.0% of revenue, compared to $88.3 million in 2006, or 9.2% of revenue. Professional fees for other operations increased to $14.7 million in 2007 compared to $3.1 million in 2006, primarily as a result of businesses acquired in the acquisitions of ABS and Horizon Health. Professional fees for our corporate office were $5.3 million in 2007 compared to $4.0 million in 2006.

Supplies. Supplies expense was $82.2 million in 2007, or 5.5% of total revenue, compared to $59.0 million in 2006, or 5.8% of total revenue. Supplies expense for owned and leased inpatient facilities was $80.9 million in 2007, or 6.0% of revenue. Same-facility supplies expense for owned and leased inpatient facilities was $59.5 million in 2007, or 5.9% of revenue, compared to $57.1 million in 2006, or 5.9% of revenue.

Provision for doubtful accounts. The provision for doubtful accounts was $27.6 million in 2007, or 1.9% of total revenue, compared to $19.5 million in 2006, or 1.9% of total revenue. The provision for doubtful accounts at owned and leased inpatient facilities comprises the majority of our provision for doubtful accounts.

Other operating expenses. Other operating expenses consist primarily of rent, utilities, insurance, travel, and repairs and maintenance expenses. Other operating expenses were approximately $160.1 million in 2007, or 10.8% of total revenue, compared to $108.8 million in 2006, or 10.6% of total revenue. Other operating expenses for owned and leased inpatient facilities were $110.7 million in 2007, or 8.2% of revenue. Same-facility other operating expenses for owned and leased inpatient facilities were $78.6 million in 2007, or 7.7% of revenue, compared to $83.4 million in 2006, or 8.7% of revenue. The decrease in same-facility other operating expenses for owned and leased inpatient facilities was primarily the result of reductions in risk management costs as a percent of revenue. Other operating expenses for other operations increased to $41.8 million in 2007 compared to $18.5 million in 2006, primarily as a result of businesses acquired in the acquisitions of ABS and Horizon Health.

Depreciation and amortization. Depreciation and amortization expense was $31.1 million in 2007 compared to $20.5 million in 2006, an increase of $10.6 million, primarily as a result of the acquisitions of ABS and Horizon Health.

Interest expense, net. Interest expense, net of interest income, was $75.1 million in 2007 compared to $40.3 million in 2006, an increase of $34.8 million. On December 31, 2007, we had $1.2 billion in long-term debt compared to $743.3 million at December 31, 2006. The increase in interest expense is primarily the result of the increase in our long-term debt to finance acquisitions. We borrowed $210.0 million in December 2006 to finance the acquisition of ABS, and we incurred net borrowings of $443.2 million in May 2007 to finance the acquisition of Horizon Health.

Loss on refinancing of long-term debt. During 2007 we incurred a loss on refinancing long-term debt of $8.2 million that consisted primarily of the amount above par value we paid to repurchase our 10⁵/₈% Notes, the write-off of capitalized financing costs associated with our 10⁵/₈% Notes and the amount paid to exit the related interest rate swap agreements.

Loss from discontinued operations, net of taxes. The loss from discontinued operations (net of income tax effect) was $1.6 million for the years ended December 31, 2007 and 2006. During the year ended December 31, 2007, we elected to dispose of one inpatient facility and accordingly we reclassified its operations to discontinued operations. During 2006, we terminated three of our contracts to manage state-owned inpatient facilities and sold a therapeutic boarding school.

Year Ended December 31, 2006 Compared To Year Ended December 31, 2005

The following table compares key total facility statistics and same-facility statistics for 2006 and 2005 for owned and leased inpatient facilities.


	Year Ended December 31,				%
	2006		2005		Change
Total facility results:
Revenue (in thousands)	$	976,324	$	669,579		45.8	%
Number of facilities at period end		73		55		34.5	%
Admissions		107,903		78,206		38.0	%
Patient days		1,891,685		1,430,090		32.3	%
Average length of stay		17.5		18.3		-4.4	%
Revenue per patient day	$	516	$	468		10.3	%

Same-facility results:
Revenue (in thousands)	$	729,602	$	669,579		9.0	%
Number of facilities at period end		55		55		0.0	%
Admissions		79,981		78,206		2.3	%
Patient days		1,474,977		1,430,090		3.1	%
Average length of stay		18.4		18.3		0.5	%
Revenue per patient day	$	495	$	468		5.8	%

Revenue. Revenue from continuing operations was $1.0 billion in 2006 compared to $715.3 million in 2005, an increase of $307.1 million, or 42.9%. Revenue from owned and leased inpatient facilities accounted for $976.3 million in 2006 compared to $669.6 million of the 2005 results, an increase of $306.7 million, or 45.8%. The increase in revenue from owned and leased inpatient facilities relates primarily to acquisitions. The remainder of the increase in revenue from owned and leased inpatient facilities is primarily attributable to same-facility growth in patient days of 3.1% and revenue per patient day of 5.8%, Other revenue was $46.1 million of the 2006 results compared to $45.7 million of the 2005 results.

Salaries, wages, and employee benefits. SWB expense was $577.2 million in 2006, or 56.5% of total revenue. Effective January 1, 2006, we adopted Statement of Financial Accounting Standards (“SFAS”) No. 123 (Revised 2004) (“SFAS 123R”), Share Based Payment, using the modified-prospective transition method. SFAS No. 123R requires companies to measure and recognize the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award. Prior to the adoption of SFAS 123R, we accounted for our stock option plans using the intrinsic value method in accordance with the provisions of

Accounting Principles Board (“APB”) Opinion No. 25, Accounting for Stock Issued to Employees, and related interpretations, and, as a result, recognized no share-based compensation expense for those prior periods. SWB expense for 2006 includes $12.5 million of share-based compensation expense. Excluding share-based compensation expense, SWB expense was $564.7 million, or 55.2% of total revenue, in 2006 compared to $392.3 million, or 54.8% of total revenue, in 2005. SWB expense for owned and leased inpatient facilities was $529.8 million in 2006, or 54.3% of revenue. Same-facility SWB expense for owned and leased inpatient facilities was $392.7 million in 2006, or 53.8% of revenue, compared to $363.8 million in 2005, or 54.3% of revenue. SWB expense for other operations was $15.8 million in 2006 compared to $14.8 million in 2005. SWB expense for our corporate office was $31.6 million in 2006, including share-based compensation expense of $12.5 million, compared to $13.7 million in 2005, increasing primarily as a result of the share-based compensation expense and the hiring of additional staff necessary to manage the inpatient facilities and inpatient management contracts acquired during 2005 and 2006.

Professional fees. Professional fees were $97.1 million in 2006, or 9.5% of total revenue, compared to $73.2 million in 2005, or 10.2% of total revenue. Professional fees for owned and leased inpatient facilities were $90.0 million in 2006, or 9.2% of revenue. Same-facility professional fees for owned and leased inpatient facilities were $67.8 million in 2006, or 9.3% of revenue, compared to $66.3 million in 2005, or 9.9% of revenue. Professional fees for other operations were $3.1 million in 2006 compared to $3.4 million in 2005. Professional fees for our corporate office were $4.0 million in 2006 compared to $3.5 million in 2005.

Supplies. Supplies expense was $59.0 million in 2006, or 5.8% of total revenue, compared to $43.0 million in 2005, or 6.0% of total revenue. Supplies expense for owned and leased inpatient facilities was $58.3 million in 2006, or 6.0% of revenue. Same-facility supplies expense for owned and leased inpatient facilities was $44.7 million in 2006, or 6.1% of revenue, compared to $42.3 million in 2005, or 6.3% of revenue.

Provision for doubtful accounts. The provision for doubtful accounts was $19.5 million in 2006, or 1.9% of total revenue, compared to $13.5 million in 2005, or 1.9% of total revenue. The provision for doubtful accounts at owned and leased inpatient facilities comprises the majority of our provision for doubtful accounts as a whole.

Other operating expenses. Other operating expenses consist primarily of rent, utilities, insurance, travel, and repairs and maintenance expenses. Other operating expenses were approximately $108.8 million in 2006, or 10.6% of total revenue, compared to $86.1 million in 2005, or 12.0% of total revenue. Other operating expenses for owned and leased inpatient facilities were $85.0 million in 2006, or 8.7% of revenue. Same-facility other operating expenses for owned and leased inpatient facilities were $64.3 million in 2006, or 8.8% of revenue, compared to $61.9 million in 2005, or 9.3% of revenue. Other operating expenses for other operations were $18.5 million in 2006 compared to $17.8 million in 2005. Other operating expenses at our corporate office were $5.4 million in 2006 compared to $6.4 million in 2005.

Depreciation and amortization. Depreciation and amortization expense was $20.5 million in 2006 compared to $14.7 million in 2005, an increase of approximately $5.7 million. This increase in depreciation and amortization expense is primarily the result of our acquisitions of inpatient facilities during 2005 and 2006.

Interest expense, net. Interest expense, net of interest income, was $40.3 million in 2006 compared to $27.1 million in 2005, an increase of $13.3 million or 49.0%. The increase in interest expense is primarily attributable to debt incurred to fund the 2006 acquisitions and the July 1, 2005 acquisition of Ardent Behavioral. On December 31, 2006, we had $743.3 million in long-term debt compared to $482.4 million at December 31, 2005. During the third and fourth quarters of 2006 we borrowed $101.0 million under our revolving credit facility and $150.0 million under our senior secured term loan facility to fund acquisitions, most notably ABS on December 1, 2006. During July 2005 we borrowed $520.0 million under a bridge loan facility ($150.0 million), senior secured term loan facility ($325.0 million) and our revolving credit facility ($45.0 million) to finance the Ardent Behavioral acquisition. We issued $220.0 million of our 7³/₄% Notes and repaid the $150.0 million bridge loan and $61.3 million of our 10⁵/₈% Notes in July 2005. During September 2005 we repaid $125.0 million of our senior secured term loan facility and all borrowings under our revolving credit facility with proceeds from an offering of our common stock.

Other expenses. Other expenses in 2005 consisted of $21.9 million in losses on the refinancing of our long-term debt relating to the refinancings of $125.0 million of our senior secured term loan facility, $111.3 million of our 10 5/8% Notes and the $150.0 million bridge loan incurred to finance the acquisition of Ardent Behavioral.

Loss from discontinued operations, net of taxes. The loss from discontinued operations (net of income tax effect) of approximately $1.6 million for the year ended December 31, 2006 and income from discontinued operations of $0.3 million for the year ended December 31, 2005 are primarily from the operations of five contracts to manage inpatient facilities for the Florida Department of Juvenile Justice and the operating results of a therapeutic boarding school sold in 2006. These contracts to manage inpatient facilities for the Florida Department of Juvenile Justice were assumed in the acquisition of Ramsay Youth Services, Inc. in 2003. Three of these contracts were terminated in 2006 and two were terminated in 2005.

Liquidity and Capital Resources

Working capital at December 31, 2007 was $157.8 million, including cash and cash equivalents of $40.0 million, compared to working capital of $103.3 million, including cash and cash equivalents of $18.6 million, at December 31, 2006. At December 31, 2007, we had $213.0 million available for future borrowings under our revolving credit facility.

Cash provided by continuing operating activities was $125.7 million in 2007 compared to $123.5 million in 2006. The increase in cash flows from operating activities was primarily due to an increase in cash generated from the inpatient facilities offset by an increase in income tax payments and interest payments. Income tax payments in 2006 were reduced by our utilization of net operating loss carryforwards and tax deductions generated by stock option exercises. Our operating loss carryforwards were substantially utilized in 2006, and as a result, income tax payments moved closer to our provision for income taxes in 2007. Interest payments in 2007 increased to $62.9 million compared to $40.2 million in 2006 primarily due to the increase in debt incurred to finance the acquisitions of ABS and Horizon Health.

Billings for patient accounts receivable are generally submitted to the payor within three days of the patient’s discharge or completion of services. Interim billings may be utilized for patients with extended lengths of stay. We verify within a reasonable period of time that claims submitted to third-party payors have been received and are being processed by such payors. Follow-up regarding the status of each claim is made on a periodic basis until payment on the claim is received. Billing notices for self-pay accounts receivable are distributed on a periodic basis. Self-pay accounts receivable are turned over to collection agencies once internal collection efforts have been exhausted. Accounts receivable under our inpatient management contracts are billed at least monthly. Follow-up collection efforts are made on a periodic basis until payment is received. Our allowance for doubtful accounts for patient receivables primarily consists of patient accounts that are greater than 180 days past the patient’s discharge date. Our allowance for doubtful accounts for receivables due under our inpatient management contracts primarily consists of amounts that are specifically identified as potential collection issues. Accounts receivable are written off when collection within a reasonable period of time is deemed unlikely.

Cash used by continuing investing activities was $538.5 million in 2007 compared to $419.5 million in 2006. Cash used in investing activities in 2007 was primarily the result of $462.8 million paid for acquisitions of behavioral health care facilities and $73.2 million paid for the purchases of fixed assets. Cash paid for acquisitions consisted primarily of the acquisition of Horizon Health. Cash used for routine and expansion capital expenditures was approximately $32.7 million and $40.5 million, respectively, for the year ended December 31, 2007. We anticipate expansion expenditures to increase in 2008 as a result of planned capital expansion projects and the construction of new facilities, which are expected to add approximately 600 new beds to our operations. We define expansion capital expenditures as those that increase the capacity of our facilities or otherwise enhance revenue. Routine or maintenance capital expenditures were 2.2% of our net revenue for 2007. Cash used in investing activities in 2006 consisted primarily of $385.1 million paid for acquisitions of behavioral health care facilities and $33.8 million paid for the purchases of fixed assets.

Cash provided by financing activities was $432.5 million in 2007 compared to $259.6 million in 2006. During 2007, we borrowed an additional $225.0 million under our senior secured term loan facility and used the net proceeds of our offering of $250 million of 7³/₄%Notes to finance the majority of the Horizon Health acquisition and repurchase $38.6 million of our 10⁵/₈% Notes. We also had net repayments of $21.0 million on our revolving credit facility and received $17.3 million from issuances of our common stock from stock option exercises in 2007. Cash provided by financing activities in 2006 consisted primarily of $150.0 million and $101.0 million borrowed under our senior secured term loan facility and revolving credit facility, respectively, primarily to finance acquisitions.

We have a universal shelf registration statement on Form S-3 under which we may sell an indeterminate amount of our common stock, common stock warrants, preferred stock and debt securities. We may from time to time offer these securities in one or more series, in amounts, at prices and on terms satisfactory to us.

During the fourth quarter of 2007, we entered into an interest rate swap arrangement with a credit worthy financial institution to manage our exposure to fluctuations in interest rates. With this interest swap arrangement we will exchange the interest payments associated with a notional amount of $225 million of LIBOR indexed variable rate debt related to our senior secured term loan for a fixed interest rate. This interest rate swap arrangement matures on November 30, 2009. We expect a definitive agreement relating to the interest rate swap to be signed in the first quarter of 2008. During the second quarter of 2007, we terminated our interest rate swap agreements related to our 10⁵/₈% Notes.

We are actively seeking acquisitions that fit our corporate growth strategy and may acquire additional inpatient psychiatric facilities. Management continually assesses our capital needs and, should the need arise, we will seek additional financing, including debt or equity, to fund potential acquisitions, facility expansions or for other corporate purposes. In negotiating such financing, there can be no assurance that we will be able to raise additional capital on terms satisfactory to us. Failure to obtain additional financing on reasonable terms could have a negative effect on our plans to acquire additional inpatient psychiatric facilities.

Obligations and Commitments


	Payments Due by Period (in thousands)
			Less than						More than
	Total		1 year		1-3 years		3-5 years		5 years
Long-term debt (1):
Senior Credit Facility:
Revolving line of credit facility, expiring on December 21, 2009 and bearing interest of 6.4% and 6.7% at December 31, 2007 and December 31, 2006, respectively		80,000	$	—	$	80,000	$	—	$	—
Senior secured term loan facility, expiring on July 1, 2012 and bearing interest of 6.8% and 7.1% at December 31, 2007 and December 31, 2006, respectively		573,313		4,688		7,500		561,125		—
7 3/4% Senior Subordinated Notes due July 15, 2015		476,508		—		—		—		476,508
Mortgage loans on facilities, maturing in 2036, 2037 and 2038 bearing fixed interest rates of 5.7% to 7.6%		33,671		397		873		988		31,413

		1,163,492		5,085		88,373		562,113		507,921
Lease and other obligations		91,107		16,762		24,990		13,322		36,033

Total contractual obligations	$	1,254,599	$	21,847	$	113,363	$	575,435	$	543,954


(1)		Excludes capital lease obligations, fair value of interest rate swap, and other obligations of $7.7 and $0.8 million, which are included in lease and other obligations.

The fair value of our $470.0 million 7³/₄% Notes was approximately $467.1 million as of December 31, 2007. The fair values of our $220.0 million 7³/₄% Notes and $38.7 million 10⁵/₈% Notes were approximately $218.6 million and approximately $42.4 million, respectively, as of December 31, 2006. The carrying value of our other long-term debt, including current maturities, of $695.5 million and $484.6 million at December 31, 2007 and December 31, 2006, respectively, approximated fair value. We had $80.0 million and $573.3 million, respectively, of variable rate debt outstanding under our revolving credit facility and senior secured term loan facility as of December 31, 2007. As a result of our interest rate swap arrangement to exchange interest payments associated with a notional amount of $225 million of LIBOR indexed variable rate debt for a fixed rate, the variable rate debt outstanding under our senior secured term loan facility was effectively $348.3 million as of December 31, 2007. At our December 31, 2007 borrowing level, a hypothetical 10% increase in interest rates would decrease our annual net income and cash flows by approximately $1.8 million.

Impact of Inflation and Economic Trends

Although inflation has not had a material impact on our results of operations, the health care industry is very labor intensive and salaries and benefits are subject to inflationary pressures as are supply costs, which tend to escalate as vendors pass on the rising costs through price increases. Some of the freestanding owned, leased and managed inpatient behavioral health care facilities we operate are experiencing the effects of the tight labor market, including a shortage of nurses, which has caused and may continue to cause an increase in our SWB expense in excess of the inflation rate. Although we cannot predict our ability to cover future cost increases, management believes that through adherence to cost containment policies, labor management and reasonable price increases, the effects of inflation on future operating margins should be manageable. Our ability to pass on increased costs associated with providing health care to Medicare and Medicaid patients is limited due to various federal, state and local laws which have been enacted that, in certain cases, limit our ability to increase prices. In addition, as a result of increasing regulatory and competitive pressures and a continuing industry wide shift of patients into managed care plans, our ability to maintain margins through price increases to non-Medicare patients is limited.

The behavioral health care industry is typically not directly impacted by periods of recession, erosions of consumer confidence or other general economic trends as most health care services are not considered a component of discretionary spending. However, our inpatient facilities may be indirectly negatively impacted to the extent such economic conditions result in decreased reimbursements by federal or state governments or managed care payors. We are not aware of any economic trends that would prevent us from being able to remain in compliance with all of our debt covenants and to meet all required obligations and commitments in the near future.

Critical Accounting Policies

Our consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States. In preparing our financial statements, we are required to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses included in the financial statements. Estimates are based on historical experience and other information currently available, the results of which form the basis of such estimates. While we believe our estimation processes are reasonable, actual results could differ from our estimates. The following represent the estimates considered most critical to our operating performance and involve the most subjective and complex assumptions and assessments.

Allowance for Doubtful Accounts

Our ability to collect outstanding patient receivables from third-party payors is critical to our operating performance and cash flows.

The primary collection risk with regard to patient receivables lies with uninsured patient accounts or patient accounts for which primary insurance has paid, but the portion owed by the patient remains outstanding. We estimate the allowance for doubtful accounts primarily based upon the age of the accounts since the patient discharge date. We continually monitor our accounts receivable balances and utilize cash collection data to support our estimates of the provision for doubtful accounts. Significant changes in payor mix or business office operations could have a significant impact on our results of operations and cash flows.

The primary collection risk with regard to receivables due under our inpatient management contracts is attributable to contractual disputes. We estimate the allowance for doubtful accounts for these receivables based primarily upon the specific identification of potential collection issues. As with our patient receivables, we continually monitor our accounts receivable balances and utilize cash collection data to support our estimates of the provision for doubtful accounts.

Allowances for Contractual Discounts

The Medicare and Medicaid regulations are complex and various managed care contracts may include multiple reimbursement mechanisms for different types of services provided in our inpatient facilities and cost settlement provisions requiring complex calculations and assumptions subject to interpretation. We estimate the allowance for contractual discounts on a payor-specific basis by comparing our established billing rates with the amount we determine to be reimbursable given our interpretation of the applicable regulations or contract terms. Most payments are determined based on negotiated per-diem rates. While the services authorized and provided and related reimbursement are often subject to interpretation that could result in payments that differ from our estimates, these differences are deemed immaterial. Additionally, updated regulations and contract renegotiations occur frequently necessitating continual review and assessment of the estimation process by our management. We periodically compare the contractual rates on our patient accounting systems with the Medicare and Medicaid reimbursement rates or the third-party payor contract for accuracy. We also monitor the adequacy of our contractual adjustments using financial measures such as comparing cash receipts to net patient revenue adjusted for bad debt expense.

As of December 31, 2007, our patient accounts receivable balance for third-party payors was $222.4 million. A theoretical 1% change in the amounts due from third-party payors at December 31, 2007 could have an after tax effect of approximately $1.4 million on our financial position and results of operations.

The following table presents the percentage by payor of our net revenue and accounts receivable for the years ended December 31, 2007 and 2006 (in thousands):


	For the Year Ended December 31,
	2007						2006
	Net			Accounts			Net			Accounts
	Revenue			Receivable			Revenue			Receivable
Payor mix:
Medicaid		32	%		27	%		36	%		32	%
Commercial/HMO/Private Pay		33	%		36	%		34	%		35	%
Medicare		13	%		11	%		13	%		12	%
State agency		16	%		18	%		13	%		18	%
Other		6	%		8	%		4	%		3	%

Total		100	%		100	%		100	%		100	%

The following table presents the percentage by aging category of our accounts receivable at December 31, 2007 and 2006 (in thousands):


	At December 31,
	2007			2006
0 - 30 days		64	%		61	%
31 - 60 days		15	%		16	%
61 - 90 days		8	%		9	%
91 - 120 days		5	%		5	%
121 - 150 days		3	%		4	%
151 - 180 days		3	%		3	%
> 180 days		2	%		2	%

Total		100	%		100	%

Our consolidated day’s sales outstanding were 53 for the years ended December 31, 2007 and 2006. Our consolidated collections as a percentage of net revenue less bad debt expense was 101.6% and 100.5% for the years ended December 31, 2007 and 2006, respectively.

Professional and General Liability

We are subject to medical malpractice and other lawsuits due to the nature of the services we provide. At December 31, 2007, all of our operations have professional and general liability insurance in umbrella form for claims in excess of $3.0 million with an insured limit of $50.0 million. The self-insured reserves for professional and general liability risks are calculated based on historical claims, demographic factors, industry trends, severity factors, and other actuarial assumptions calculated by an independent third-party actuary. This self-insurance reserve is discounted to its present value using a 5% discount rate. This estimated accrual for professional and general liabilities could be significantly affected should current and future occurrences differ from historical claim trends and expectations. We have utilized our captive insurance company to manage the self-insured retention. While claims are monitored closely when estimating professional and general liability accruals, the complexity of the claims and wide range of potential outcomes often hampers timely adjustments to the assumptions used in these estimates.

Income Taxes

As part of our process for preparing our consolidated financial statements, our management is required to compute income taxes in each of the jurisdictions in which we operate. This process involves estimating the current tax benefit or expense of future deductible and taxable temporary differences. The future deductible and taxable temporary differences are recorded as deferred tax assets and liabilities which are components of our balance sheet. Management then assesses our ability to realize the deferred tax assets based on reversals of deferred tax liabilities and, if necessary, estimates of future taxable income. A valuation allowance for deferred tax assets is established when we believe that it is more likely than not that the deferred tax asset will not be realized. Management must also assess the impact of our acquisitions on the realization of deferred tax assets subject to a valuation allowance to determine if all or a portion of the valuation allowance will be offset by reversing taxable differences or future taxable income of the acquired entity. To the extent the valuation allowance can be reversed due to the estimated future taxable income of an acquired entity, then our valuation allowance is reduced accordingly as an adjustment to purchase price.

We adopted FASB Interpretation No. 48 (“FIN 48”), Accounting for Uncertainty in Income Taxes - An Interpretation of FASB Statement No. 109, on January 1, 2007. Applying the provisions of FIN 48 requires significant judgments regarding the recognition and measurement of each tax position. Changes in these judgments may materially affect the estimate of our effective tax rate and our operating results.

Share-Based Compensation

We adopted SFAS No. 123R under the modified-prospective transition method on January 1, 2006, which requires us to measure and recognize the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of such awards. We utilize the Black-Scholes option pricing model to estimate the grant-date fair value of our stock options. The Black-Scholes model includes certain variables and assumptions that require judgment, such as the expected volatility of our stock price and the expected term of our stock options. Additionally, SFAS 123R requires us to use judgment in the estimation of forfeitures over the vesting period of share-based awards.

Item 7A. Quantitative and Qualitative Disclosures About Market Risk.

Our interest expense is sensitive to changes in the general level of interest rates. With respect to our interest-bearing liabilities and including our interest rate swap, approximately $735.2 million of our long-term debt outstanding at December 31, 2007 was subject to a weighted-average fixed interest rate of 7.0%. Our variable rate debt is comprised of our senior secured term loan facility, which had $348.3 million outstanding at December 31, 2007 (excluding $225 million associated with our interest rate swap) and on which interest is generally payable at LIBOR plus 1.75%, and our $300.0 million revolving credit facility, which had a $80.0 million balance outstanding at December 31, 2007 and on which interest is generally payable at LIBOR plus 1.25% to 2.25% (depending on a certain covenant ratio). We have entered into an interest rate swap arrangement with a creditworthy financial institution to exchange the interest payments associated with a notional amount of $225 million of LIBOR indexed variable rate debt for a fixed rate. A hypothetical 10% increase in interest rates would decrease our net income and cash flows by approximately $1.8 million on an annual basis based upon our borrowing level at December 31, 2007. In the event we draw on our revolving credit facility and interest rates change significantly, we expect management would take actions intended to further mitigate our exposure to such change. Information on quantitative and qualitative disclosure about market risk is included in Part II, Item 7 of this Annual Report on Form 10-K under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Liquidity and Capital Resources.”

Item 8. Financial Statements and Supplementary Data.

Information with respect to this Item is contained in our consolidated financial statements indicated in the Index on Page F-1 of this Annual Report on Form 10-K.

Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure.

None.

Item 9A. Controls and Procedures.

Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures

We carried out an evaluation, under the supervision and with the participation of management, including our Chief Executive Officer and Chief Accounting Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report pursuant to Exchange Act Rule 13a-15. Based upon that evaluation, our Chief Executive Officer and Chief Accounting Officer concluded that our disclosure controls and procedures were effective in ensuring that information required to be disclosed by us (including our consolidated subsidiaries) in reports that we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported on a timely basis.

Pursuant to Section 404 of the Sarbanes-Oxley Act of 2002, we have included a report of management’s assessment of the design and operating effectiveness of our internal controls as part of this report. Our independent registered public accounting firm also reported on the effectiveness of our internal control over financial reporting. Management’s report and the independent registered public accounting firm’s report are included in our 2007 consolidated financial statements beginning with the index on page F-1 of this report under the captions entitled “Management’s Report on Internal Control Over Financial Reporting” and “Report of Independent Registered Public Accounting Firm.”

Changes in Internal Control Over Financial Reporting

There has been no change in our internal control over financial reporting during the fourth quarter ended December 31, 2007 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Item 9B. Other Information.

On November 29, 2007, we entered into an interest rate swap transaction (the “Swap”) with Merrill Lynch Capital Services, Inc. (“Merrill Lynch”) to manage our exposure to fluctuations in interest rates. The Swap was effective on November 30, 2007 and applies to a notional amount of $225 million (the “Notional Amount”) of LIBOR indexed variable rate debt related to our senior secured term loan. The Swap expires on November 30, 2009. Under the Swap, we have agreed with Merrill Lynch to exchange interest payments on the Notional Amount. On a monthly basis, we have agreed to pay a fixed interest rate of 3.825% and Merrill Lynch has agreed to pay a floating interest rate equal to the one-month LIBOR. Although the parties entered into this transaction in November 2007, the parties have not executed a written agreement concerning the Swap, but expect to do so in the first quarter of 2008.

The Swap has standard defaults and is cross-defaulted to the underlying Credit Agreement. The Swap can be terminated by Merrill Lynch upon an event of default, upon release of substantially all of the collateral under the Credit Agreement, or if Merrill Lynch loses its position on the collateral. The Swap can also be terminated if the Credit Agreement is refinanced in a way that (i) results in weaker covenants in the new credit agreement, (ii) leaves the Swap unsecured or (iii) leaves the Swap secured by collateral that is weaker than the collateral under the current arrangement. If the Swap is terminated early, it is possible that PSI would have to pay a breakage fee.

Affiliates of Merrill Lynch have provided investment and commercial banking and financial advisory services from time to time for us in the ordinary course of business for which they have received customary fees. Merrill Lynch and its affiliates may in the future engage in investment banking or other transactions of a financial nature with us or our affiliates, including the provision of advisory services and the making of loans to us or our affiliates, for which they would receive customary fees or other payments.

PART III

Item 10. Directors and Executive Officers and Corporate Governance.

Directors

The information relating to our directors set forth in the Company’s Proxy Statement relating to the 2008 Annual Meeting of Stockholders under the caption “Proposal 1: Election of Directors” and “Corporate Governance — Committees of the Board of Directors — Audit Committee” is incorporated herein by reference.

Executive Officers of the Registrant

The executive officers of the Company are:


Name	Age		Officer Since	Positions
Joey A. Jacobs		54	April 1997	President and Chief Executive Officer
Terrance R. Bridges		55	July 2007	Chief Operating Officer
Jack E. Polson		41	August 2002	Executive Vice President, Chief Accounting Officer
Brent Turner		42	February 2003	Executive Vice President, Finance and Administration
Christopher L. Howard		41	September 2005	Executive Vice President, General Counsel and Secretary
Steven T. Davidson		50	August 1997	Chief Development Officer

Joey A. Jacobs, President and Chief Executive Officer. Mr. Jacobs serves as President and Chief Executive Officer and was one of our co-founders in April 1997. Prior to our founding, Mr. Jacobs served for 21 years in various capacities with HCA Inc. (“HCA,” also formerly known as Hospital Corporation of America, Columbia and Columbia/HCA), most recently as President of the Tennessee Division. Mr. Jacobs’ background at HCA also includes serving as President of HCA’s Central Group, Vice President of the Western Group, Assistant Vice President of the Central Group and Assistant Vice President of the Salt Lake City Division.

Terrance R. Bridges, Chief Operating Officer. Mr. Bridges has served as Chief Operating Officer since July 1, 2007. Mr. Bridges most recently served as President of PSI’s Western Division and prior to that as Chief Executive Officer of Fremont Hospital. From 1996 until 2004, Mr. Bridges worked at Cedars-Sinai Medical Center where he held administrative director roles. From 1986 until 1996 Mr. Bridges served as an officer and directed regional or divisional operations for Community Psychiatric Centers and Ramsay Healthcare Inc.

Jack E. Polson, Executive Vice President, Chief Accounting Officer. Mr. Polson has served as an Executive Vice President since September 2006 and as Chief Accounting Officer since August 2002. Prior to being appointed Chief Accounting Officer, Mr. Polson had served as Controller since June 1997. From June 1995 until joining us, Mr. Polson served as Controller for Columbia Healthcare Network, a risk-bearing physician health organization. From May 1992 until June 1995, Mr. Polson served as an Internal Audit Supervisor for HCA.

Brent Turner, Executive Vice President, Finance and Administration. Mr. Turner has served as the Executive Vice President, Finance and Administration since August 2005 and previously had served as the Vice President, Treasurer and Investor Relations since February 2003. From April 2002 until joining us, Mr. Turner served as Executive Vice President and Chief Financial Officer of a privately-held owner and operator of schools for children with learning disabilities. From November 2001 until March 2002, Mr. Turner served as Senior Vice President of Business Development for The Brown Schools, Inc., a provider of educational and therapeutic services for at-risk youth. From 1996 until January 2001, Mr. Turner was employed by Corrections Corporation of America, a private prison operator, serving as Treasurer from 1998 to 2001.

Chris Howard, Executive Vice President, General Counsel and Secretary. Mr. Howard has served as the Executive Vice President, General Counsel and Secretary since September 2005. Prior to joining us, Mr. Howard was a member of Waller Lansden Dortch & Davis, LLP, a law firm based in Nashville, Tennessee.

Steven T. Davidson, Chief Development Officer. Mr. Davidson has served as Chief Development Officer since August 1997 and has over 24 years of health care experience. Prior to joining us, Mr. Davidson served as the Director of Development at HCA from 1991 until 1997. Mr. Davidson also served as Senior Audit Supervisor and Hospital Controller during his term at HCA, which began in 1983, where he supervised audits of hospitals and other corporate functions. Prior to joining HCA, Mr. Davidson was employed by Ernst & Young LLP as a Senior Auditor. Mr. Davidson is a Certified Public Accountant and a member of the American Institute of Certified Public Accountants.

Code of Ethics

We adopted a Code of Ethics that applies to all of our directors, officers and employees. The Code of Ethics is available on our website at www.psysolutions.com. We will disclose any amendment to, other than technical, administrative or non-substantive amendments, or waiver of our Code of Ethics granted to a director or executive officer by filing a Current Report on Form 8-K disclosing the amendment or waiver within four business days. Upon the written request of any person, we will furnish, without charge, a copy of our Code of Ethics. Requests should be directed to Psychiatric Solutions, Inc., 6640 Carothers Parkway, Suite 500, Franklin, Tennessee 37067, Attention: Christopher L. Howard, Esq., Executive Vice President, General Counsel and Secretary.

Section 16(a) Compliance

The information relating to Section 16(a) beneficial ownership reporting compliance set forth in our Proxy Statement relating to the 2008 Annual Meeting of Stockholders under the caption “Section 16(a) Beneficial Ownership Reporting Compliance” is incorporated herein by reference.

Item 11. Executive Compensation.

The information set forth in our Proxy Statement relating to the 2008 Annual Meeting of Stockholders under the caption “Compensation Discussion and Analysis” and “Executive Compensation” is incorporated herein by reference. The “Compensation Committee Report” also included in the Proxy Statement is expressly not incorporated herein by reference.

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.

The information set forth in our Proxy Statement relating to the 2008 Annual Meeting of Stockholders under the caption “Security Ownership of Certain Beneficial Owners and Management” and “Executive Compensation — Equity Compensation Plan Information” is incorporated herein by reference.

Item 13. Certain Relationships and Related Transactions, and Director Independence.

The information set forth in our Proxy Statement relating to the 2008 Annual Meeting of Stockholders under the caption “Corporate Governance — Standards of Independence for the Board of Directors” and “Certain Relationships and Related Transactions” is incorporated herein by reference.

Item 14. Principal Accountant Fees and Services.

The information set forth in our Proxy Statement relating to the 2008 Annual Meeting of Stockholders under the caption “Proposal 3: Ratification of Appointment of Independent Registered Public Accounting Firm” is incorporated herein by reference.

PART IV

Item 15. Exhibits and Financial Statement Schedules.

(a) The following documents are filed as part of this Annual Report on Form 10-K:

1. Consolidated Financial Statements: The consolidated financial statements of Psychiatric Solutions are included as follows:


		Page
Report of Independent Registered Public Accounting Firm		F-2
Management’s Report on Internal Control Over Financial Reporting		F-3
Report of Independent Registered Public Accounting Firm		F-4
Consolidated Balance Sheets		F-5
Consolidated Statements of Income		F-6
Consolidated Statements of Stockholders’ Equity		F-7
Consolidated Statements of Cash Flows		F-8
Notes to Consolidated Financial Statements		F-10

2. Financial Statement Schedules.

All schedules are omitted because they are not applicable or are not required, or because the required information is included in the consolidated financial statements or notes in this report.

3. Exhibits. The exhibits which are filed with this report or which are incorporated herein by reference are set forth in the Exhibit Index on pages 32 through 36.

(b) Exhibits.


Exhibit
Number		Description
2.1		Agreement and Plan of Merger by and among PMR Corporation, PMR Acquisition Corporation and Psychiatric Solutions, Inc., dated May 6, 2002, as amended by Amendment No. 1, dated as of June 10, 2002, and Amendment No. 2, dated as of July 9, 2002 (included as Annex A to Amendment No. 1 to the Company’s Registration Statement on Form S-4, filed on July 11, 2002 (Reg. No. 333-90372)).

2.2		Agreement and Plan of Merger, dated April 8, 2003, by and among Psychiatric Solutions, Inc., PSI Acquisition Sub, Inc. and Ramsay Youth Services, Inc. (incorporated by reference to Exhibit 2.1 of the Company’s Current Report on Form 8-K, filed on April 10, 2003).

2.3		Amended and Restated Stock Purchase Agreement, dated June 30, 2005, by and among Ardent Health Services LLC, Ardent Health Services, Inc. and Psychiatric Solutions, Inc. (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K, filed July 8, 2005).

2.4		Amended and Restated Stock Purchase Agreement, dated as of October 27, 2006, by and between FHC Health Systems, Inc. and Psychiatric Solutions, Inc. (incorporated by reference to Exhibit 2 to the Company’s Current Report on Form 8-K, filed on December 7, 2006).

2.5		Agreement and Plan of Merger, dated December 20, 2006, by and among Psychiatric Solutions, Inc., Panther Acquisition Sub, Inc. and Horizon Health Corporation (incorporated by reference to Exhibit 2.5 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2006 (the “2006 10-K).

3.1		Amended and Restated Certificate of Incorporation of PMR Corporation, filed with the Delaware Secretary of State on March 9, 1998 (incorporated by reference to Exhibit 3.1 to the Company’s Annual Report on Form 10-K for the fiscal year ended April 30, 1998).

3.2		Certificate of Amendment to Amended and Restated Certificate of Incorporation of PMR Corporation, filed with the Delaware Secretary of State on August 5, 2002 (incorporated by reference to Exhibit 3.2 to the Company’s Quarterly Report on Form 10-Q for the quarter ended July 31, 2002).

3.3		Certificate of Amendment to Amended and Restated Certificate of Incorporation of Psychiatric Solutions, Inc., filed with the Delaware Secretary of State on March 21, 2003 (incorporated by reference to Appendix A of the Company’s Definitive Proxy Statement, filed on January 22, 2003).


Exhibit
Number		Description
3.4		Certificate of Amendment to Amended and Restated Certificate of Incorporation of Psychiatric Solutions, Inc., filed with the Delaware Secretary of State on December 15, 2005.

3.5		By-Laws (incorporated by reference to Exhibit 3 to the Company’s Current Report on Form 8-K filed on November 6, 2007).

4.1		Reference is made to Exhibits 3.1 through 3.5.

4.2		Common Stock Specimen Certificate (incorporated by reference to Exhibit 4.2 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2002).

4.3		Indenture, dated as of June 30, 2003, among Psychiatric Solutions, Inc., the Guarantors named therein and Wachovia Bank, National Association, as Trustee (incorporated by reference to Exhibit 4.10 to the Company’s Registration Statement on Form S-4, filed on July 30, 2003 (Registration No. 333-107453).

4.4		Form of Notes (included in Exhibit 4.3).

4.5		Indenture, dated as of July 6, 2005, by and among Psychiatric Solutions, Inc., the Guarantors named therein and Wachovia Bank, National Association, as Trustee (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K, filed July 8, 2005).

4.6		Form of Notes (included in Exhibit 4.5).

4.7		Thirty-Fifth Supplemental Indenture, dated as of May 21, 2007, by and among Psychiatric Solutions, Inc., the Guarantors named therein and U.S. Bank National Association, as Trustee (incorporated by reference to Exhibit 4 to the Company’s Current Report on Form 8-K, filed on May 22, 2007).

4.8		Purchase Agreement, dated as of May 24, 2007, among Psychiatric Solutions, Inc., the subsidiaries named as guarantors thereto, and Citigroup Global Markets Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated, as representatives of the initial purchasers named therein (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K, filed on May 25, 2007).

4.9		Seventeenth Supplemental Indenture, dated as of May 31, 2007, among Psychiatric Solutions, Inc., the subsidiaries of Psychiatric Solutions, Inc. party thereto as guarantors and U.S. Bank National Association, as Trustee (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K, filed on June 1, 2007).

4.10		Exchange and Registration Rights Agreement, dated as of May 31, 2007, among Psychiatric Solutions, Inc., the subsidiaries of Psychiatric Solutions, Inc. party thereto as guarantors, and Citigroup Global Markets Inc., Merrill, Lynch, Pierce, Fenner & Smith Incorporated, Banc of America Securities LLC, and J.P. Morgan Securities Inc. (incorporated by reference to Exhibit 4.3 to the Company’s Current Report on Form 8-K, filed June on 1, 2007).

10.1†		Employment Agreement, dated as of May 10, 2007, between Joey A. Jacobs and Psychiatric Solutions, Inc. (incorporated by reference to Exhibit 10 to the Company’s Current Report on Form 8-K, filed on May 15, 2007).

10.2†		Form of Indemnification Agreement executed by each director of Psychiatric Solutions, Inc. and Psychiatric Solutions, Inc. (incorporated by reference to Exhibit 10.4 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2004).

10.3		Second Amended and Restated Credit Agreement, dated as of July 1, 2005, by and among Psychiatric Solutions, Inc., the subsidiaries named as guarantors thereto, Citicorp North America, Inc., as term loan facility administrative agent, co-syndication agent and documentation agent, Bank of America, N.A., as revolving loan facility administrative agent, collateral agent swing line lender and co-syndication agent, and the various other agents and lenders party thereto. (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed on July 8, 2005).


Exhibit
Number		Description
10.4		Amendment No. 1 to Psychiatric Solutions, Inc.’s Second Amended and Restated Credit Agreement, dated as of December 1, 2006, by and between Psychiatric Solutions, Inc., BHC Holdings, Inc., Premier Behavioral Solutions, Inc., Alternative Behavioral Services, Inc., the subsidiaries of Psychiatric Solutions, Inc. party thereto as guarantors, Citicorp North America, Inc., as Term Loan Facility Administrative Agent, Bank of America, N.A., as Revolving Credit Facility Administrative Agent, Citigroup Global Markets Inc. and Banc of America Securities LLC, as the Arrangers (incorporated by reference to Exhibit 10 to the Company’s Current Report on Form 8-K, filed on December 7, 2006).

10.5		Amendment No. 2 to Second Amended and Restated Credit Agreement, dated as of December 1, 2006, by and among Psychiatric Solutions, Inc., BHC Holdings, Inc., Premier Behavioral Solutions, Inc., Alternative Behavioral Services, Inc., Horizon Health Corporation, ABS LINCS PR, Inc., First Hospital Panamericano, Inc., FHCHS of Puerto Rico, Inc., First Corrections — Puerto-Rico, Inc., the subsidiaries of Psychiatric Solutions, Inc. party thereto as guarantors, Citicorp North America, Inc., as term loan facility administrative agent, Bank of America, N.A., as revolving credit facility administrative agent, Citigroup Global Markets Inc. and Merrill, Lynch, Pierce, Fenner & Smith Incorporated, as joint lead arrangers and joint book-running managers (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed on June 1, 2007).

10.6		Interest Rate Swap Agreement, dated January 28, 2004, between Bank of America, N.A. and Psychiatric Solutions, Inc. (incorporated by reference to Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2004).

10.7		Confirmation of Interest Rate Swap Agreement, dated April 26, 2004, between Bank of America, N.A. and Psychiatric Solutions, Inc. (incorporated by reference to Exhibit 10.5 to the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2004).

10.8†		Psychiatric Solutions, Inc. 2007 Long-Term Equity Compensation Plan (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K, filed on February 22, 2007).

10.9†		Psychiatric Solutions, Inc. 2008 Long-Term Equity Compensation Plan (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K, filed on February 27, 2008).

10.10†		Amended and Restated Psychiatric Solutions, Inc. Equity Incentive Plan, as amended by an Amendment adopted on May 4, 2004 (incorporated by reference to Appendix A to the Company’s Definitive Proxy Statement, filed on April 9, 2004).

10.11†		Second Amendment to the Psychiatric Solutions, Inc. Equity Incentive Plan (incorporated by reference to Appendix A to the Company’s Definitive Proxy Statement, filed on April 22, 2005).

10.12†		Third Amendment to the Psychiatric Solutions, Inc. Equity Incentive Plan (incorporated by reference to Appendix B of the Company’s Definitive Proxy Statement, filed on April 21, 2006).

10.13†		Psychiatric Solutions, Inc. Executive Performance Incentive Plan (incorporated by reference to Appendix A of the Company’s Definitive Proxy Statement, filed on April 21, 2006).

10.14†		Form of Nonstatutory Stock Option Agreement under the 1997 Plan (incorporated by reference to Exhibit 10.3 to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2007).

10.15†		Form of Restricted Stock Agreement (incorporated by reference to Exhibit 10.3 to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2006).

10.16†		Amended and Restated Psychiatric Solutions, Inc. Outside Directors’ Non-Qualified Stock Option Plan (incorporated by reference to Appendix C to the Company’s Definitive Proxy Statement, filed on April 14, 2003).

10.17†		Amendment to the Amended and Restated Psychiatric Solutions, Inc. Outside Directors’ Stock Option Plan (incorporated by reference to Appendix B to the Company’s Definitive Proxy Statement, filed on April 22, 2005).

10.18†		Form of Outside Directors’ Non-Qualified Stock Option Agreement (incorporated by reference to Exhibit 10.5 to the Company’s Annual Report on Form 10-K for the year ended April 30, 1997).


Exhibit
Number		Description
10.19†		2008 Executive Officer Compensation (incorporated by reference to the Company’s Current Report on Form 8-K, filed on October 29, 2007).

10.20†		Psychiatric Solutions, Inc. 2007 Cash Bonus Plans (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed on February 22, 2007).

10.21†		Psychiatric Solutions, Inc. 2008 Cash Bonus Plans (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed on February 27, 2008).

10.22†		Summary of Director Compensation (incorporated by reference to Exhibit 10.22 to the 2006 10-K).

21.1*		List of Subsidiaries.

23.1*		Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm.

31.1*		Certification of the Chief Executive Officer of Psychiatric Solutions, Inc. Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2*		Certification of the Chief Accounting Officer of Psychiatric Solutions, Inc. Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1*		Certifications of the Chief Executive Officer and Chief Accounting Officer of Psychiatric Solutions, Inc. Pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.


*		Filed herewith

†		Management contract or compensatory plan or arrangement

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Board of Directors and Stockholders of Psychiatric Solutions, Inc.

We have audited the accompanying consolidated balance sheets of Psychiatric Solutions, Inc. as of December 31, 2007 and 2006, and the related consolidated statements of income, stockholders’ equity, and cash flows for each of the three years in the period ended December 31, 2007. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial position of Psychiatric Solutions, Inc. at December 31, 2007 and 2006, and the consolidated results of its operations and its cash flows for each of the three years in the period ended December 31, 2007, in conformity with U.S. generally accepted accounting principles.

As discussed in Note 8 to the consolidated financial statements, the Company adopted FASB Interpretation No. 48, Accounting for Uncertainty in Income Taxes-An Interpretation of FASB Statement No. 109, effective January 1, 2007.

As discussed in Note 1 to the consolidated financial statements, the Company adopted SFAS No. 123(R), Share-Based Payment, effective January 1, 2006.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), Psychiatric Solutions, Inc.’s internal control over financial reporting as of December 31, 2007, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated February 26, 2008 expressed an unqualified opinion thereon.

/s/ Ernst & Young LLP

Nashville, Tennessee
February 26, 2008

F-2

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Board of Directors and Stockholders of Psychiatric Solutions, Inc.

We have audited Psychiatric Solutions, Inc.’s internal control over financial reporting as of December 31, 2007, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (the COSO criteria). Psychiatric Solutions, Inc.’s management is responsible for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management’s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit.

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

In our opinion, Psychiatric Solutions, Inc. maintained, in all material respects, effective internal control over financial reporting as of December 31, 2007, based on the COSO criteria.

We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheets of Psychiatric Solutions, Inc. as of December 31, 2007 and 2006 and the related consolidated statements of income, stockholders’ equity and cash flows for each of the three years in the period ended December 31, 2007 of Psychiatric Solutions, Inc. and our report dated February 26, 2008 expressed an unqualified opinion thereon.

/s/ Ernst & Young LLP

Nashville, Tennessee
February 26, 2008

F-4

PSYCHIATRIC SOLUTIONS, INC.

CONSOLIDATED BALANCE SHEETS
(in thousands)


	December 31,
	2007			2006
ASSETS
Current assets:
Cash and cash equivalents	$	39,975		$	18,572
Accounts receivable, less allowance for doubtful accounts of $35,587 and $18,672, respectively		233,945			179,050
Prepaids and other		66,159			45,364

Total current assets		340,079			242,986
Property and equipment:
Land		153,573			118,509
Buildings		541,338			414,493
Equipment		76,270			55,103
Less accumulated depreciation		(77,163	)		(48,347	)

		694,018			539,758
Cost in excess of net assets acquired		1,073,583			760,268
Other assets		71,843			37,910

Total assets	$	2,179,523		$	1,580,922


LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	31,394		$	25,222
Salaries and benefits payable		82,899			66,236
Other accrued liabilities		61,939			45,855
Current portion of long-term debt		6,016			2,386

Total current liabilities		182,248			139,699
Long-term debt, less current portion		1,166,008			740,921
Deferred tax liability		49,131			44,924
Other liabilities		23,235			27,599

Total liabilities		1,420,622			953,143
Minority Interest		4,159			—
Stockholders’ equity:
Common stock, $0.01 par value, 125,000 shares authorized; 55,107 and 53,421 issued and outstanding, respectively		551			534
Additional paid-in capital		574,943			523,193
Accumulated other comprehensive loss		(479	)		—
Retained earnings		179,727			104,052

Total stockholders’ equity		754,742			627,779

Total liabilities and stockholders’ equity	$	2,179,523		$	1,580,922

See accompanying notes.

F-5

PSYCHIATRIC SOLUTIONS, INC.

CONSOLIDATED STATEMENTS OF INCOME
(in thousands, except for per share amounts)


	Year Ended December 31,
	2007			2006			2005
Revenue	$	1,481,952		$	1,022,428		$	715,324

Salaries, wages and employee benefits (including share-based compensation of $16,104 and $12,535 for the years ended December 31, 2006 and 2007)		824,645			577,237			392,309
Professional fees		147,521			97,116			73,177
Supplies		82,244			58,986			42,993
Rentals and leases		21,329			13,662			11,450
Other operating expenses		138,763			95,137			74,609
Provision for doubtful accounts		27,554			19,530			13,498
Depreciation and amortization		31,080			20,475			14,738
Interest expense		75,100			40,307			27,056
Loss on refinancing long-term debt		8,179			—			21,871

		1,356,415			922,450			671,701

Income from continuing operations before income taxes		125,537			99,978			43,623
Provision for income taxes		47,779			37,754			16,805

Income from continuing operations		77,758			62,224			26,818
(Loss) income from discontinued operations, net of income tax (benefit) provision of $(872), $(971) and $211 for 2007, 2006 and 2005, respectively		(1,550	)		(1,592	)		336

Net income available to common stockholders	$	76,208		$	60,632		$	27,154


Basic earnings per share:
Income from continuing operations	$	1.43		$	1.18		$	0.60
(Loss) income from discontinued operations, net of taxes		(0.03	)		(0.03	)		0.01

Net income	$	1.40		$	1.15		$	0.61


Diluted earnings per share:
Income from continuing operations	$	1.40		$	1.15		$	0.58
(Loss) income from discontinued operations, net of taxes		(0.03	)		(0.03	)		0.01

Net income	$	1.37		$	1.12		$	0.59


Shares used in computing per share amounts:
Basic		54,258			52,953			44,792
Diluted		55,447			54,169			46,296

See accompanying notes.

F-6

PSYCHIATRIC SOLUTIONS, INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(in thousands)


							Accumulated
					Additional		Other
	Common Stock				Paid-In		Comprehensive			Retained
	Shares		Amount		Capital		Loss			Earnings			Total
Balance at December 31, 2004		40,935	$	409	$	227,840	$	—		$	16,266		$	244,515
Issuance of common stock, net of issuance costs		8,050		81		191,917		—			—			191,998
Common stock issued in acquisition		2,726		27		64,738		—			—			64,765
Exercise of stock options		719		7		6,378		—			—			6,385
Income tax benefit of stock option exercises		—		—		4,895		—			—			4,895
Net Income		—		—		—		—			27,154			27,154

Balance at December 31, 2005		52,430		524		495,768		—			43,420			539,712
Share-based compensation		—		—		12,535		—			—			12,535
Common stock issued in acquisition		130		1		4,276		—			—			4,277
Exercise of stock options and grant of restricted stock, net of issuance costs		861		9		6,260		—			—			6,269
Income tax benefit of stock option exercises		—		—		4,354		—			—			4,354
Net income		—		—		—		—			60,632			60,632

Balance at December 31, 2006		53,421		534		523,193		—			104,052			627,779
Comprehensive income:
Net income		—		—		—		—			76,208			76,208
Change in fair value of interest rate swap, net of tax benefit of $308		—		—		—		(479	)		—			(479	)

Total comprehensive income														75,729


Share-based compensation		—		—		16,104		—			—			16,104
Common stock issued in acquisition		243		2		8,998		—			—			9,000
Exercise of stock options and grants of restricted stock, net of issuance costs		1,443		15		17,220		—			—			17,235
Cumulative adjustment for adoption of FIN 48		—		—		—		—			(533	)		(533	)
Income tax benefit of stock option exercises		—		—		9,428		—			—			9,428

Balance at December 31, 2007		55,107	$	551	$	574,943	$	(479	)	$	179,727		$	754,742

See accompanying notes.

F-7

PSYCHIATRIC SOLUTIONS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)


	Year Ended December 31,
	2007			2006			2005
Operating activities:
Net income	$	76,208		$	60,632		$	27,154
Adjustments to reconcile net income to net cash provided by continuing operating activities:
Depreciation and amortization		31,080			20,475			14,738
Amortization of loan costs and bond premium		2,151			1,672			1,187
Share-based compensation		16,104			12,535			—
Loss on refinancing long-term debt		8,179			—			21,871
Change in income tax assets and liabilities		8,639			35,322			9,494
Loss (income) from discontinued operations, net of taxes		1,550			1,592			(336	)
Changes in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable		(10,725	)		(11,636	)		(9,399	)
Prepaids and other current assets		4,175			(8,712	)		(3,673	)
Accounts payable		(7,560	)		240			2,116
Salaries and benefits payable		2,185			5,584			2,598
Accrued liabilities and other liabilities		(6,319	)		5,839			13,340
Other		—			—			463

Net cash provided by continuing operating activities		125,667			123,543			79,553
Net cash (used in) provided by discontinued operating activities		(193	)		195			222

Net cash provided by operating activities		125,474			123,738			79,775


Investing activities:
Cash paid for acquisitions, net of cash acquired		(462,820	)		(385,078	)		(514,525	)
Capital purchases of leasehold improvements, equipment and software		(73,222	)		(33,816	)		(21,750	)
Purchases of short-term investments		—			—			(29,400	)
Sales of short-term investments		—			—			29,400
Cash paid for investments in equity method investees		—			—			(1,340	)
Other assets		(2,451	)		(594	)		1,219

Net cash used in continuing investing activities		(538,493	)		(419,488	)		(536,396	)
Net cash provided by discontinued investing activities		1,909			—			—

Net cash used in investing activities		(536,584	)		(419,488	)		(536,396	)

(Continued)

F-8

PSYCHIATRIC SOLUTIONS, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)


	Year Ended December 31,
	2007			2006			2005
Financing activities:
Net (decrease) increase in revolving credit facility, less acquisitions	$	(21,000	)	$	101,000		$	—
Borrowings on long-term debt		481,875			150,000			545,000
Principal payments on long-term debt		(41,281	)		(465	)		(236,822	)
Payment of loan and issuance costs		(6,661	)		(1,576	)		(13,932	)
Refinancing of long-term debt		(7,127	)		—			(15,398	)
Excess tax benefit from share based payment arrangements		9,428			4,354			—
Proceeds from public offering of common stock		—			—			192,637
Proceeds from exercises of common stock options		17,279			6,309			6,385

Net cash provided by financing activities		432,513			259,622			477,870

Net increase (decrease) in cash		21,403			(36,128	)		21,249
Cash and cash equivalents at beginning of the year		18,572			54,700			33,451

Cash and cash equivalents at end of the year	$	39,975		$	18,572		$	54,700


Supplemental Cash Flow Information:
Interest paid	$	62,864		$	40,177		$	16,694

Income taxes paid (refunded)	$	29,924		$	(2,656	)	$	7,490


Effect of Acquisitions:
Assets acquired, net of cash acquired	$	518,348		$	432,533		$	624,821
Cash paid for prior year acquisitions		—			—			5,793
Liabilities assumed		(37,826	)		(32,819	)		(51,324	)
Common stock issued		(9,000	)		(4,277	)		(64,765	)
Long-term debt assumed		(8,702	)		(10,359	)		—

Cash paid for acquisitions, net of cash acquired	$	462,820		$	385,078		$	514,525

See accompanying notes.

F-9

PSYCHIATRIC SOLUTIONS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2007

1. Summary of Significant Accounting Policies

Description of Business

Psychiatric Solutions, Inc. was incorporated in 1988 as a Delaware corporation and has its corporate office in Franklin, Tennessee. Psychiatric Solutions, Inc. and its subsidiaries (“we,” “us” or “our”) are a leading provider of inpatient behavioral health care services in the United States. Through our owned and leased facilities, we operated 90 owned or leased inpatient behavioral health care facilities with approximately 10,000 beds in 31 states, Puerto Rico and the U.S. Virgin Islands at December 31, 2007. Our other behavioral health care business primarily consists of our contract management and employee assistance program (“EAP”) businesses. Our contract management business involves the development, organization and management of behavioral health care programs within medical/surgical hospitals. Our EAP business contracts with employers to assist employees and their dependents with resolution of behavioral conditions or other personal concerns.

Recent Developments

On May 31, 2007, we completed the acquisition of Horizon Health Corporation (“Horizon Health”), a provider of behavioral health care services, for $426.7 million in cash and the assumption of a mortgage loan of approximately $7.0 million. Prior to this acquisition, Horizon Health’s common shares were traded on The NASDAQ Global Select Market under the ticker symbol “HORC”. We also repurchased in a tender offer substantially all of our 10⁵/₈% Senior Subordinated Notes due 2013 (the “10⁵/₈% Notes”). These transactions were financed with an additional $225 million of term loans pursuant to our senior secured credit facility and the net proceeds of our offering of $250 million of 7³/₄%Senior Subordinated Notes due 2015 (the “7³/₄%Notes”). During January 2007, we completed the acquisition of an 86-bed inpatient behavioral health care facility in Columbia, South Carolina.

Basis of Presentation

The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates. The majority of our expenses are “cost of revenue” items. Costs that could be classified as general and administrative expenses at our corporate office, excluding share-based compensation expense, were approximately 2.6% of net revenue for the year ended December 31, 2007.

The consolidated financial statements include all wholly-owned subsidiaries and entities controlled by Psychiatric Solutions, Inc. The consolidated financial statements include one inpatient behavioral health care facility in which we own a controlling interest and account for the ownership interest of the non-controlling partner as minority interest. All significant intercompany balances and transactions are eliminated in consolidation.

Cash and Cash Equivalents

Cash consists of demand deposits held at financial institutions. We place our cash in financial institutions that are federally insured. At December 31, 2007, the majority of our cash is deposited with two financial institutions. Cash equivalents are short-term investments with original maturities of three months or less.

Accounts Receivable

Accounts receivable vary according to the type of service being provided. Accounts receivable for our owned and leased facilities segment is comprised of patient service revenue and is recorded net of allowances for contractual discounts and estimated doubtful accounts. Such amounts are owed by various governmental agencies, insurance companies and private patients. Medicare comprised approximately 11% and 12% of net patient receivables for our owned and leased facilities at December 31, 2007 and 2006, respectively. Medicaid comprised approximately 27% and 32% of net patient receivables for our owned and leased facilities at December 31, 2007 and 2006, respectively. Concentration of credit risk from other payors is reduced by the large number of patients and payors.

Accounts receivable for our management contracts is comprised of contractually determined fees for services rendered. Such amounts are recorded net of estimated allowances for doubtful accounts. Concentration of credit risk is reduced by the large number of customers.

F-10

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2007

Allowance for Doubtful Accounts

Our ability to collect outstanding patient receivables from third party payors is critical to our operating performance and cash flows.

The primary collection risk with regard to patient receivables is uninsured patient accounts or patient accounts for which primary insurance has paid, but the portion owed by the patient remains outstanding. We estimate the allowance for doubtful accounts primarily based upon the age of the accounts since the patient discharge date. We continually monitor our accounts receivable balances and utilize cash collection data to support our estimates of the provision for doubtful accounts. Significant changes in payor mix or business office operations could have a significant impact on our results of operations and cash flows.

Allowances for Contractual Discounts

Income Taxes

We account for income taxes under the asset and liability method. Under this method, deferred tax assets and liabilities are determined based upon differences between the financial statement carrying amounts and tax bases of assets and liabilities and are measured using the enacted tax laws that will be in effect when the differences are expected to reverse. A valuation allowance for deferred tax assets is established when we believe that it is more likely than not that the deferred tax asset will not be realized. We adopted FASB Interpretation No. 48 (FIN 48), Accounting for Uncertainty in Income Taxes - An Interpretation of FASB Statement No. 109, on January 1, 2007, which requires significant judgments regarding the recognition and measurement of each tax position. Our policy is to classify interest and penalties related to income taxes as a component of our tax provision.

Long-Lived Assets

Property and Equipment

Property and equipment are stated at cost and depreciated using the straight-line method over the useful lives of the assets, which range from 25 to 35 years for buildings and improvements and 2 to 7 years for equipment. Leasehold improvements are amortized on a straight-line basis over the shorter of the lease term or estimated useful lives of the assets. Depreciation expense was $29.2 million, $19.8 million and $14.0 million for the years ended December 31, 2007, 2006 and 2005, respectively. Depreciation expense includes the amortization of assets recorded under capital leases.

Cost in Excess of Net Assets Acquired (Goodwill)

We account for acquisitions using the purchase method of accounting. Goodwill is generally allocated to reporting units based on operating results. Goodwill is reviewed at least annually for impairment. Potential impairment is noted for a reporting unit if its carrying value exceeds the fair value of the reporting unit. For those reporting units that we have identified with potential impairment of goodwill, we determine the implied fair value of goodwill. If the carrying value of goodwill exceeds its implied fair value, an impairment loss is recorded. Our annual impairment test of goodwill in 2007, 2006 and 2005 resulted in no goodwill impairment.

The following table presents the changes in the carrying amount of goodwill for the years ended December 31, 2007 and 2006 (in thousands):


Balance at December 31, 2005	$	526,536
Acquisition of National Deaf Academy		32,524
Acquisition of Alternative Behavioral Services		148,332
Other Acquisitions		52,876

Balance at December 31, 2006		760,268
Acquisition of Horizon Health		284,446
Other Acquisitions		28,869

Balance at December 31, 2007	$	1,073,583

Other Assets

Other assets include contracts that represent the fair value of inpatient management contracts and service contracts purchased and are being amortized using the straight-line method over their estimated life, which is between 4 years and 9 years. At December 31, 2007

F-11

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2007

and 2006, contracts totaled $26.5 million and $0.7 million and are net of accumulated amortization of $4.4 million and $2.6 million, respectively. The 2007 increase in intangible contract value is primarily the result of the fair value assigned to contracts assumed in the acquisition of Horizon Health. Amortization expense related to contracts was $1.7 million, $0.7 million and $0.7 million for the years ended December 31, 2007, 2006 and 2005, respectively. Estimated amortization expense related to contracts for the years ending December 31, 2008, 2009, 2010, 2011 and 2012 is approximately $3.4 million, $3.1 million, $3.1 million, $3.1 million and $3.1 million, respectively.

When events, circumstances and operating results indicate that the carrying values of certain long-lived assets and the related identifiable intangible assets might be impaired, we prepare projections of the undiscounted future cash flows expected to result from the use of the assets and their eventual disposition. If the projections indicate that the recorded amounts are not expected to be recoverable, such amounts are reduced to estimated fair value. Fair value is estimated based upon projections of discounted cash flows.

Other assets also include loan costs that are deferred and amortized over the term of the related debt. Loan costs at December 31, 2007 and 2006 totaled $16.8 million and $13.8 million and are net of accumulated amortization of $5.2 million and $3.3 million, respectively. The weighted average amortization period for loan costs incurred in 2007 is approximately 6 years. Amortization expense related to loan costs, which is reported as interest expense, was approximately $2.5 million, $1.7 million and $1.2 million for the years ended December 31, 2007, 2006 and 2005, respectively. Estimated amortization expense of loan costs for the years ending December 31, 2008, 2009, 2010, 2011 and 2012 is $2.9 million, $2.9 million, $2.3 million, $2.4 million and $1.8 million, respectively.

Other Accrued Liabilities

At December 31, 2007 and 2006, we had approximately $21.9 million and $10.9 million, respectively, of accrued interest expense in other accrued liabilities.

Share-Based Compensation

We adopted Statement on Financial Accounting Standards (“SFAS”) No. 123 (Revised 2004), Share Based Payment (“SFAS 123R”), under the modified-prospective transition method on January 1, 2006. SFAS 123R requires companies to measure and recognize the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value. Share-based compensation recognized under the modified-prospective transition method of SFAS 123R includes share-based compensation based on the grant-date fair value determined in accordance with the original provisions of SFAS No. 123, Accounting for Stock-Based Compensation (“SFAS 123”), for all share-based payments granted prior to and not yet vested as of January 1, 2006 and share-based compensation based on the grant-date fair-value determined in accordance with SFAS 123R for all share-based payments granted on or after January 1, 2006. We use the Black-Scholes valuation model to determine grant-date fair value and use straight-line amortization of share-based compensation expense over the requisite service period of the grant. SFAS 123R eliminates the ability to account for the award of these instruments under the intrinsic value method prescribed by Accounting Principles Board (“APB”) Opinion No. 25, Accounting for Stock Issued to Employees, and allowed under the original provisions of SFAS 123. Prior to the adoption of SFAS 123R, we accounted for our stock option plans using the intrinsic value method in accordance with the provisions of APB Opinion No. 25 and related interpretations.

Derivatives

We may periodically enter into interest rate swap agreements to manage our exposure to fluctuations in interest rates. These interest rate swap agreements effectively exchange fixed or variable interest payments between two parties. During 2007, we entered into an arrangement to exchange the interest payments associated with a notional amount of $225 million LIBOR indexed variable rate debt related to our senior secured term loan for a fixed interest rate. Under SFAS No. 133, Accounting for Derivative Instruments and Hedging Activities, as amended (“SFAS 133”), we have designated this arrangement a cash flow hedge and have deemed it to be highly effective. We assess the effectiveness of the hedge quarterly. All changes in the fair value of a highly effective cash flow hedge are recognized as a component of other comprehensive income. Any change in the fair value of an ineffective portion of a cash flow hedge would be recorded to the income statement. If the interest rate swap arrangement is canceled, the gain or loss associated with the cancellation would be amortized through interest expense over the life of the agreement.

Risk Management

F-12

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2007

range of potential outcomes often hampers timely adjustments to the assumptions used in these estimates. The reserve for professional and general liability was approximately $15.1 million and $18.1 million as of December 31, 2007 and 2006, respectively. This decrease is primarily due to favorable developments in our professional and general liability experience.

We carry statutory workers’ compensation insurance from an unrelated commercial insurance carrier. Our statutory workers’ compensation program is fully insured with a $350,000 deductible per accident. We believe that adequate provision has been made for workers’ compensation and professional and general liability risk exposures. The reserve for workers’ compensation liability was approximately $18.1 million and $18.7 million as of December 31, 2007 and 2006, respectively.

Fair Value of Financial Instruments

The carrying amounts reported in the accompanying Consolidated Balance Sheets for cash, accounts receivable, and accounts payable approximate their fair value given the short-term maturity of these instruments. At December 31, 2007, the carrying value and fair value of our 7³/₄% Notes was $470.0 million and $467.1 million, respectively. At December 31, 2006, the carrying value and fair value of our 7³/₄% Notes was $220 million and $218.6 million, respectively, and the carrying value and fair value of our 10⁵/₈% Notes was $38.7 million and $42.4 million, respectively.

Reclassifications

Certain reclassifications have been made to the prior year to conform with current year presentation.

Recent Accounting Pronouncements

In December 2007, the FASB issued SFAS No. 141(R), Business Combinations (“SFAS 141(R)”), to replace Statement of Financial Accounting Standards No. 141, Business Combinations. SFAS 141(R) requires use of the acquisition method of accounting, defines the acquirer, establishes the acquisition date, requires acquisition-related costs to be expensed as incurred and broadens the scope of a business combination to include transactions and other events in which one entity obtains control over one or more other businesses. This statement is effective for financial statements issued for fiscal years beginning on or after December 15, 2008, with earlier adoption prohibited. We are currently evaluating the impact of SFAS 141(R) on our consolidated financial statements.

In December 2007, the FASB issued SFAS No. 160, Noncontrolling Interests in Consolidated Financial Statements—an Amendment of ARB No. 51, (“SFAS 160”). SFAS 160 establishes accounting and reporting standards for the noncontrolling interest in a subsidiary and for the retained interest and gain or loss when a subsidiary is deconsolidated. This statement is effective for financial statements issued for fiscal years beginning on or after December 15, 2008 with earlier adoption prohibited. We are currently evaluating the impact of SFAS 160 on our consolidated financial statements.

In September 2006, the FASB issued SFAS No. 157, Fair Value Measurements (“SFAS 157”). SFAS 157 defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles and expands disclosures about fair value measurements. We will adopt SFAS 157 effective January 1, 2008 for financial assets and liabilities and are currently evaluating the impact of SFAS 157 on our consolidated financial statements.

In February 2007, the FASB issued SFAS No. 159, The Fair Value Option for Financial Assets and Financial Liabilities—Including an Amendment of SFAS 115 (“SFAS 159”), which permits, but does not require, the measurement of financial instruments and certain other items at fair value. Unrealized gains and losses on items for which the fair value option has been elected are reported in earnings. This statement is effective for financial statements issued for fiscal years beginning after November 15, 2007. We will adopt SFAS 159 effective January 1, 2008 and do not expect to elect the fair value option for any of our financial instruments.

2. Revenue

Revenue consists of the following amounts (in thousands):


	December 31,
	2007		2006		2005
Patient service revenue	$	1,357,827	$	976,324	$	669,579
Other revenue		124,125		46,104		45,745

Total revenue	$	1,481,952	$	1,022,428	$	715,324

F-13

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2007

Patient Service Revenue

Patient service revenue is generated by our inpatient facilities as a result of providing services provided to patients on an inpatient and outpatient basis. Patient service revenue is recorded at our established billing rates less contractual adjustments. Generally, collection in full is not expected on our established billing rates. Contractual adjustments are recorded to state our patient service revenue at the amount we expect to collect for the services provided based on amounts reimbursable by Medicare or Medicaid under provisions of cost or prospective reimbursement formulas or amounts due from other third-party payors at contractually determined rates. During the years ended December 31, 2007, 2006 and 2005, approximately 32%, 36% and 35%, respectively, of our revenue was obtained from providing services to patients participating in the Medicaid program. During the years ended December 31, 2007, 2006 and 2005, approximately 13% of our revenue was obtained from providing services to patients participating in the Medicare program.

We provide care without charge to patients who are financially unable to pay for the health care services they receive. Because we do not pursue collection of amounts determined to qualify as charity care, they are not reported as revenue. Settlements under cost reimbursement agreements with third-party payors are estimated and recorded in the period in which the related services are rendered and are adjusted in future periods as final settlements are determined. Final determination of amounts earned under the Medicare and Medicaid programs often occur in subsequent years because of audits by such programs, rights of appeal and the application of numerous technical provisions.

Our revenue is particularly sensitive to regulatory and economic changes in the State of Texas. At December 31, 2007, we operated ten inpatient facilities in Texas and at December 31, 2006 and 2005, we operated eight inpatient facilities in Texas. We generated approximately 12%, 17% and 19% of our revenue from our Texas operations for the years ended December 31, 2007, 2006 and 2005, respectively.

Other Revenue

Other revenue primarily consists of our contract management and EAP businesses. Our contract management business involves the development, organization and management of behavioral health care programs within medical/surgical hospitals. Our EAP business contracts with employers to assist employees and their dependents with resolution of behavioral conditions or other personal concerns. Services provided are recorded as revenue at contractually determined rates in the period the services are rendered, provided that collectability of such amounts is reasonably assured.

3. Earnings Per Share

SFAS No. 128, Earnings per Share (“SFAS 128”), requires dual presentation of basic and diluted earnings per share by entities with complex capital structures. Basic earnings per share includes no dilution and is computed by dividing net income available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share reflects the potential dilution of securities that could share in the earnings of the entity. We have calculated earnings per share in accordance with SFAS 128 for all periods presented.

The following table sets forth the computation of basic and diluted earnings per share (in thousands, except per share amounts):

F-14

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2007


	Year ended December 31,
	2007			2006			2005
Numerator:
Basic and diluted earnings per share:
Income from continuing operations	$	77,758		$	62,224		$	26,818
(Loss) income from discontinued operations, net of taxes		(1,550	)		(1,592	)		336

Net income	$	76,208		$	60,632		$	27,154


Denominator:
Weighted average shares outstanding for basic earnings per share		54,258			52,953			44,792
Effects of dilutive stock options and restriced stock outstanding		1,189			1,216			1,504

Shares used in computing diluted earnings per common share		55,447			54,169			46,296


Basic earnings per share:
Income from continuing operations	$	1.43		$	1.18		$	0.60
(Loss) income from discontinued operations, net of taxes		(0.03	)		(0.03	)		0.01

	$	1.40		$	1.15		$	0.61


Diluted earnings per share:
Income from continuing operations	$	1.40		$	1.15		$	0.58
(Loss) income from discontinued operations, net of taxes		(0.03	)		(0.03	)		0.01

	$	1.37		$	1.12		$	0.59

4. Discontinued Operations

SFAS No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets, requires that all components of an entity that have been disposed of (by sale, by abandonment or in a distribution to owners) or are held for sale and whose cash flows can be clearly distinguished from the rest of the entity be presented as discontinued operations. During the second quarter of 2007, we elected to dispose of one facility. During 2006, we terminated three of our contracts to manage state-owned inpatient facilities and sold a therapeutic boarding school. During 2005, we terminated two of our contracts. Accordingly, these operations, net of applicable income taxes, have been presented as discontinued operations and prior period consolidated financial statements have been reclassified.

The components of (loss) income from discontinued operations, net of taxes, are as follows (in thousands):


	Year Ended December 31,
	2007			2006			2005
Revenue	$	2,217		$	6,149		$	14,911

Operating expenses		3,872			7,287			14,364
Loss on disposal		767			1,425			—

		4,639			8,712			14,364


(Loss) income from discontinued operations before income taxes		(2,422	)		(2,563	)		547
(Benefit) provision for income taxes		(872	)		(971	)		211

(Loss) income from discontinued operations, net of income taxes	$	(1,550	)	$	(1,592	)	$	336

F-15

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2007

5. Acquisitions

2007 Acquisitions

During 2007, we acquired 16 inpatient behavioral health care facilities with an aggregate of approximately 1,600 beds, including the May 31, 2007 acquisition of Horizon Health, which operated 15 inpatient facilities. Each acquisition was accounted for by the purchase method and the aggregate purchase prices of these transactions were allocated to the assets acquired and liabilities assumed based upon their respective fair values. The consolidated financial statements include the accounts and operations of the acquired entities for the period subsequent to the acquisition date. As the acquisition of Horizon Health involved a merger, the goodwill associated with this acquisition is not deductible for federal income tax purposes. The purchase price allocation for Horizon Health and certain other 2007 acquisitions is preliminary as of December 31, 2007, pending final measurement of certain assets and liabilities related to the acquisitions.

The following table summarizes the preliminary allocation of the aggregate purchase price of Horizon Health at December 31, 2007 (in thousands):


	Horizon Health
Assets acquired:
Accounts receivable	$	42,201
Other current assets		15,079
Fixed assets		96,190
Costs in excess of net assets acquired		284,446
Other assets		33,528

		471,444
Liabilities assumed		35,469
Long-term debt assumed		6,998

Cash paid, net of cash acquired	$	428,977

Acquisition-related direct costs paid subsequent to closing have been included as a part of the acquisition

2006 Acquisitions

During 2006, we acquired 19 inpatient behavioral health care facilities with an aggregate of approximately 1,900 beds, including the December 1, 2006 purchase of the capital stock of Alternative Behavioral Services, Inc. (“ABS”), which owned nine inpatient facilities. Each acquisition was accounted for by the purchase method and the aggregate purchase prices of these transactions were allocated to the assets acquired and liabilities assumed based upon their respective fair values. The consolidated financial statements include the accounts and operations of the acquired entities for the periods subsequent to the acquisition date. As the acquisition of ABS involved the acquisition of stock, the goodwill associated with this acquisition is not deductible for federal income tax purposes.

The following table summarizes the allocation of the aggregate purchase price of ABS (in thousands):


	ABS
Assets acquired:
Accounts receivable	$	23,420
Other current assets		9,129
Fixed assets		65,438
Costs in excess of net assets acquired		149,077
Other assets		240

		247,304
Liabilities assumed		31,313
Common stock issued		4,277

Cash paid, net of cash acquired	$	211,714

F-16

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2007

2005 Acquisitions

On July 1, 2005, we acquired Ardent Health Services, Inc. (“Ardent Behavioral”), an owner and operator of 20 inpatient behavioral health care facilities. This acquisition was accounted for by the purchase method and the aggregate purchase price of this transaction was allocated to the assets acquired and liabilities assumed based upon their respective fair values. The consolidated financial statements include the accounts and operations of the acquired entities for the periods subsequent to the acquisition date. As the acquisition of Ardent Behavioral involved the acquisition of stock, the goodwill associated with this acquisition is not deductible for federal income tax purposes.

The following table summarizes the allocation of the aggregate purchase price of the Ardent Behavioral (in thousands):


	Ardent
	Behavioral

Assets acquired:
Accounts receivable	$	47,670
Other current assets		23,436
Fixed assets		152,355
Costs in excess of net assets acquired		393,017
Other assets		4,601

		621,079
Liabilities assumed		50,114
Common stock issued		64,765

Cash paid, net of cash acquired	$	506,200

Other Information

The following represents the unaudited pro forma results of consolidated operations as if the aforementioned acquisition of Horizon Health had occurred at the beginning of the immediately preceding period, after giving effect to certain adjustments, including the depreciation and amortization of the assets acquired based upon their fair values and changes in interest expense resulting from changes in consolidated debt:


	Year Ended December 31,
	2007		2006
Revenue	$	1,603,868	$	1,316,298
Net income		77,297		61,853
Earnings per common share, basic		1.42		1.17
Earnings per common share, diluted		1.39		1.14

The pro forma information for the year ended December 31, 2007 includes a loss on refinancing long-term debt of approximately $8.2 million. The pro forma information given does not purport to be indicative of what our results of operations would have been if the acquisitions had in fact occurred at the beginning of the periods presented, and is not intended to be a projection of the impact on future results or trends.

F-17

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2007

6. Long-term debt

Long-term debt consists of the following (in thousands):


	December 31,
	2007		2006
Senior credit facility:
Revolving line of credit facility, expiring on December 21, 2009 and bearing interest of 6.4% and 6.7% at December 31, 2007 and December 31, 2006, respectively	$	80,000	$	101,000
Senior secured term loan facility, expiring on July 1, 2012 and bearing interest of 6.8% and 7.1% at December 31, 2007 and December 31, 2006, respectively		573,312		350,000
7 3/4% Notes		476,508		220,000
10 5/8% Notes		34		38,681
Mortgage loans on facilities, maturing in 2036, 2037 and 2038 bearing fixed interest rates of 5.7% to 7.6%		33,671		27,062
Other		8,499		6,564

		1,172,024		743,307
Less current portion		6,016		2,386

Long-term debt	$	1,166,008	$	740,921

Senior Credit Facility

On July 1, 2005, we amended and restated our Credit Agreement (the “Credit Agreement”) with Bank of America, N.A. (“Bank of America”) to include a $325 million senior secured term loan facility with Citicorp North America, Inc. We borrowed $325 million on the senior secured term loan facility on July 1, 2005 to finance a portion of the purchase price for Ardent Behavioral. During the quarter ended September 30, 2005, we repaid $125 million of the senior secured term loan facility with a portion of the proceeds received from the sale of 8,050,000 shares of our common stock. On December 1, 2006, we amended our Credit Agreement to increase our senior secured term loan facility by $150 million and to increase our revolving credit facility to $300 million. On December 1, 2006, we borrowed $150 million under our senior secured term loan facility and $60 million under our revolving credit facility to finance the acquisition of ABS. On May 31, 2007, we amended our Credit Agreement to increase our senior secured term loan facility from $350 million to $575 million to finance a portion of the acquisition of Horizon Health and complete the tender offer for our 10⁵/₈% Notes. Quarterly principal payments of $0.9 million are due on our senior secured term loan facility and the balance of our senior secured term loan facility is payable in full on July 1, 2012.

Our Credit Agreement is secured by substantially all of the personal property owned by us or our subsidiaries, substantially all real property owned by us or our subsidiaries that has a value in excess of $5.0 million and the stock of our operating subsidiaries. In addition, the Credit Agreement is fully and unconditionally guaranteed by substantially all of our operating subsidiaries. The revolving credit facility and senior secured term loan facility accrue interest at our choice of the “Base Rate” or the “Eurodollar Rate” (as defined in the Credit Agreement) and are due December 21, 2009 and July 1, 2012, respectively. The “Base Rate” and “Eurodollar Rate” fluctuate based upon market rates and certain leverage ratios, as defined in the Credit Agreement. At December 31, 2007, we had $80.0 million in borrowings outstanding and $213.0 million available for future borrowings under the revolving credit facility. Until the maturity date, we may borrow, repay and re-borrow an amount not to exceed $300 million on our revolving credit facility. All repayments made under the senior secured term loan facility are a permanent reduction in the amount available for future borrowings. We pay a quarterly commitment fee on the unused portion of our revolving credit facility that fluctuates, based upon certain leverage ratios, between 0.25% and 0.5% per annum. Commitment fees were approximately $0.5 million for the year ended December 31, 2007.

Our Credit Agreement contains customary covenants that include: (1) a limitation on capital expenditures and investments, sales of assets, mergers, changes of ownership, new principal lines of business, indebtedness, transactions with affiliates, dividends and redemptions; (2) various financial covenants; and (3) cross-default covenants triggered by a default of any other indebtedness of at least $5.0 million. As of December 31, 2007, we were in compliance with all debt covenant requirements. If we violate one or more of these covenants, amounts outstanding under the revolving credit facility, senior secured term loan facility and the majority of our other debt arrangements could become immediately payable and additional borrowings could be restricted.

F-18

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2007

7³/₄% Notes

On July 6, 2005, we issued $220 million in 7³/₄% Notes. On May 31, 2007, we issued an additional $250 million in 7³/₄% Notes to finance a portion of the acquisition of Horizon Health and complete the tender offer for our 10⁵/₈% Notes. The 7³/₄% Notes are fully and unconditionally guaranteed on a senior subordinated basis by substantially all of our existing operating subsidiaries. We received a premium of 2.75% plus accrued interest from January 15, 2007 from the sale of the $250 million 7³/₄% Notes on May 31, 2007. This premium is being amortized over the remaining life of the 7³/₄% Notes using the effective interest method, which results in an effective interest rate of 7.3% on the $250 million issuance. Interest on these notes accrues at the rate of 7³/₄% per annum and is payable semi-annually in arrears on January 15 and July 15. The 7³/₄% Notes will mature on July 15, 2015.

10⁵/₈% Notes

On June 30, 2003, we issued $150 million in 10⁵/₈% Notes, which are fully and unconditionally guaranteed on a senior subordinated basis by substantially all of our existing operating subsidiaries. Interest on these notes accrues at the rate of 10⁵/₈% per annum and is payable semi-annually in arrears on June 15 and December 15. The 10⁵/₈% Notes will mature on June 15, 2013.

On January 14, 2005, we redeemed $50 million of our 10⁵/₈% Notes and paid a 10⁵/₈% penalty and related accrued interest on the amount redeemed. On July 6, 2005, we repurchased approximately $61.3 million of our 10⁵/₈% Notes and paid a premium of approximately $8.6 million on the notes repurchased using proceeds from the issuance of our 7³/₄% Notes.

On May 31, 2007, we used a portion of the proceeds from our sale of 7³/₄% Notes and borrowings under our senior secured term loan facility to complete the tender offer for substantially all of our 10⁵/₈% Notes.

Mortgage Loans

During 2002 and 2003, we borrowed approximately $23.8 million under mortgage loan agreements insured by the U.S. Department of Housing and Urban Development (“HUD”). During 2006, in connection with the purchase of real estate at a formerly leased inpatient facility, we assumed a mortgage loan agreement insured by HUD of approximately $4.0 million. During 2007, in connection with the Horizon Health acquisition, we assumed an additional HUD mortgage of approximately $7.0 million. The mortgage loans insured by HUD are secured by real estate located at Holly Hill Hospital in Raleigh, North Carolina, West Oaks Hospital in Houston, Texas, Riveredge Hospital near Chicago, Illinois, Canyon Ridge Hospital in Chino, California and MeadowWood Behavioral Health in New Castle, Delaware. Interest accrues on the Holly Hill, West Oaks, Riveredge, Canyon Ridge and MeadowWood HUD loans at 6.0%, 5.9%, 5.7%, 7.6% and 7.0% and principal and interest are payable in 420 monthly installments through December 2037, September 2038, December 2038, January 2036 and October 2036, respectively. The carrying amount of assets held as collateral approximated $37.4 million at December 31, 2007.

Interest Rate Swap Agreements

We periodically enter into interest rate swap agreements to manage our exposure to fluctuations in interest rates. During 2007, we entered into an arrangement with a creditworthy financial institution to exchange the interest payments associated with a notional amount of $225 million of LIBOR indexed variable rate debt related to our senior secured term loan for a fixed interest rate. The arrangement matures on November 30, 2009. The interest payments associated with this arrangement are settled on a net basis. The fair value of our interest rate swap at December 31, 2007, reflected a liability of $0.8 million, which represents the estimated amount we would have paid if the arrangement was canceled.

Other

The aggregate maturities of long-term debt, including capital lease obligations, are as follows (in thousands):


2008	$	6,016
2009		85,692
2010		4,717
2011		4,678
2012		558,369
Thereafter		512,552

Total	$	1,172,024

F-19

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2007

7. Leases

Our operating leases consist primarily of the lease of eight inpatient behavioral health care facilities, our corporate office and our office for our contract management and EAP business. At December 31, 2007, future minimum lease payments under operating leases having an initial or remaining non-cancelable lease term in excess of one year are as follows (in thousands):


2008	$	15,831
2009		13,141
2010		9,812
2011		7,077
2012		5,311
Thereafter		31,403

Total	$	82,575

8. Income Taxes

Total provision for income taxes for the years ended December 31, 2007, 2006 and 2005 was allocated as follows (in thousands):


	2007			2006			2005
Provision for income taxes attributable to income from continuing operations	$	47,779		$	37,754		$	16,805
(Benefit from) provision for income taxes attributable to income from discontinued operations		(872	)		(971	)		211

Total provision for income taxes	$	46,907		$	36,783		$	17,016

The provision for (benefit from) income taxes attributable to income from continuing operations consists of the following (in thousands):


	2007			2006		2005
Current:
Federal	$	32,035		$	10,327	$	(1,802	)
State		4,930			2,441		2,701
Foreign		4,121			219		—

		41,086			12,987		899
Deferred:
Federal		8,078			24,132		16,580
State		(460	)		342		(908	)
Foreign		(925	)		293		234

		6,693			24,767		15,906

Provision for income taxes	$	47,779		$	37,754	$	16,805

The tax benefits associated with exercises of nonqualified stock options decreased the current tax liability by $9.4 million, $4.4 million and $4.3 million in 2007, 2006 and 2005, respectively. Such benefits were recorded as increases to stockholders’ equity.

The reconciliation of income tax computed by applying the U.S. federal statutory rate to the actual income tax (benefit) expense attributable to income from continuing operations is as follows (in thousands):


	2007		2006		2005
Federal tax	$	43,938	$	34,992	$	15,268
State income taxes (net of federal)		2,906		1,809		1,165
Other		935		953		372

Provision for income taxes	$	47,779	$	37,754	$	16,805

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The tax effects of significant items comprising temporary differences at December 31, 2007 and 2006 are as follows (in thousands):

F-20

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2007


	2007			2006
Deferred tax assets:
Net operating loss carryforwards	$	10,210		$	11,708
Allowance for doubtful accounts		11,218			3,562
Alternative minimum tax credit carryovers		1,150			1,150
Accrued liabilities		24,757			14,027

Total gross deferred tax assets		47,335			30,447
Less: Valuation allowance		(5,640	)		(2,988	)

Total deferred tax assets		41,695			27,459
Deferred tax liabilities:
Intangible assets		(16,611	)		(16,404	)
Property and equipment		(51,509	)		(43,690	)

Net deferred tax liability	$	(26,425	)	$	(32,635	)

Deferred income taxes of $22.7 million and $12.3 million at December 31, 2007 and 2006, respectively, are included in other current assets. Noncurrent deferred income tax liabilities totaled $49.1 million and $44.9 million at December 31, 2007 and 2006, respectively. In connection with the Horizon Health acquisition, we recorded net deferred tax assets of approximately $11.7 million as of December 31, 2007, with a corresponding reduction in goodwill. Horizon Health’s final income tax returns for the period ending on the acquisition date have not been completed at the time of this filing. Upon completion of those tax returns, we will finalize the determination of deferred tax assets and liabilities resulting from the Horizon Health acquisition.

GAAP requires that deferred income taxes reflect the tax consequences of differences between the tax basis of assets and liabilities and their carrying values for GAAP. Future tax benefits are recognized to the extent that realization of such benefits is more likely than not. A valuation allowance is established for those benefits that do not meet the more likely than not criteria. We have evaluated the need for a valuation allowance against deferred tax assets and have recorded valuation allowances of $5.6 million, $3.0 million and $4.1 million at December 31, 2007, 2006 and 2005, respectively. The net change in valuation allowance was an increase of $2.6 million for the year ended December 31, 2007 and a decrease of $1.1 million for the year ended December 31, 2006. The valuation allowance reported as of December 31, 2007 of $5.6 million relates primarily to amounts recorded in various acquisitions and any subsequent reductions to this valuation allowance would reduce goodwill. Increase in valuation allowances of $2.2 million and reduction in valuation allowances of $0.4 million during the years ended December 31, 2007 and December 31, 2006, respectively, were allocated to goodwill.

As of December 31, 2007, we had an unrecognized deferred tax liability for temporary differences of $1.8 million related to investments in our Puerto Rico subsidiaries that are essentially permanent in duration.

As of December 31, 2007, we had federal net operating loss carryforwards of $9.0 million expiring in the years 2018 through 2022, state net operating loss carryforwards of $94.6 million expiring in various years through 2026, foreign net operating loss carryforwards of $12.0 million expiring through 2011 and an alternative minimum tax credit carryover of approximately $1.2 million available to reduce future federal income taxes.

We adopted FIN 48 effective January 1, 2007. As a result, we recognized a cumulative effect adjustment of approximately $0.5 million to decrease the January 1, 2007 retained earnings balance. Our policy is to classify interest and penalties related to income taxes as a component of our tax provision. We had gross unrecognized tax benefits of $1.6 million upon adoption of FIN 48 and $1.3 million as of December 31, 2007. The total amount of interest and penalties recognized in our consolidated balance sheet was $0.2 million upon adoption of FIN 48 and as of December 31, 2007. The tax effect of deductible state tax and interest was $0.3 million upon adoption of FIN 48 and $0.5 million as of December 31, 2007. The net impact on provision for income tax of unrecognized tax benefits, if recognized, would have been $0.5 million upon adoption of FIN 48 and $0.3 million as of December 31, 2007.

F-21

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2007

A reconciliation of the beginning and ending amount of gross unrecognized tax benefits is as follows:


Balance as of January 1, 2007	$	1,594
Increases for tax positions taken in the current year		274
Increases for tax positions taken in prior years		430
Reductions due to lapse of statute of limitations		(43	)
Settlements		(983	)

Balance as of December 31, 2007	$	1,272

Our tax years 2004 through 2007 remain open to examination by federal and state taxing authorities. In addition, our 2003 tax year remains open to examination in certain states. During the year ended December 31, 2007, we entered into a closing agreement with the IRS with respect to an examination of our 2004 tax year. Although the statute of limitations remains open for 2004, it is highly unlikely that the IRS will conduct further examination of that year.

In addition, ABS, an entity acquired in 2006, has pre-acquisition federal income tax returns which remain open to examination back to the year 2002. Certain pre-acquisition state income tax returns of acquired ABS subsidiaries also remain open to examination for the years 2002 through 2006. We are fully indemnified under the ABS stock purchase agreement for any liabilities resulting from examinations of pre-acquisition tax returns. During 2007, we recorded unrecognized tax benefits in the amount of $0.5 million in the related to certain pre-acquisition state tax liabilities of acquired ABS subsidiaries, and we recorded an offsetting receivable from the selling shareholders under the terms of the indemnification provisions. During 2007, ABS entered into a closing agreement with Puerto Rico taxing authorities. The selling shareholders paid all taxes and interest due under the terms of the settlement agreement in accordance with the indemnification provisions of the ABS stock purchase agreement. The Puerto Rico settlement effectively closed to examination all tax years prior to 2006 with respect to the acquired ABS entities.

Horizon Health has federal and state tax years which remain open to examination going back to 2004 and in certain states going back to 2003. We have no indemnification for any pre-acquisition liabilities that may result from examinations of Horizon Health income tax returns for pre-acquisition periods.

In the next twelve months we anticipate increases in unrecognized tax benefits of approximately $0.4 million related to certain state tax issues, and we anticipate potential reductions in unrecognized tax benefits of approximately $0.2 million related to certain state tax expired statutes of limitation. In addition, we may record additional unrecognized tax benefits related to pre-acquisition tax years of Horizon Health. We are unable to estimate the potential increase in unrecognized tax benefits related to pre-acquisition tax years and any such increases would result in an increase in goodwill.

9. Stock Option Plans

A maximum of 11,116,666 shares of our common stock are authorized for grant as stock options, restricted stock or other share-based compensation under the Psychiatric Solutions, Inc. Equity Incentive Plan (the “Equity Incentive Plan”). Under the Equity Incentive Plan, stock options may be granted for terms of up to ten years. Grants to employees generally vest in annual increments of 25% each year, commencing on the date of grant or one year after the date of grant. The exercise prices of stock options are equal to the closing sales prices of our common stock on the date of grant or the trading day immediately preceding the date of grant.

A maximum of 683,334 shares of our common stock are authorized for grant as stock options under the Psychiatric Solutions, Inc. Outside Directors’ Stock Option Plan (the “Directors’ Plan”). The Director’s Plan provides for a grant of 8,000 stock options at each annual meeting of stockholders to each outside director at the fair market value of our common stock on the trading day immediately preceding the date of grant. The Directors’ Plan also provides for an initial grant of 12,000 stock options to each new outside director on the date of the director’s initial election or appointment to the board of directors. The options vest 25% on the grant date and 25% on the succeeding three anniversaries of the grant date and generally have terms of ten years.

F-22

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2007

Stock option activity during 2007 is as follows (number of options and aggregate intrinsic value in thousands):


						Weighted
				Weighted		Average
	Number			Average		Remaining		Aggregate
	of			Exercise		Contractual		Intrinsic
	Options			Price		Term (in years)		Value
Outstanding at December 31, 2006		5,655		$	20.76		n/a		n/a
Granted		2,668		$	39.65		n/a		n/a
Canceled		(1,023	)	$	28.31		n/a		n/a
Exercised		(1,245	)	$	14.01		n/a		n/a

Outstanding at December 31, 2007		6,055		$	28.41		8.0	$	40,978

Exercisable at December 31, 2007		2,415		$	18.75		6.9	$	33,568

Of the 2.7 million stock options granted in 2007, approximately 660,000 stock options were granted to management employees related to recent acquisitions.

Restricted stock activity is as follows (number of restricted shares in thousands):


				Weighted
	Number			Average
	of			Grant-
	Restricted			Date Fair
	Shares			Value
Unvested at December 31, 2006		55		$	33.11
Granted		253		$	41.02
Canceled		(52	)	$	38.56
Vested		(14	)	$	33.11

Unvested at December 31, 2007		242		$	40.20

We recognized $16.1 million and $12.5 million in share-based compensation expense and approximately $6.1 million and $4.7 million of related income tax benefit for the years ended December 31, 2007 and 2006, respectively. Share-based compensation expense for the year ended December 31, 2006 includes $2.2 million recorded in the quarter ended March 31, 2006 resulting from reversing the cancellation and accelerating the vesting of 89,014 stock options previously granted to our former Chief Operating Officer. Remaining share-based compensation expense was recorded as a result of adopting SFAS 123R. The impact of share-based compensation expense, net of tax, on our basic and diluted earnings per share was approximately $0.18 and $0.14 per share for the years ended December 31, 2007 and 2006, respectively. Also as a result of adopting SFAS 123R, we classified $9.4 million and $4.4 million in income tax benefits in excess of share-based compensation expense on stock options exercised in 2007 and 2006, respectively, as a cash flow from financing activities in our Condensed Consolidated Statement of Cash Flows for the years ended December 31, 2007 and 2006, respectively. Prior to the adoption of SFAS 123R, income tax benefits in excess of share-based compensation expense recognized on stock options exercised were classified as cash flows from operations. The fair value of our stock options was estimated using the Black-Scholes option pricing model. We recognize expense on all share-based awards on a straight-line basis over the requisite service period of the entire award.

F-23

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2007

For periods presented prior to the adoption of SFAS 123R, pro forma information regarding net income and earnings per share as required by SFAS 123R has been determined as if we had accounted for our employee stock options under the original provisions of SFAS 123. The fair value of these options was estimated using the Black-Scholes option pricing model. For purposes of pro forma disclosure, the estimated fair value of the options is amortized to expense over the option’s vesting period. Our pro forma information follows for the year ended December 31, 2005 (in thousands, except per share amounts):


Net income	$	27,154
Pro forma compensation expense from stock options, net of tax		4,361

Pro forma net income	$	22,793

Basic earnings per share:
As reported	$	0.61
Pro forma	$	0.51
Diluted earnings per share:
As reported	$	0.59
Pro forma	$	0.49

The following table summarizes the weighted average grant-date fair values of options and the weighted average assumptions we used to develop the fair value estimates under each of the option valuation models for options granted in the years ended December 31, 2007, 2006 and 2005:


	2007			2006			2005
Weighted average grant-date fair value of options	$	14.25		$	9.96		$	7.73
Risk-free interest rate		5	%		5	%		4	%
Expected volatility		35	%		31	%		33	%
Expected life		5			4			5
Dividend yield		0	%		0	%		0	%

Our estimate of expected volatility for stock options granted in 2007 and 2006 is based upon the historical volatility of our common stock. Our estimate of expected volatility for stock options granted prior to 2006 is based upon the historical volatility of comparable companies. Our estimate of expected term is based upon our historical stock option exercise experience.

Based on our stock option and restricted stock grants outstanding at December 31, 2007, we estimate remaining unrecognized share-based compensation expense to be approximately $41.1 million with a weighted average remaining amortization period of 3.3 years.

The total intrinsic value, which represents the difference between the underlying stock’s market price and the option’s exercise price, of options exercised during the years ended December 31, 2007, 2006 and 2005 was $31.2 million, $19.4 million and $11.8 million, respectively.

10. Employee Benefit Plan

We sponsor the Psychiatric Solutions, Inc. Retirement Savings Plan (the “Plan”). The Plan is a tax-qualified profit sharing plan with a cash or deferred arrangement whereby employees who have completed three months of service and are age 21 or older are eligible to participate. The Plan allows eligible employees to make contributions of 1% to 85% of their annual compensation, subject to annual limitations. The Plan enables us to make discretionary contributions into each participants’ account that fully vest over a four year period based upon years of service.

11. Contingencies and Health Care Regulation

Contingencies

We are subject to various claims and legal actions which arise in the ordinary course of business. We have professional liability insurance to protect against such claims or legal actions. We believe the ultimate resolution of such matters will be adequately covered by insurance and will not have a material adverse effect on our financial position or results of operations.

Employment Agreements

We entered into a new employment agreement with Joey A. Jacobs, our Chairman, President and Chief Executive Officer, on May 10, 2007. The employment agreement superseded Mr. Jacobs’ prior employment agreement with us. The employment agreement expires on December 31, 2008, but is subject to automatic annual renewals absent prior notice from either party of the intent not to renew the

F-24

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2007

employment agreement. Pursuant to the employment agreement, Mr. Jacobs’ base salary, cash bonuses and incentive compensation are subject to adjustment from time to time at the discretion of the Compensation Committee.

If we terminate Mr. Jacobs’ employment “without cause” or if Mr. Jacobs resigns as a result of a “constructive discharge,” as those terms are defined in the employment agreement: (a) Mr. Jacobs will receive a lump sum severance payment equal to two times the sum of (i) his base salary on the date of termination and (ii) the most recent annual bonus paid to Mr. Jacobs during the immediately previous 12-month period; (b) Mr. Jacobs will receive any earned but unpaid base salary, which shall be paid in accordance with our normal payroll practices; (c) Mr. Jacobs will receive bonus compensation payable on a prorated basis for the year of termination, which shall be paid at the same time our executive officers receive their bonuses for the year in which the termination occurred; (d) to the extent that Mr. Jacobs is eligible for and has elected continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985 (“COBRA”), we agreed to waive all premiums for elected continuation coverage during such COBRA period but not to exceed 18 months; (e) to the extent that Mr. Jacobs is covered by an individual health policy, we will pay all reasonable premiums under such policy for 24 months following the termination date; and (f) all shares of restricted stock and unvested stock options held by Mr. Jacobs and scheduled to vest during the succeeding 24-month period will immediately vest and any such options will remain exercisable for 12 months from the date of termination. Termination, whether voluntary or involuntary, of Mr. Jacobs’ employment within 12 months following a “change in control,” as defined in the employment agreement, shall be treated as a termination without cause.

If Mr. Jacobs’ employment terminates as a result of his disability or death, Mr. Jacobs or his beneficiaries will be entitled to receive any earned but unpaid base salary, which shall be paid in accordance with the normal payroll practices of the Company. In addition, Mr. Jacobs or his beneficiaries will also receive any bonus compensation, which is payable on a prorated basis for the year of termination, and which shall be paid at the same time our executive officers receive their bonuses for the year in which the termination occurred. Finally, all shares of restricted stock and unvested stock options held by Mr. Jacobs will immediately vest upon his death or termination for disability.

If Mr. Jacobs’ employment is terminated for cause, as defined in the employment agreement, or he resigns other than pursuant to a triggering event described above, any earned but unpaid base salary shall be paid in accordance with our normal payroll practices, but we will not make any other payments or provide any benefits to Mr. Jacobs.

Current Operations

Final determination of amounts earned under prospective payment and cost-reimbursement arrangements is subject to review by appropriate governmental authorities or their agents. We believe adequate provision has been made for any adjustments that may result from such reviews.

Laws and regulations governing the Medicare and Medicaid programs are complex and subject to interpretation. We believe that we are in substantial compliance with all applicable laws and regulations and are not aware of any material pending or threatened investigations involving allegations of potential wrongdoing. While no material regulatory inquiries have been made, compliance with such laws and regulations can be subject to future government review and interpretation as well as significant regulatory action including fines, penalties, and exclusion from the Medicare and Medicaid programs.

We have acquired and may continue to acquire corporations and other entities with prior operating histories. Acquired entities may have unknown or contingent liabilities for failure to comply with health care laws and regulations, such as billing and reimbursement, fraud and abuse and similar anti-referral laws. Although we attempt to assure ourselves that no such liabilities exist and obtain indemnification from prospective sellers covering such matters, there can be no assurance that any such matter will be covered by indemnification or, if covered, that the liability sustained will not exceed contractual limits or the financial capacity of the indemnifying party.

12. Related Party Transactions

William M. Petrie, M.D., a member of our Board of Directors, serves as President of Psychiatric Consultants, P.C. (“PCPC”), a practice group managed by us, and owns a 14% interest in PCPC. The initial term of the management agreement was for three years. It was most recently renewed for an additional three year term on April 11, 2006. The management agreement will continue to automatically renew for three year terms unless terminated by either party. Our management fee was for the years ended December 31, 2007, 2006 and 2005 was $0.1 million. At December 31, 2007 and 2006, PCPC owed us $0.1 million.

F-25

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2007

13. Disclosures About Reportable Segments

In accordance with the criteria of SFAS No. 131, Disclosures About Segments of an Enterprise and Related Information (“SFAS 131”), owned and leased facilities is our only reportable segment. Each of our inpatient facilities qualifies as an operating segment under SFAS 131; however, none is individually material. We have aggregated our inpatient facilities into one reportable segment based on the characteristics of the services provided. As of December 31, 2007, the owned and leased facilities segment provides mental health and behavioral heath services to patients in its 81 owned and 9 leased inpatient facilities in 31 states, Puerto Rico and the U.S. Virgin Islands. The column entitled “Other” in the schedules below includes management contracts to provide inpatient psychiatric management and development services to inpatient behavioral health units in hospitals and clinics, employee assistance programs and a managed care plan in Puerto Rico. The operations included in the “Other” column do not qualify as reportable segments under SFAS 131. Activities classified as “Corporate” in the following schedules relate primarily to unallocated home office items and discontinued operations.

Adjusted EBITDA is a non-GAAP financial measure and is defined as net income (loss) before discontinued operations, interest expense (net of interest income), income taxes, depreciation, amortization, stock compensation and other items included in the caption labeled “Other expenses.” These other expenses may occur in future periods, but the amounts recognized can vary significantly from period to period and do not directly relate to ongoing operations of our health care facilities. Our management relies on adjusted EBITDA as the primary measure to review and assess the operating performance of our inpatient facilities and their management teams. We believe it is useful to investors to provide disclosures of our operating results on the same basis as that used by management. Management and investors also review adjusted EBITDA to evaluate our overall performance and to compare our current operating results with corresponding periods and with other companies in the health care industry. You should not consider adjusted EBITDA in isolation or as a substitute for net income, operating cash flows or other cash flow statement data determined in accordance with U. S. generally accepted accounting principles. Because adjusted EBITDA is not a measure of financial performance under U. S. generally accepted accounting principles and is susceptible to varying calculations, it may not be comparable to similarly titled measures of other companies. The following is a financial summary by reportable segment for the periods indicated (dollars in thousands):

Year Ended December 31, 2007


	Owned and
	Leased
	Facilities		Other		Corporate			Consolidated
Revenue	$	1,357,827	$	124,125	$	—		$	1,481,952

Adjusted EBITDA	$	272,782	$	21,850	$	(38,632	)	$	256,000
Interest expense, net		30,470		513		44,117			75,100
Provision for income taxes		—		—		47,779			47,779
Depreciation and amortization		27,094		2,526		1,460			31,080
Inter-segment expenses		56,032		4,914		(60,946	)		—
Other expenses:
Share-based compensation		—		—		16,104			16,104
Loss on refinancing long-term debt		—		—		8,179			8,179

Total other expenses		—		—		24,283			24,283

Income (loss) from continuing operations	$	159,186	$	13,897	$	(95,325	)	$	77,758

Total assets	$	1,862,117	$	210,645	$	106,761		$	2,179,523

Capital expenditures	$	50,431	$	159	$	22,632		$	73,222

Cost in excess of net assets acquired	$	922,353	$	151,230	$	—		$	1,073,583

F-26

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2007

Year Ended December 31, 2006


	Owned and
	Leased
	Facilities		Other			Corporate			Consolidated
Revenue	$	976,324	$	46,104		$	—		$	1,022,428

Adjusted EBITDA	$	193,790	$	8,074		$	(28,569	)	$	173,295
Interest expense, net		13,429		(1	)		26,879			40,307
Provision for income taxes		—		—			37,754			37,754
Depreciation and amortization		18,538		677			1,260			20,475
Inter-segment expenses		28,834		1,668			(30,502	)		—
Other expenses:
Share-based compensation		—		—			12,535			12,535

Total other expenses		—		—			12,535			12,535

Income (loss) from continuing operations	$	132,989	$	5,730		$	(76,495	)	$	62,224

Total assets	$	1,454,466	$	48,003		$	78,453		$	1,580,922

Capital expenditures	$	28,858	$	69		$	4,889		$	33,816

Cost in excess of net assets acquired	$	730,237	$	30,031		$	—		$	760,268

Year Ended December 31, 2005


	Owned and
	Leased
	Facilities		Other		Corporate			Consolidated
Revenue	$	669,579	$	45,745	$	—		$	715,324

Adjusted EBITDA	$	121,803	$	9,202	$	(23,717	)	$	107,288
Interest expense, net		16,406		—		10,650			27,056
Provision for income taxes		2,142		—		14,663			16,805
Depreciation and amortization		13,334		654		750			14,738
Inter-segment expenses		25,963		2,672		(28,635	)		—
Other expenses:
Loss on refinancing long-term debt		—		—		21,871			21,871

Total other expenses		—		—		21,871			21,871

Income (loss) from continuing operations	$	63,958	$	5,876	$	(43,016	)	$	26,818

Total assets	$	1,019,037	$	27,595	$	128,399		$	1,175,031

Capital expenditures	$	17,592	$	52	$	4,106		$	21,750

Cost in excess of net assets acquired	$	506,160	$	20,376	$	—		$	526,536

14. Other Information

A summary of activity in allowance for doubtful accounts follows (in thousands):


	Balances		Additions		Additions		Accounts written		Balances
	at beginning		charged to costs		charged to		off, net of		at end
	of period		and expenses		other accounts (1)		recoveries		of period
Allowance for doubtful accounts:
Year ended December 31, 2005	$	10,662	$	13,498	$	5,844	$	14,649	$	15,355
Year ended December 31, 2006		15,355		19,530		12,023		28,236		18,672
Year ended December 31, 2007		18,672		27,554		12,982		23,621		35,587


(1)		Allowances as a result of acquisitions.

F-27

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2007

15. Quarterly Information (Unaudited)

Summarized results for each quarter in the years ended December 31, 2007 and 2006 are as follows (in thousands, except per share data):


	1^st Quarter		2^nd Quarter		3^rd Quarter		4^th Quarter		Total Year
2007
Revenue	$	322,438	$	354,126	$	402,021	$	403,367	$	1,481,952
Income from continuing operations	$	18,249	$	15,266	$	20,842	$	23,401	$	77,758
Net income	$	18,125	$	14,607	$	20,325	$	23,151	$	76,208

Earnings per share:
Basic	$	0.34	$	0.27	$	0.37	$	0.42	$	1.40
Diluted	$	0.33	$	0.26	$	0.37	$	0.42	$	1.37

2006
Revenue	$	241,601	$	247,237	$	253,696	$	279,894	$	1,022,428
Income from continuing operations	$	12,534	$	15,884	$	15,651	$	18,155	$	62,224
Net income	$	12,192	$	15,361	$	15,524	$	17,555	$	60,632

Earnings per share:
Basic	$	0.23	$	0.29	$	0.29	$	0.33	$	1.15
Diluted	$	0.23	$	0.28	$	0.29	$	0.32	$	1.12

As discussed in Note 4, we disposed of one inpatient behavioral health care facility in 2007, terminated three of our contracts to manage state-owned inpatient facilities during 2006 and sold a therapeutic boarding school during 2006. In accordance with SFAS 144, these operations, net of income tax, have been presented as discontinued operations and all prior quarterly data has been reclassified.

We incurred a loss on refinancing long-term debt of approximately $8.2 million in the second quarter of 2007.

16. Financial Information for the Company and Its Subsidiaries

We conduct substantially all of our business through our subsidiaries. Presented below is consolidated financial information for Psychiatric Solutions, Inc. and its subsidiaries as of December 31, 2007 and 2006, and for the years ended December 31, 2007, 2006 and 2005. The information segregates the parent company (Psychiatric Solutions, Inc.), the combined wholly-owned subsidiary guarantors, the combined non-guarantors, and eliminations. All of the subsidiary guarantees are both full and unconditional and joint and several.

F-28

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2007

Condensed Consolidating Balance Sheet
As of December 31, 2007
(Dollars in thousands)


				Combined							Total
				Subsidiary		Combined Non-		Consolidating			Consolidated
	Parent			Guarantors		Guarantors		Adjustments			Amounts
Current Assets:
Cash and cash equivalents	$	—		$	19,159	$	20,816	$	—		$	39,975
Accounts receivable, net		—			226,501		7,444		—			233,945
Prepaids and other		—			64,604		1,555		—			66,159

Total current assets		—			310,264		29,815		—			340,079
Property and equipment, net of accumulated depreciation		—			643,838		57,526		(7,346	)		694,018
Cost in excess of net assets acquired		—			1,073,583		—		—			1,073,583
Investment in subsidiaries		1,058,235			—				(1,058,235	)		—
Other assets		15,441			52,298		22,359		(18,255	)		71,843

Total assets	$	1,073,676		$	2,079,983	$	109,700	$	(1,083,836	)	$	2,179,523


Current Liabilities:
Accounts payable	$	—		$	30,335	$	1,059	$	—		$	31,394
Salaries and benefits payable		—			81,242		1,657		—			82,899
Other accrued liabilities		25,171			36,526		242		—			61,939
Current portion of long-term debt		5,619			—		397		—			6,016

Total current liabilities		30,790			148,103		3,355		—			182,248
Long-term debt, less current portion		1,132,735			—		33,273		—			1,166,008
Deferred tax liability		—			49,131		—		—			49,131
Other liabilities		2,659			10,912		31,096		(21,432	)		23,235

Total liabilities		1,166,184			208,146		67,724		(21,432	)		1,420,622
Minority Interest		—			—		—		4,159			4,159
Total stockholders’ (deficit) equity		(92,508	)		1,871,837		41,976		(1,066,563	)		754,742

Total liabilities and stockholders’ (deficit) equity	$	1,073,676		$	2,079,983	$	109,700	$	(1,083,836	)	$	2,179,523

Condensed Consolidating Balance Sheet
As of December 31, 2006
(Dollars in thousands)


				Combined							Total
				Subsidiary		Combined Non-		Consolidating			Consolidated
	Parent			Guarantors		Guarantors		Adjustments			Amounts
Current Assets:
Cash and cash equivalents	$	—		$	1,149	$	17,423	$	—		$	18,572
Accounts receivable, net		—			179,050		—		—			179,050
Prepaids and other		—			44,154		1,210		—			45,364

Total current assets		—			224,353		18,633		—			242,986
Property and equipment, net of accumulated depreciation		—			511,263		36,085		(7,590	)		539,758
Cost in excess of net assets acquired		—			760,268		—		—			760,268
Investment in subsidiaries		681,856			—		—		(681,856	)		—
Other assets		12,349			21,856		3,705		—			37,910

Total assets	$	694,205		$	1,517,740	$	58,423	$	(689,446	)	$	1,580,922


Current Liabilities:
Accounts payable	$	—		$	25,222	$	—	$	—		$	25,222
Salaries and benefits payable		—			66,236		—		—			66,236
Other accrued liabilities		13,247			32,461		1,737		(1,590	)		45,855
Current portion of long-term debt		2,084			—		302		—			2,386

Total current liabilities		15,331			123,919		2,039		(1,590	)		139,699
Long-term debt, less current portion		714,061			—		26,860		—			740,921
Deferred tax liability		—			44,924		—		—			44,924
Other liabilities		6,539			12,140		8,920		—			27,599

Total liabilities		735,931			180,983		37,819		(1,590	)		953,143
Total stockholders’ (deficit) equity		(41,726	)		1,336,757		20,604		(687,856	)		627,779

Total liabilities and stockholders’ (deficit) equity	$	694,205		$	1,517,740	$	58,423	$	(689,446	)	$	1,580,922

F-29

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2007

Condensed Consolidating Statement of Income
For the Year Ended December 31, 2007
(Dollars in thousands)


				Combined								Total
				Subsidiary			Combined Non-		Consolidating			Consolidated
	Parent			Guarantors			Guarantors		Adjustments			Amounts
Revenue	$	—		$	1,481,952		$	39,903	$	(39,903	)	$	1,481,952
Salaries, wages and employee benefits		—			809,577			15,068		—			824,645
Professional fees		—			142,666			4,855		—			147,521
Supplies		—			81,017			1,227		—			82,244
Rentals and leases		—			21,108			221		—			21,329
Other operating expenses		—			134,184			13,079		(8,500	)		138,763
Provision for doubtful accounts		—			26,890			664		—			27,554
Depreciation and amortization		—			29,430			1,893		(243	)		31,080
Interest expense		73,860			—			1,240		—			75,100
Loss on refinancing long-term debt		8,179			—			—		—			8,179

		82,039			1,244,872			38,247		(8,743	)		1,356,415
(Loss) income from continuing operations before income taxes		(82,039	)		237,080			1,656		(31,160	)		125,537
(Benefit from) provision for income taxes		(31,257	)		78,856			180		—			47,779

(Loss) income from continuing operations		(50,782	)		158,224			1,476		(31,160	)		77,758
Loss from discontinued operations, net of taxes		—			(1,550	)		—		—			(1,550	)

Net (loss) income	$	(50,782	)	$	156,674		$	1,476	$	(31,160	)	$	76,208

Condensed Consolidating Statement of Income
For the Year Ended December 31, 2006
(Dollars in thousands)


				Combined								Total
				Subsidiary			Combined Non-		Consolidating			Consolidated
	Parent			Guarantors			Guarantors		Adjustments			Amounts
Revenue	$	—		$	1,022,428		$	11,601	$	(11,601	)	$	1,022,428
Salaries, wages and employee benefits		—			577,237			—		—			577,237
Professional fees		—			96,093			1,023		—			97,116
Supplies		—			58,986			—		—			58,986
Rentals and leases		—			13,662			—		—			13,662
Other operating expenses		—			94,326			2,504		(1,693	)		95,137
Provision for doubtful accounts		—			19,530			—		—			19,530
Depreciation and amortization		—			19,629			1,089		(243	)		20,475
Interest expense		39,105			—			1,202		—			40,307

		39,105			879,463			5,818		(1,936	)		922,450
(Loss) income from continuing operations before income taxes		(39,105	)		142,965			5,783		(9,665	)		99,978
(Benefit from) provision for income taxes		(15,067	)		52,704			117		—			37,754

(Loss) income from continuing operations		(24,038	)		90,261			5,666		(9,665	)		62,224
(Loss) income from discontinued operations, net of taxes		—			(1,592	)		—		—			(1,592	)

Net (loss) income	$	(24,038	)	$	88,669		$	5,666	$	(9,665	)	$	60,632

F-30

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2007

Condensed Consolidating Statement of Income
For the Year Ended December 31, 2005
(Dollars in thousands)


				Combined							Total
				Subsidiary		Combined Non-		Consolidating			Consolidated
	Parent			Guarantors		Guarantors		Adjustments			Amounts
Revenue	$	—		$	715,324	$	11,073	$	(11,073	)	$	715,324
Salaries, wages and employee benefits		—			392,309		—		—			392,309
Professional fees		—			72,703		474		—			73,177
Supplies		—			42,993		—		—			42,993
Rentals and leases		—			11,450		—		—			11,450
Other operating expenses		—			73,808		8,313		(7,512	)		74,609
Provision for doubtful accounts		—			13,498		—		—			13,498
Depreciation and amortization		—			14,005		976		(243	)		14,738
Interest expense		25,823			—		1,233		—			27,056
Loss on refinancing long-term debt		21,871			—		—		—			21,871

		47,694			620,766		10,996		(7,755	)		671,701
(Loss) income from continuing operations before income taxes		(47,694	)		94,558		77		(3,318	)		43,623
(Benefit from) provision for income taxes		(18,376	)		35,181		—		—			16,805

(Loss) income from continuing operations		(29,318	)		59,377		77		(3,318	)		26,818
Income from discontinued operations, net of taxes		—			336		—		—			336

Net (loss) income	$	(29,318	)	$	59,713	$	77	$	(3,318	)	$	27,154

F-31

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2007

Condensed Consolidating Statement of Cash Flows
For the Year Ended December 31, 2007
(Dollars in thousands)


				Combined									Total
				Subsidiary			Combined Non-			Consolidating			Consolidated
	Parent			Guarantors			Guarantors			Adjustments			Amounts
Operating activities:
Net (loss) income	$	(50,782	)	$	156,674		$	1,476		$	(31,160	)	$	76,208
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:
Depreciation and amortization		—			29,430			1,893			(243	)		31,080
Amortization of loan costs and bond premium		2,106			—			45			—			2,151
Share-based compensation		—			16,104			—			—			16,104
Loss on refinancing of long-term debt		8,179			—			—			—			8,179
Change in income tax assets and liabilities		—			8,639			—			—			8,639
Loss (income) from discontinued operations, net of taxes		—			1,550			—			—			1,550
Changes in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable		—			(11,303	)		578			—			(10,725	)
Prepaids and other current assets		—			3,798			377			—			4,175
Accounts payable		—			(7,069	)		(491	)		—			(7,560	)
Salaries and benefits payable		—			1,921			264			—			2,185
Accrued liabilities and other liabilities		(345	)		(7,400	)		1,426			—			(6,319	)

Net cash (used in) provided by continuing operating activities		(40,842	)		192,344			5,568			(31,403	)		125,667
Net cash (used in) provided by discontinued operating activities		—			(193	)		—			—			(193	)

Net cash (used in) provided by operating activities		(40,842	)		192,151			5,568			(31,403	)		125,474
Investing activities:
Cash paid for acquisitions, net of cash acquired		(462,820	)		—			—			—			(462,820	)
Capital purchases of leasehold improvements, equipment and software		—			(72,655	)		(567	)		—			(73,222	)
Other assets		—			(2,866	)		415			—			(2,451	)

Net cash used in continuing investing activities		(462,820	)		(75,521	)		(152	)		—			(538,493	)
Net Cash provided by discontinued investing activities		1,909			—			—			—			1,909

Net cash used in investing activities		(460,911	)		(75,521	)		(152	)		—			(536,584	)
Financing activities:
Net decrease in revolving credit facility, less acquisitions		(21,000	)		—									(21,000	)
Borrowings on long-term debt		481,875			—			—			—			481,875
Principal payments on long-term debt		(40,936	)		—			(345	)		—			(41,281	)
Net transfers to and from members		68,895			(98,620	)		(1,678	)		31,403			—
Payment of loan and issuance costs		(6,661	)		—			—			—			(6,661	)
Refinancing of long-term debt		(7,127	)		—			—			—			(7,127	)
Excess tax benefits from share-based payment arrangements		9,428			—			—			—			9,428
Proceeds from exercises of common stock options		17,279												17,279

Net cash provided by financing activities		501,753			(98,620	)		(2,023	)		31,403			432,513

Net increase in cash		—			18,010			3,393			—			21,403
Cash and cash equivalents at beginning of period		—			1,149			17,423			—			18,572

Cash and cash equivalents at end of period	$	—		$	19,159		$	20,816		$	—		$	39,975

F-32

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2007

Condensed Consolidating Statement of Cash Flows
For the Year Ended December 31, 2006
(Dollars in thousands)


				Combined									Total
				Subsidiary			Combined Non			Consolidating			Consolidated
	Parent			Guarantors			Guarantors			Adjustments			Amounts
Operating activities:
Net (loss) income	$	(24,038	)	$	88,669		$	5,666		$	(9,665	)	$	60,632
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:
Depreciation and amortization		—			19,629			1,089			(243	)		20,475
Amortization of loan costs		1,627			—			45			—			1,672
Stock based compensation		—			12,535			—			—			12,535
Change in income tax assets and liabilities		—			35,205			117			—			35,322
Loss (income) from discontinued operations, net of taxes		—			1,592			—			—			1,592
Changes in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable		—			(11,636	)		—			—			(11,636	)
Prepaids and other current assets		—			(9,922	)		1,210			—			(8,712	)
Accounts payable		—			240			—			—			240
Salaries and benefits payable		—			5,584			—			—			5,584
Accrued liabilities and other liabilities		(1,366	)		5,050			2,155			—			5,839

Net cash (used in) provided by continuing operating activities		(23,777	)		146,946			10,282			(9,908	)		123,543
Net cash provided by discontinued operating activities		—			195			—			—			195

Net cash (used in) provided by operating activities		(23,777	)		147,141			10,282			(9,908	)		123,738
Investing activities:
Cash paid for acquisitions, net of cash acquired		(385,078	)		—			—			—			(385,078	)
Capital purchases of leasehold improvements, equipment and software		—			(33,816	)		—			—			(33,816	)
Other assets		—			(611	)		17			—			(594	)

Net cash (used in) provided by investing activities		(385,078	)		(34,427	)		17			—			(419,488	)
Financing activities:
Net increase in revolving credit facility		101,000			—			—			—			101,000
Borrowings on long-term debt		150,000			—			—			—			150,000
Principal payments on long-term debt		(187	)		—			(278	)		—			(465	)
Net transfers to and from members		153,309			(160,034	)		(3,183	)		9,908			—
Payment of loan and issuance costs		(1,576	)		—			—			—			(1,576	)
Excess tax benefits from share-based payment arrangements		—			4,354			—			—			4,354
Proceeds from exercises of common stock options		6,309			—			—			—			6,309

Net cash provided by (used in) financing activities		408,855			(155,680	)		(3,461	)		9,908			259,622

Net (decrease) increase in cash		—			(42,966	)		6,838			—			(36,128	)
Cash and cash equivalents at beginning of year		—			44,115			10,585			—			54,700

Cash and cash equivalents at end of year	$	—		$	1,149		$	17,423		$	—		$	18,572

F-33

PSYCHIATRIC SOLUTIONS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2007

Condensed Consolidating Statement of Cash Flows
For the Year Ended December 31, 2005
(Dollars in thousands)


				Combined									Total
				Subsidiary			Combined Non-			Consolidating			Consolidated
	Parent			Guarantors			Guarantors			Adjustments			Amounts
Operating activities:
Net (loss) income	$	(29,318	)	$	59,713		$	77		$	(3,318	)	$	27,154
Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities:
Depreciation and amortization		—			14,005			976			(243	)		14,738
Amortization of loan costs		1,140			—			47			—			1,187
Loss on refinancing long-term debt		21,871			—			—			—			21,871
Change in income tax assets and liabilities		—			9,494			—			—			9,494
Income from discontinued operations		—			(336	)		—			—			(336	)
Changes in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable		—			(9,399	)		—			—			(9,399	)
Prepaids and other current assets		—			(4,647	)		974			—			(3,673	)
Accounts payable		—			2,116			—			—			2,116
Salaries and benefits payable		—			2,598			—			—			2,598
Accrued liabilities and other liabilities		10,965			(4,519	)		6,894			—			13,340
Other		—			463			—			—			463

Net cash provided by (used in) continuing operating activities		4,658			69,488			8,968			(3,561	)		79,553
Net cash provided by discontinued operating activities		—			222			—			—			222

Net cash provided by (used in) operating activities		4,658			69,710			8,968			(3,561	)		79,775
Investing activities:
Cash paid for acquisitions, net of cash acquired		(514,525	)		—			—			—			(514,525	)
Capital purchases of property and equipment		—			(21,750	)		—			—			(21,750	)
Purchases of short-term investments		(29,400	)		—			—			—			(29,400	)
Sales of short-term investments		29,400			—			—			—			29,400
Cash paid for investments in equity method investees		—			(1,340	)		—			—			(1,340	)
Other assets		—			1,115			104			—			1,219

Net cash (used in) provided by investing activities		(514,525	)		(21,975	)		104			—			(536,396	)
Financing activities:
Borrowings on long-term debt		545,000			—			—			—			545,000
Principal payments on long-term debt		(236,587	)		—			(235	)		—			(236,822	)
Net transfers to and from members		31,762			(34,608	)		(715	)		3,561			—
Payment of loan and issuance costs		(13,932	)		—			—			—			(13,932	)
Refinancing of long-term debt		(15,398	)		—			—			—			(15,398	)
Proceeds from public offering of common stock		192,637			—			—			—			192,637
Proceeds from exercises of common stock options		6,385			—			—			—			6,385

Net cash provided by (used in) financing activities		509,867			(34,608	)		(950	)		3,561			477,870

Net increase in cash		—			13,127			8,122			—			21,249
Cash and cash equivalents at beginning of year		—			30,988			2,463			—			33,451

Cash and cash equivalents at end of year	$	—		$	44,115		$	10,585		$	—		$	54,700

F-34

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.



		Psychiatric Solutions, Inc.

		By:		/s/ Joey A. Jacobs

				Joey A. Jacobs
				Chief Executive Officer

Dated: February 26, 2008

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.


Signature	Title	Date

/s/ Joey A. Jacobs	Chairman of the Board, President	February 26, 2008
Joey A. Jacobs	and Chief Executive Officer
	(Principal Executive Officer)

/s/ Jack E. Polson	Executive Vice President, Chief	February 26, 2008
Jack E. Polson	Accounting Officer (Principal Financial
	and Accounting Officer)

/s/ Mark P. Clein	Director	February 26, 2008
Mark P. Clein

/s/ David M. Dill	Director	February 26, 2008
David M. Dill
/s/ Richard D. Gore	Director	February 26, 2008
Richard D. Gore

/s/ Christopher Grant, Jr.	Director	February 26, 2008
Christopher Grant, Jr.

/s/ William M. Petrie, M.D.	Director	February 26, 2008
William M. Petrie, M.D.

/s/ Edward K. Wissing	Director	February 26, 2008
Edward K. Wissing


	PAGE
PART I
Item 1. Business		1
Item 1A. Risk Factors		13
Item 1B. Unresolved Staff Comments		19
Item 2. Properties		19
Item 3. Legal Proceedings		20
Item 4. Submission of Matters to a Vote of Security Holders		21
PART II
Item 5. Market For Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities		21
Item 6. Selected Financial Data		21
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations		22
Item 7A. Quantitative and Qualitative Disclosures About Market Risk		30
Item 8. Financial Statements and Supplementary Data		30
Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure		31
Item 9A. Controls and Procedures		31
Item 9B. Other Information		31
PART III
Item 10. Directors, Executive Officers and Corporate Governance		31
Item 11. Executive Compensation		32
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters		32
Item 13. Certain Relationships and Related Transactions, and Director Independence		32
Item 14. Principal Accountant Fees and Services		32
PART IV
Item 15. Exhibits and Financial Statement Schedules		33
Index to Financial Statements		F-1
Signatures
Ex-21.1 List of Subsidiaries
Ex-23.1 Consent of Ernst & Young LLP
Ex-31.1 Section 302 Certification of the CEO
Ex-31.2 Section 302 Certification of the CAO
Ex-32.1 Section 906 Certification of the CEO and CAO
Ex-21.1 List of Subsidiaries
Ex-23.1 Consent of Ernst & Young LLP
Ex-31.1 Section 302 Certification of the CEO
Ex-31.2 Section 302 Certification of the CFO
Ex-32.1 Section 906 Certification of the CEO & CFO


		State of
Name		Organization
ABS—First Step, Inc.		Virginia
ABS LINCS DC, LLC		Virginia
ABS LINCS KY, Inc.		Virginia
ABS LINCS, LLC		Virginia
ABS LINCS NJ, Inc.		Virginia
ABS LINCS PA, Inc.		Virginia
ABS LINCS SC, Inc.		South Carolina
ABS LINCS TN, Inc.		Virginia
ABS LINCS TX, Inc.		Kentucky
ABS LINCS VA, Inc.		Virginia
Alliance Crossings, LLC		Delaware
Alliance Health Center, Inc.		Mississippi
Alternative Behavioral Services, Inc.		Virginia
Atlantic Shores Hospital, LLC		Delaware
Behavioral Educational Services, Inc.		Delaware
Behavioral Healthcare LLC		Delaware
Benchmark Behavioral Health System, Inc.		Utah
BHC Alhambra Hospital, Inc.		Tennessee
BHC Belmont Pines Hospital, Inc.		Tennessee
BHC Cedar Vista Hospital, Inc.		California
BHC Fairfax Hospital, Inc.		Tennessee
BHC Fort Lauderdale Hospital, Inc.		Tennessee
BHC Fox Run Hospital, Inc.		Tennessee
BHC Fremont Hospital, Inc.		Tennessee
BHC Health Services of Nevada, Inc.		Nevada
BHC Heritage Oaks Hospital, Inc.		Tennessee
BHC Holdings, Inc.		Delaware
BHC Intermountain Hospital, Inc.		Tennessee
BHC Management Services of Louisiana, LLC		Delaware
BHC Management Services of New Mexico, LLC		Delaware
BHC Management Services of Streamwood, LLC		Delaware
BHC Mesilla Valley Hospital, LLC		Delaware
BHC Montevista Hospital, Inc.		Nevada
BHC Newco 4, LLC		Delaware
BHC Newco 5, LLC		Delaware
BHC Newco 6, LLC		Delaware
BHC Newco 7, LLC		Delaware
BHC Newco 8, LLC		Delaware
BHC Newco 9, LLC		Delaware
BHC Newco 10, LLC		Delaware
BHC Northwest Psychiatric Hospital, LLC		Delaware
BHC of Indiana General Partnership		N/A
BHC Pinnacle Pointe Hospital, Inc.		Tennessee
BHC Properties, LLC		Tennessee
BHC Sierra Vista Hospital, Inc.		Tennessee
BHC Spirit of St. Louis Hospital, Inc.		Tennessee
BHC Streamwood Hospital, Inc.		Tennessee
BHC Windsor Hospital, Inc.		Ohio

	(i)		Registration Statement (Form S-8, No. 333-100635) pertaining to the Psychiatric Solutions, Inc. 1997 Incentive and Nonqualified Stock Option Plan for Key Personnel of Psychiatric Solutions, Inc.;

	(ii)		Registration Statement (Form S-8, No. 333-94983) pertaining to the 1997 Equity Incentive Plan of PMR Corporation;

	(iii)		Registration Statement (Form S-8, No. 333-38419) pertaining to the 1997 Equity Incentive Plan, 1995 Warrant Grant and the 1996 Stock Option Grants of PMR Corporation;

	(iv)		Registration Statement (Form S-8, No. 333-118529) pertaining to the Amended and Restated Psychiatric Solutions, Inc. Equity Incentive Plan and the Amended and Restated Outside Directors’ Non-Qualified Stock Option Plan;

	(v)		Registration Statement (Form S-3, No. 333-139013) of Psychiatric Solutions, Inc.;

	(vi)		Registration Statement (Form S-8, No. 333-128047) pertaining to the Amended and Restated Psychiatric Solutions, Inc. Equity Incentive Plan; and

	(vii)		Registration Statement (Form S-8, No. 333-136339) pertaining to the Amended and Restated Psychiatric Solutions, Inc. Equity Incentive Plan;



Date: February 28, 2008	/s/ Joey A. Jacobs
	Joey A. Jacobs
	Chairman, Chief Executive Officer and President